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     Abstract 
Abstract 
 
In recent years there has been a dramatic increase in the number of 
nanomaterials being developed, thus increasing the need for hazard assessment 
methods beyond the capacity of toxicological screening methods using animals. 
Current in vitro assays have a number of shortcomings, which were addressed in 
this thesis. These include: (i) high dependence on immortalized cell lines, (ii) 
inaccurate dosimetry descriptors, (iii) poor robustness of assay systems, and (iv) 
hyperoxic culture conditions. A method for harvesting viable human nasal 
epithelial cells using a washout technique was developed to provide squamous 
epithelial cells for use in culture assays. However, poor proliferation of these cells 
in vitro limited their use in toxicological assays. A particokinetic model was 
developed to relate the ‘delivered dose’, i.e. the number of nanoparticles reaching 
immortalized airway cell layers by gravitational force and diffusional 
mechanisms, to toxicological endpoints measured in vitro. This model was 
applied to a panel of rigorously characterized nanoparticles (CuO, TiO2, 
polystyrene and in-house manufactured lipid nanocapsules) and the results 
provided compelling evidence that the delivered dose is a more appropriate dose 
descriptor for cell-based toxicity assays than the widely used nominal dose, as it 
reflects the number of particles (or their equivalent surface area) available to 
interact with the cell layer over a given exposure time. The results were confirmed 
in two airway epithelial cell lines RPMI 2650 and A549 after 6 and 24 h using 
two standard toxicological end-points. However, when cells were cultured in 
normoxic (for the respiratory tract) oxygen concentration, 13%, as opposed to the 
standard culture conditions of 21% they were found to be more responsive to 
nanoparticle exposure in terms of both production of reactive oxygen species and 
reduced cell viability. This suggests that standard incubation conditions of 21% 
oxygen provide a baseline of oxidative stress within a cell culture system that 
induces adaptive mechanisms and reduces their sensitivity to materials that exert 
adverse effects through oxidative stress. 
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Chapter 1                               
Introduction 
 
1.1  Nanotechnology: Reality and Future 
“There’s plenty of room at the bottom” – stated Richard Feyman (1) in his 
grand vision presented in a lecture at Caltech in 1959. From modern day iPods and 
cars, there have already been revolutionary advances in the field of nanotechnology 
such as the development of low cost water purifier using silver nanoparticles by Tata 
Swach
®
 (2). Nanotechnologies incorporate materials composed of particles that have 
by definition at least one dimension in a size range between one and one hundred 
nanometers (3). The promise of nanotechnology lies in the development of new 
materials with unique properties and unique capabilities. The successful development 
of nanomedicines such as Doxil® (doxorubicin-encapsulated stealth liposomes), 
Abraxane® (paclitaxel-encapsulated albumin nanoparticles; Abraxis BioScience Ltd.), and 
Elan’s NanoCrystal technology (Rapamune®, Emend®, TriCor®, Megace®ES and 
Invega®Sustenna™) provides examples of products at the forefront of a projected 
nanomedicine boom (4). According to one estimate, global research and development 
investment in nanotechnologies exceeded $18 billion in 2008 and the value of 
products utilizing nanotechnologies has been projected to exceed $3 trillion by 2015 
(Lux Research 2009) (5). Nanomaterials are already incorporated into a wide variety 
of industrial products and processes, such as semiconductors, electronics, catalysts, 
sunscreens, food, clothing, cosmetics, medicines etc. According to the 
Nanotechnology Consumer Products Inventory, more than 600 self-claimed 
nanotechnology products are currently being produced by 322 companies in 20 
countries (6).  
 
1.2 Nanotoxicology: A New Discipline 
The diversity and increasing number of applications of manufactured and 
engineered nanomaterials carries with it a potential for human exposure to 
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nanomaterials. Unintentional exposure to engineered nanomaterials may take the form 
of emissions into air from transport vehicles, power plants, occupational settings and 
consumer goods and the primary exposure routes are via inhalation and dermal 
exposure (7). Intentional exposure can also occur when nanomaterials are used in 
medical applications (major exposure routes include parenteral, dermal, oral and 
pulmonary) as well as in food additives (ingestion).  
Historically, the most extensive and well-documented research on the health 
impacts of nanoparticle exposure have come from the mining industry and air 
pollution research. In both fields, a significant body of evidence has been accumulated 
showing that the inhalation of nanoparticles, regardless of whether they are derived 
from aerosolised dusts or emissions from combustion processes, can lead not only to a 
wide variety of progressive lung diseases, such as silicosis or asbestosis (8), but also 
are implicated in cardiovascular effects (9-11) and increases in population morbidity 
and mortality rates (12, 13). The evidence that inhalation exposure to nanoparticles 
can have a negative impact on human health has prompted research into the health 
impacts of other types of nanomaterials, especially those engineered for specific 
purposes, such as incorporation in consumer products. Exposure scenarios to 
engineered nanomaterials will differ greatly and will depend upon the production 
method, nanomaterial composition, bulk material composition, product use and 
lifecycle. Therefore, currently exposure is to likely be restricted to the workplace, 
particularly research laboratories; start-up companies; pilot production facilities; and 
operations where engineered nanomaterials are processed, used, disposed, or recycled 
(14). However, as the number of products containing nanomaterials increases, it is 
important to understand how human exposure to engineered nanomaterials may occur 
and what the possible health impacts may be. 
Over the past 20 years, concerns about the safety of engineered NP have been 
further expressed by scientists and governmental organizations (3, 15-18). As research 
began to focus on the potential risk associated with NP, the term ‘nanotoxicology’ 
was formalized in an editorial in Occupational and Environmental Medicine by 
Donaldson et al. (19) –  
 
“NP [nanoparticles] have greater potential to travel through the 
organism than other materials or larger particles. The various 
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interactions of NP with fluids, cells, and tissues need to be considered, 
starting at the portal of entry and then via a range of possible pathways 
towards target organs. The potential for significant biological response 
at each of these sites requires investigation. In addition, at the site of 
final retention in the target organ(s), NP may trigger mediators which 
then may activate inflammatory or immunological responses. 
Importantly, NP may also enter the blood or the central nervous system, 
where they have the potential to directly affect cardiac and cerebral 
functions. We therefore propose that a new subcategory of toxicology—
namely nanotoxicology—be defined to address gaps in knowledge and to 
specifically address the special problems likely to be caused by 
nanoparticles.”  
 
Due to the significant detrimental impacts of certain types of inhaled 
nanomaterials (e.g. silicosis and development of lung cancer or increased adverse 
health effects after exposure to air pollution (8, 12, 13, 20)), the inhalation route of 
nanoparticle exposure has been of greatest concern and the most widely studied. Thus, 
new engineered nanomaterials are now in most cases evaluated for their impact on the 
respiratory tract in addition to other relevant exposure routes. The effect of 
nanoparticles on the respiratory tract is measured both at a whole organism level (e.g. 
in vivo studies) and at a cellular level (e.g. in vitro studies). The following sections 
will provide a more detailed account of evidence of respiratory toxicity after 
pulmonary exposure to nanomaterials both in vivo and in vitro, thus also introducing 
the most common methodologies used in nanotoxicology research (Section 1.3). This 
will be followed by a detailed description of the primary mechanisms of nanotoxicity 
in the respiratory tract, as identified to date (Section 1.4). Finally, a perspective on the 
challenges of future nanomaterial safety testing will be given in light of the increasing 
number of nanomaterials being generated for a larger number of applications. This 
will incorporate a discussion on the potential for developing in vitro nanotoxicity 
assays which are predictive of in vivo nanotoxicity outcomes. The current state-of-the-
art in in vitro nanotoxicity will be presented along with a number of recognised flaws 
in these systems (Section 1.5). The overall aim of this thesis has been to investigate 
identified flaws in in vitro nanotoxicity testing and provide recommendations for 
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assay improvement which will enhance the usefulness of such assays for future 
implementation in routine nanomaterial safety testing (Section 1.6). 
  
1.3 How do inhaled nanoparticles result in lung toxicity? 
When NPs deposit in the respiratory tract, the site of deposition and the nature 
of the NPs will determine both the fate of the particles and the response of the lung. 
Particles deposited in the upper airways are cleared by the mucociliary escalator, 
which is an efficient system and has been suggested to be valid for NPs (21). Kreyling 
et al. (21) studied the translocation of ultrafine (15 and 80 nm) insoluble iridium 
particles from the lung. The authors observed that both particles were cleared 
predominantly from the peripheral lung via thoracic airways to the larynx into the GI 
tract and feces one day after inhalation. The authors noted that iridium particle 
translocation to liver or spleen was minimal. However, in another study by 
Oberdorster et al. (22) significant amounts of ultrafine carbon particles (25 nm) were 
found to have translocated to the liver after whole body exposure of rats. Therefore, 
one cannot exclude adverse health effects in secondary target tissues that are not 
evolved to deal with particles compared to tissues of the respiratory tract. When 
particles enter the deep lung, the clearance is facilitated primarily by alveolar 
macrophage (AM) phagocytosis and to a lesser extent by epithelial cell uptake. 
Successful particle phagocytosis by AM has been linked to chemotactic attraction of 
AM to the site of particle deposition (23). This is followed by a gradual movement of 
the macrophages with internalized particles toward the mucociliary escalator.  
Experimental data indicates that there is significant size dependent effect on 
this clearance mechanism. For example, in several studies rats were exposed to 
different sized iridium particles of 15-20 nm, 80 nm and polystyrene particles of 
0.5 µm, 3 µm and 10 µm (24-27). Twenty four hours later the lungs were repeatedly 
lavaged and it was observed that approximately 80% of the 0.5-, 3- and 10- µm 
particles were retrieved within the macrophages where as only 20% of nanosized 15–
20-nm and 80-nm particles could be recovered from the cellular component of the 
lavage. In effect, approximately 80% of the NP <100 nm were retained in the lung 
after exhaustive lavage. This may indicate that the nanoparticles were not 
phagocytised by macrophages and entered the epithelial cells or had translocated to 
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the interstitium (28). It is thought that, due to the inefficiency of macrophage 
clearance, NP< 100nm in diameter may accumulate in the lung after deposition, 
leading to inflammation and eventually fibrotic changes (29).  
In the study by Ferrin et al. (30) rats were exposed, via inhalation, to both NP 
(21 nm diameter) and fine (250 nm diameter) TiO2 particles, as well as intratracheally 
instilled with TiO2 particles of various sizes (12, 21, 230 and 250 nm in diameter) 
over a period of 12 weeks. Examination of the effects of treatment with each particle 
size was then performed over a 70-week post-exposure period. It was demonstrated 
that TiO2 NPs promoted an acute inflammatory response following both intratracheal 
instillation and sub-chronic inhalation techniques compared to the larger particles 
(230 and 250 nm). The inflammation observed in exposure animals was subsequently 
found to reduce to control levels post-exposure (64 weeks), with a noted decrease 
(from peak levels) in the number of neutrophils present in the lung at this time. NPs 
were also found to remain within the lung longer (501 days) than fine particles 
(174 days). The prolonged retention of TiO2 NPs in the lung was suggested to be an 
effect of the finding that at equivalent masses, NPs were able to translocate to the 
pulmonary interstitium more efficiently than the larger TiO2 particles. It was 
suggested that the translocation of NPs to the interstitium was due to the smaller 
particles (12 and 21 nm) not being taken up by alveolar macrophages and undergoing 
clearance from the alveoli via uptake by alveolar type-1 epithelial cells instead. In 
addition to this, it was found that an increased dose (increased number of particles and 
decreased particle size) promoted movement of particles within the pulmonary 
system. It was also observed that the number of particles present, particle size, 
delivered dose and the delivered dose rate also had an effect on the translocation 
process. The authors concluded that the observed inflammation was due to rat lung 
exposure to NPs, impaired lung clearance and NP redistribution.  
In a subsequent publication, these findings were supported by Oberdorster et 
al. (25) who showed increased levels of inflammation to be present in the alveolar 
space of rats after instillation with 500 μg TiO2 NPs (20 nm) over 24 h, compared to 
TiO2 fine particles (250 nm) at the same mass dose. The author further suggested that 
the increased inflammatory response to acute NP exposure could not be explained 
fully by the movement of particles to the interstitium but could be related to the larger 
surface area of the particles and their interaction with alveolar macrophages and 
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interstitial cells. These two studies challenged the long held assumption that response 
to particulate exposure could be understood in terms of chemical composition and 
suggested unusual biological activity associated with NPs. The two studies prompted 
increased interest into the effects of NPs on the lung, as well as the possible health 
effects that exposure to NPs might pose to respiratory system. 
Further studies have demonstrated that inspiration of nanoparticles could 
cause acute inflammation, progressive fibrosis, granulomas and functional respiratory 
deficiencies. A study by Hamilton et al. (31) of carbon nanoparticles exposure 
through intranasal route in BALB/c murine model showed that nanoparticles 
significantly exacerbated airway hyperresponsiveness as measured by the whole body 
plethysmography and caused an influx of macrophages in the lungs measured by lung 
lavage differential cell count. In vitro assays on the alveolar macrophages isolated 
from the mice gave evidence of nanoparticle presence in the plasma membranes of the 
cells as seen in the transmission electron microscopy images and altered the alveolar 
macrophage cellular function of antigen presentation, as well as subsequent cytokine 
production in response to the antigen. It is theoretically possible that long term 
exposure to engineered nanoparticles may cause serious damage to humans as well as 
animals.  
A recent report on the clinical toxicity in humans due to long term exposure to 
nanoparticles has been reported by Song et al. (32). Seven patients working in the 
same department of a printing plant were admitted to a hospital in Beijing, China. The 
patients presented the symptoms of shortness of breath, pleural effusion and 
pericardial effusion. At the hospital the patients underwent a variety of procedures 
including drainage of pleural effusions, bronshoscopic examinations with BAL, 
transbronchial lung biopsy, transmission electron microscopy of the pleura, pleural 
fluid and lung tissue. The analysis of the particles collected from the workplace using 
electron microscopy showed that the particles were ~ 30 nm in diameter. Examination 
of BAL fluid showed decreased macrophages, increased lymphocytes, and elevated 
neutrophils in 5 of the 7 patients. Lung biopsies in all the patients showed swollen and 
widened alveolar septums, pulmonary fibrosis and aggregation of phagocytes and 
inflammatroy cells. TEM imaging of the lung tissue showed nanoparticles to be 
lodged in the cytoplasm and caryoplasm of the pulmonary epithelial cells. Thus this 
study raises concern that exposure to some nanoparticles may be related to damage of 
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human lungs. The possible pathways for clearance of insoluble particles deposited in 
the pulmonary region are illustrated in Figure 1-1. 
 
 
Figure 1-1: Clearance pathways for insoluble particles deposited in the pulmonary region (33).  
 
The reduction in particle size and increase in specific surface area that 
accompanies formation of nanoparticles (NP), gives the NP quite different 
physicochemical properties as compared to the bulk material of identical chemical 
composition such as surface reactivity, improved solubility etc. This emergence of 
unique properties at nanoscale can be illustrated by taking the example of water as in 
Table 1-1. If 1 kg of water were in particles of 1 nm, 1 µm or 1 mm and the density of 
water at 25°C is 997 kg/m
3
 then the particle number, surface area and surface energy 
would change according to Table 1-1.  
 
Table 1-1: Changes in particle number, surface area and surface energy of water particles with 
change in diameter from 1 nm to 1 mm. 
Diameter 
Particle number  
(N) 
Total surface 
area Atotal= N x 
4πr2 (m2) 
Surface energy 
S = 0.072 x 
Atotal (J) 
1 nm 2 x 10
24
 6 x 10
6
 4 x 10
5
 
1 µm 2 x 10
15
 6 x 10
3
 4 x 10
2
 
1 mm 2 x10
6
 6 x 10
0
 4 x 10
-1
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In agreement with the collision theory in chemistry, a high collision probability 
of particles due to large number of particles would lead to high reactivity. Hence, it is 
understandable that the biological behavior of NPs become dramatically different to 
bulk material of identical chemical composition. 
 
1.4 Mechanisms of NP toxicity in the respiratory tract 
1.4.1 Generation of reactive oxygen species (ROS) 
1.4.1.1 Mechanisms by which NP may induce ROS production 
Reactive oxygen species (ROS) is a term used to describe a range of species 
including both oxygen radicals and non-radical derivatives of molecular oxygen. Free 
radicals and ROS are produced naturally within the body, for example during 
metabolism and by phagocytic cells for purposes of host defence (34). The enhanced 
surface reactivity of nanoparticles and their related ability to increase oxidative stress 
is one of the principal mechanisms hypothesized to drive both nanoparticle-induced 
inflammation and cellular damage (35-38). NP can react with molecular oxygen 
present in biological fluid either by energy transfer reactions such as those occurring 
under the influence of light in the presence of appropriate photosensitizers, or by 
electron transfer i.e. by reduction (39). NP may act as photosensitizers, causing the 
production of both singlet oxygen and superoxide from ground state molecular 
oxygen under the influence of light.  
It was demonstrated that irradiated (photoactivated) TiO2, a constituent of NP 
employed for dermatological and cosmetic purposes, could stimulate the formation of 
singlet oxygen and superoxide (40). Furthermore, it has been shown that the ability of 
NPs to trigger generation of reactive oxygen species (ROS) is greater than that of 
larger micron-sized particles in biological systems. In a study by Li et al. (41) coarse 
(2.5-10 µm), fine (< 2.5 µm), and ultrafine (< 0.1 µm) particulate matter were 
examined for the potential to induce oxidative stress in RAW 264.7 murine 
macrophage cell line and BEAS-2B transformed human bronchial epithelial cell line. 
The authors measured production of ROS by measurement of hemeoxygenase-1 and 
glutathione depletion in the cells. The results indicated that ultrafine particle was 
more potent in generation of ROS than fine or coarse particles. This size differential 
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with respect to ROS generation and toxicity may be explained by the significant 
increase in the surface area and therefore surface reactivity of the NPs with decreasing 



















Figure 1-2: Possible mechanisms by which nanomaterials interact with biological tissue. 
Examples illustrate the importance of material composition, electronic structure, bonded 
surface species (e.g., metal-containing), surface coatings (active or passive), and solubility, 
including the contribution of surface species and coatings and interactions with other 
environmental factors (e.g., UV activation). Image reproduced from Nel et al. (42). 
 
1.4.1.2 ROS production stimulates an inflammatory response and cell death 
A model for NP-induced oxidative stress has been proposed under which cells 
undergo a hierarchy of responses: Upregulation of antioxidant defences (Tier I), 
inflammation (Tier II) and cell death (Tier III) (Figure 1-3).   
Figure 1-3 illustrates a number of genes known to be up-regulated in these 
adaptive responses, under the regulation of Nrf2 and AP-1, including glutathione S- 
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transferase and heme oxygenase-1. Further oxidative stress causes a decrease in the 
cellular GSH/GSSH ratio leading to the transcription of genes under the regulation of 
NFκB to produce mediators such as pro-inflammatory cytokines and inducible nitric 
oxide (Tier II responses). Further oxidative stress leads to cell arrest and induction of 
cell death, either by apoptosis or necrosis (Tier III).   
 
 
Figure 1-3: Diagrammatic representation of the hierarchical response of cells to NP-induced 
oxidative stress at the air-lung interface. This diagram is modified from the model proposed by 
Nel et al. (38, 43), to include the influence of the antioxidant defences within the respiratory 
tract lining fluids which overlay the epithelium. In this modified model the initial defence 
against NP-induced oxidative stress resides within the respiratory tract lining fluid (RTLFs), 
initially characterised by acute early losses of ascorbate (AA), urate (UA) and glutathione 
(GSH). When these defences are overwhelmed the underlying cells employ adaptive strategies to 
deal with the oxidative stress (Tier I responses). The figure illustrates a number of genes known 
to be up-regulated in these adaptive responses. Image reproduced with permission from Dr. Ian 
Mudway. 
 
Tier I. The human body has a number of natural antioxidant defence systems 
to protect us against NP-derived ROS. Antioxidant enzymes include superoxide 
dismutases (SOD) (44), which are present in almost all aerobic cells and in 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 26 - 
Chapter 1- Introduction 
extracellular fluids, catalases which are localized to peroxisomes in most eukaryotic 
cells (45) and peroxiredoxins. These enzymes are responsible for the conversion of 
superoxide radical and hydrogen peroxide to water and oxygen (46) as shown in 
Figure 1-4. Under oxidative stress there is overexpression of the antioxidant enzymes 
mediated through Jun Kinase, AP-1 or NF-κB which attenuates the oxidative stress 
and helps in restoring the oxy-homeostasis (47). Further, small molecule antioxidants 
such as uric acid, ascorbic acid, vitamin E and glutathione help to remove ROS. 
However, when the amount of ROS generated overwhelms the body’s natural 




Figure 1-4: Activity of antioxidant enzymes under the presence of oxidative stress in the form of 
oxide radical. 
 
Glutathione is one of the most important antioxidants abundantly present in 
cells and biological fluids throughout the body. Glutathione is present as GSH in its 
reduced formed and this reacts with ROS to form oxidized glutathione, GSSG. The 
body rapidly converts GSSG back to GSH using NADPH (reduced nicotinamide 
adenine dinucleotide phosphate) as a reducing agent. The ratio of GSH/GSSG is often 
used as an indicator of oxidative stress. However, the GSSG concentration in reality is 
very low and difficult to detect. This problem is further complicated by the fact that 
cells will actively convert GSSG to GSH as a protective mechanism thereby 
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decreasing the ability to detect GSSG in vitro. It is therefore common to measure 
GSH nmol/mg protein to express oxidative stress.  
Other markers of oxidative stress include measurement of lipid peroxidase and 
levels of mRNA expression for oxidative stress dependent genes, such as heme 
oxygenase-1 (HO-1). The stratified response commences with HO-1 expression when 
the GSH/GSSG ratio is minimally disturbed, proceeds to Jun kinase activation at 
intermediary levels of oxidative stress, and culminates in cellular toxicity at high 
oxidative stress levels (41). The significance of Jun kinase (JNK) activation is the 
transcriptional activation of cytokine, chemokine, and adhesion receptor promoters. 
These products play a role in the proinflammatory effects of PM in the lung and 
possibly also the cardiovascular system (48). The JNK activation leads to induction of 
AP-1-dependent target genes involved in cell proliferation, cell death, inflammation, 
and DNA repair (49). Inflammation occurs via the induction of redox sensitive 
pathways such as the mitogen activated protein kinase (MAPK) cascade and the 
nuclear factor kappa –B (NFk-B) pathway (42). These pathways are thought to act in 
a synergistic manner to upregulate the expression of pro-inflammatory cytokines, 
chemokines and adhesion molecules which have all been shown to contribute to the 
induction of inflammation (50). Induction of cytotoxic pathways are thought to 
involve the programmed release of apoptotic mediators such as cytochrome C from 
the mitochondria (42). The continued oxidative stress leads to the transcription of 
genes under the regulation of NFκB to produce mediators such as pro-inflammatory 
cytokines and inducible nitric oxide. 
Tier II. Oxidation of cellular glutathione leads to activation of transcription 
factors, NFκB and activator protein-1 (AP-1), which leads to the production of pro-
inflammatory cytokines such as TNF-α, IL6 and IL-8 (51, 52). Study of oxidative 
effects on cultured macrophages has shown that the generation of ROS (37) leads to 
antioxidant depletion (37, 41), generation of pro and anti-inflammatory lipid 
mediators (53, 54) and expression of pro-inflammatory cytokines such as TNF-α (55), 
IL-6 and IL-8 (56). 
The role of oxidative stress in the control of the pro-inflammatory cytokine 
TNF-α was investigated by Brown et al. (57) in rat macrophages. The authors found 
that after exposure to ultrafine carbon black (14 nm) the macrophages showed a dose 
dependent increase of TNF-α where as for fine carbon black (260 nm) no such effect 
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was observed. The expression of TNF-α was inhibited by pre-treatment of cells with 5 
mM of the thiol antioxidant, Nacystelin, which indicated a role for ROS mediated 
mechanism in the activation of this cytokine. The authors also incubated peripheral 
human blood monocytes with the carbon black particles (14 nm) and found a 
significant increase (30%) in nuclear localisation of both the p5 and the p65 subunit of 
NFκ-B using a fluorescent staining technique. However, upon pre-incubation of 
monocytes with vitamin E analogue trolox and Nacystelin inhibition of nanoparticle 
induced nuclear translocation of NFκ-B was observed thus implicating ROS in the 
induction of NFκ-B.  
An example of NP-induced transcription factor activation was also provided 
by Xia et al., who conducted a series of experiments exposing RAW 264.7 mouse 
monocyte derived macrophages to ultrafine particles (UFP collected in the Los 
Angeles basin through the use of particle concentrator technology), carbon black 
(CB), titanium dioxide (TiO2), fullerol, polystyrene (PS), amine substituted 
polystyrene (PS-NH2) and carboxyl substituted polystyrene (PS-COOH) and then 
measured intracellular ROS generation, glutathione depletion, induction of HO-1, 
induction of JNK and TNF-α (58). The size of the UFP, CB, TiO2, fullerol, PS, PS-
NH2 and PS-COOH particles in cell culture medium was reported as 1778, 154, 175, 
106, 90, 527 and 82 nm respectively. The measurement of intracellular ROS showed 
that only UFP, fullerol and PS-NH2 showed a significant increase in ROS production 
as measured by dichlorofluorescein diacetate (DCFH-DA). Pre-treatment of cells with 
the thiol antioxidant, N-acetylcysteine (NAC), significantly suppressed ROS 
production in the presence of UFP. Cellular thiol was measured by thiol-interactive 
fluorescent dye, monobromobimane. UFP and PS-NH2 showed a dose dependent 
decline in monobromobimane fluorescence whereas CB, TiO2, fullerol PS and PS-
COOH had no effect. Using an immunoblotting approach to assess HO-1 expression 
the authors found that both UFP and PS-NH2 particles elicit a response, while fullerol, 
CB, TiO2, and other PS nanoparticles were ineffective. HO-1 is an example of a phase 
II enzyme that mediates antioxidant, antiinflammatory, and cytoprotective effects and 
is useful as a marker for particle-induced oxidative stress. The induction of HO-1 
expression was suppressed by pre-treatment of cells with NAC thus showing role of 
ROS in induction of HO-1. Among the NP’s tested only UFP’s were capable of JNK 
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activation and TNF-α production. The production of TNF-α was suppressed in the 
presence of NAC thus confirming the role of oxidative stress.  
Tier III. The mitochondrial membrane lipids, proteins and nucleic acids are 
subjected to ROS attack and prone to oxidative damage (59). It is hypothesised that 
oxidant accumulation results in early alterations in steady-state mRNA levels of two 
mitochondrially encoded components of mitochondrial enzymes, cytochrome c 
oxidase subunit III (COIII) and NADH dehydrogenase subunit 5 (ND5), in a dose-
related fashion (59). The decreased expression of COIII and ND5 triggers and effects 
later cell death (59). Tier III responses towards NP-induced toxicity include the 
activation of apoptosis (i.e. programmed cell death) through mitochondrial injury, 
nuclear DNA damage and also necrotic cell death. A possible mechanism for 
mitochondria damage was hypothesised by Wang et al. (60) who used gold nanorod 
of 55 nm length and 13 nm width on A549 cells and studied the uptake and selective 
accumulation of the nanorods in A549 mitochondria. The authors found using 
acridine orange stain, a probe to study lysosomal integrity that there was a significant 
change in lysosomal membrane potential after internalization of gold nanorods. This 
disruption of lysosome caused the release of nanorods in the cytosol which was partly 
translocated to mitochondria verified using TEM to observe the presence of gold 
nanorods in the mitochondria. The Figure 1-5 illustrates the proposed mechanism of 
the fate and effect of gold nanorod on A549 cells. Further the authors used 
mitochondrion specific JC-1 dye to show that gold nanorods after 24 h exposure 
induced mitochondrial damage in A549 cells. 
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Figure 1-5: Fate and effect of gold nanorods in A549 cells (60). 
 
In the study by Xia et al. (58) the mitochondrial membrane potential (MMP) 
was measured as a marker for perturbation of mitochondrial function. The 
fluorescence of a mitochondrial dye, DiOC6 was tracked by flow cytometry. Decrease 
in mitochondrial membrane potential led to the release of dye and decrease in 
fluorescence as seen during the treatment with UFP (within an hour) and PS (after >6 
h incubation). In another study by George et al. (61) [Ca
2+
]i flux, MMP and 
propidium iodide uptake was assessed on BEAS-2B and RAW 267.4 cell lines as 
markers of Tier III responses after incubation with quantum dots (443 nm), zinc oxide 
(45 nm), platinum (173 nm), silicon dioxide (528 nm), gold (29 nm), silver (110 nm) 
and aluminium dioxide (57 nm) NP. These particle sizes were reported in bronchial 
epithelial growth medium supplemented with growth factors and 2 mg/ml bovine 
serum albumin but no serum. However, in 10% v/v serum supplemented Dulbecco’s 
modified Eagle’s medium the authors reported the particle size of quantum dots (48.5 
nm), zinc oxide (24.2 nm), platinum (28.6 nm), silicon dioxide (341.5 nm), gold (21.9 
nm), silver (77.2 nm) and aluminium dioxide (25.8 nm).The authors ranked the 
quantum dot and zinc oxide NP as more toxic than other NPs tested based on the 
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lowering of MMP, increased [Ca
2+
]i flux and increased propidium iodide uptake. 
However, it must be noted that the quantum dots used by the authors had size in cell 
culture medium which was not in the quantum dot size range of 1 to 10 nm. The 
supplier (Sigma-Aldrich) reported the size of quantum dots as 6.5 nm dispered in 
toluene. The particle size measured in cell culture medium might be indicative of the 
quantum dot aggregation.   
 
1.4.2 Other mechanisms of NP toxicity 
Some NPs cause toxicity by what’s called a "Trojan horse" mechanism. Once 
a metal-containing nanoparticle has penetrated a cell, metal ions can leach from the 
particle and generate ROS in the cell interior. The work by Limbach et al. (62), Park 
et al. (63) and Lubick et al. (64) demonstrated that easily solubleparticles such as 
cobalt, manganese and silver NPs could efficiently enter the cells by a Trojan horse-
type mechanism which provoked higher oxidative stress if compared to reference 
cultures exposed to aqueous solutions of the same metals. 
Another possible mechanism of action for the toxicity of NPs includes injury 
of epithelial tissues/cells. Ruenraroengsak et al. (65) have shown that positively 
charged amine modified polystyrene latex NP of 50 and 100 nm when exposed to 
alveolar epithelial type 1 like-cells (TT-1) caused severe damage and holes on the cell 
membranes. The authors performed live cell imaging using hopping probe ion 
conductance microscopy after exposing the TT-1 cells to NP’s for 4 h.  
1.5 Traditional assessment of risk in vivo and the need for 
predictive in vitro nanotoxicology 
One of the primary drivers for the growth in nanotoxicology research is the 
rapid expansion of engineered nanomaterials designed for use in consumer products. 
The use of laboratory animals provides an alternative to testing of NPs on human 
beings, however the resultant data is often difficult to extrapolate to humans due to 
significant species-dependent differences in airway architecture and dimensions, 
breathing patterns, as well as respiratory tract cell populations (66) (67). Another 
disadvantage of the whole animal model is the large number of animals and quantities 
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of nanomaterials required for toxicology assessment (68) which leads to an increase in 
the cost of research.  
According to the Project on Emerging Nanotechnologies, there are currently 
more than 1300 consumer products that incorporate nanomaterials and this number is 
expected to grow to 10
4
 materials within a decade (6). Thus, the rate of expansion 
must be considered when deciding what constitutes an appropriate toxicological 
paradigm so as to avoid the conundrum of the chemical industry, where among the 
>40 000 industrial chemicals, fewer than 1000 have undergone toxicity testing. One 
of the major factors contributing to this backlog is the high cost and length of time to 
complete even a single toxicological screen through animal testing. The traditional 
approach of using whole animal exposure models to assess the safety of all 
nanomaterials via all exposure routes will not be feasible given the rapid rate of 
development in the materials science sector (69, 70). Instead, the development of 
predictive in vitro models of nanotoxicology based on robust paradigms linking 
nanoparticle (NP) physicochemical properties and in vivo outcomes is the way 
forward.  
It has been demonstrated that toxicity testing carried out using the 
conventional cell culture techniques show little correlation to the results obtained 
from in vivo testing (71, 72). Sayes and co-workers (71) assessed the pulmonary 
toxicity of five different particle types -carbonyl ion (CI), crystalline silica (CS), 
amorphous silica (AS), nano-zinc oxide (NZnO), and fine-zinc oxide (FZnO) using 
both in vivo and in vitro assessments. The authors exposed rats to the above 
mentioned particles by intratracheal instillation and measured the in vivo LDH level 
and PMN recruitment in BAL after 24 h, 1 week, 1 month and 3 months. The authors 
also cultured immortalized rat L2 lung epithelial cells, primary rat lung alveolar 
macrophages and coculture of rat lung epithelial cells and lung alveolar macrophage 
and exposed them to the particles and measured LDH release, production of 
inflammatory mediators (MIP-2) and cytokine production (TNF-α and IL-6) after 1h, 
4 h, 24 h and 48 h. The study was designed to assess the capacity of in vitro screening 
studies to predict in vivo pulmonary toxicity of the particle types tested in rats. Results 
of in vivo pulmonary toxicity studies demonstrated that CI did not produce any LDH 
or PMN recruitment. CS caused a significant increase in the production of LDH and 
PMN recruitment and this was sustained over the 3 month period. AS caused a 
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significant increase in production of LDH and PMN recruitment at 24 h but was this 
was reversible after a week. NZnO caused a significant increase in LDH release and 
PMN recruitment and this was resolved only after a week. FZnO did not cause an 
increase in LDH release but caused a significant increase in PMN recruitment which 
was resolved after a week. In vitro cytotoxicity testing showed that in L2 cell line all 
the five particles tested caused LDH release but none of them showed MIP-2, TNF-α 
or IL-6 production. In macrophages only CI and CS caused LDH release, AS and CS 
caused the production of MIP-2 and none of the particles caused the production of 
TNF-α or IL-6. In cocultures all the particles except CI caused the release of LDH, 
AS and CS caused the production of MIP-2, AS caused the production of TNF-α and 
CS, AS and NZnO caused the production of IL-6. These results were inconsistent 
with the findings of in vivo study which found CS, NZnO, FZnO to cause LDH 
release and PMN recruitment. Therefore the authors concluded that under the 
conditions of this study, the results of in vivo and in vitro cytotoxicity and 
inflammatory cell measurements demonstrated little correlation.  
Faux et al. (73) exposed A549 cells to a range of nanoparticles (ultrafine 
carbon black, ultrafine titanium dioxide, fine carbon black, fine titanium dioxide, 
barium sulphate and DQ12 quarth) and measured cytotoxicity in terms of LDH 
release, oxidative stress in terms of GSH depletion and inflammation in terms of IL-8 
(mRNA and protein). When the IL-8 mRNA result was plotted against particle 
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In another recently published study George and co-workers (61) demonstrated 
the correlation between in vitro and in vivo results using a high throughput screening 
technique. They screened seven commercially available particles using two different 
airway cells BEAS-2B and RAW 264.7 (murine derived macrophage cell line) and 
used calcium ion flux (calcium ions can activate NFκ-B (76)), mitochondrial 
depolarization, mitochondrial superoxide generation and propidium iodide uptake 
(nuclear dye that fluoresces red and enters cells showing compromised membrane 
integrity) as toxicity endpoints. The multidimensional data set generated by primary 
high throughput screening (HTS) analysis included 4032 data points (2 cell lines × 4 
cytotoxicity responses × 8 time points × 7 NPs × 9 doses). The authors further used 
self-organising maps (SOM) analysis to project the HTS data set onto a two-
dimensional display wherein the spatial distribution of the different NPs at given 
concentrations provided a qualitative indicator of the degree of similarities or 
differences between materials that generated one or more of the cellular response 
outcomes. 
The authors used a zebrafish (Danio rerio) model for screening NP toxicity in 
vivo. It must be noted that although zebrafish model qualifies as a system for chemical 
and NP toxicity, it is not a model for in vivo respiratory nanotoxicology. Zebrafish 
In vitro dose-response curve In vivo dose response curve 
a b 
 
Figure 1-6: Dose-response curve, (a) in vitro (b) in vivo. Slopes of the dose-response 
relationship after exposure to ultrafine TiO2, fine TiO2 and BaSO4. The threshold dose 
identified in each dataset appears to be approximately the same dose of particulate surface 




). The graph has been reproduced 
from Faux et al. (73). 
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embryos were exposed to NP suspensions at 4 h post-fertilization (hpf) and were 
assessed for toxicity every 24 h, starting at 24 hpf and continuing for a 120 h 
observation period. Toxicity end points involved scoring of hatching rates, mortality 
rates, cardiac rate, and the appearance of abnormal morphological features (e.g., 
pericardial/yolk sac edema, large/small yolk, short tail, body length, bent spine, etc. 
The authors then compared the hazard ranking from HTS in vitro experiments and in 
vivo zebrafish embryos and upon comparison they observed a strong correlation 
between in vitro and in vivo data hazard ranking although there was a difference in 
species. Thus, this study demonstrated that through the use of an integrated cellular 
response pathway for screening, advanced in silico data analysis tools, and zebrafish 
embryo screening, it was possible to develop a predictive toxicological paradigm for 
NP hazard assessment. However, this study does not demonstrate the ability to predict 
NP toxicity in the human lung. 
The examples cited above should be viewed as snapshots, which shows that 
there is a considerable debate about how to proceed with nanomaterial toxicity testing 
in terms of physicochemical characterization of NP, toxicological endpoints to screen 
for, as well as the balance of use between in vitro vs. in vivo testing methods (77-80). 
A recent report by National Academy of Science, Toxicity Testing in the 21
st
 Century 
(81) has set forth a vision of paradigm shift needed in toxicity screening of NP. The 
vision rests fundamentally on a comprehensive suite of high-throughput in vitro 
assays in human cells and cell lines enabling us to identify and evaluate the 
perturbations of toxicity pathways. Clearly, there are a number of scientific challenges 
to be met before implementing this vision.  
 
1.5.1 Limitations of in vitro nanotoxicology assays and thesis aims 
Major limitations of in vitro studies, such as 1) the use of cell lines single cell 
types in culture that differ in response to cells in the body, 2) the lack of relevant NP 
characterisation (this is also a limitation for in vivo assays), or 3) unrealistic exposure 
conditions must be considered.  
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1.5.1.1 Shortcomings of immortalised cells and cell monocultures 
Hypothesis 1: If nasal epithelial cell  harvesting depends on the lavage technique, 
then optimizing this technique will increase the quality (yield, % epithelial cells, 
viability) of th recovered cells. 
Physiological relevance comes into question in the first case, as immortalized 
cell lines often exhibit more rapid division, differential gene expression patterns and 
higher endocytosis/phagocytosis rates compared to their in vivo counterparts. An in 
vivo scenario in which only a single cell type interacts with the NPs is unrealistic as 
organ systems are diverse in their cellular makeup, and different cell types often 
participate in coordinated responses. Recent work focusing on the lung, for example, 
has demonstrated how cultured epithelial cells, macrophages, and dendritic cells 
cooperate in nanoparticle trafficking, and that uptake into the cells is enhanced in 
vitro with co-cultured cells in comparison to monocultures (82). Increasingly, the use 
of primary cells use is urged, but the isolation of these cells, yield, maintenance and 
the problem with attachment to the plate surface makes the process tedious and 
expensive. Another limitation with the methods used for establishing primary human 
cell culture systems is the difficulty in obtaining primary cells from the donors as the 
procedure is often highly invasive. Also, with this collection method, the cell pool 
originates from a limited number of individuals so inter-individual variations of 
response are difficult to obtain. On top of this, unlike immortalized cell lines, primary 
cells do not survive for a long time. This means that there is a need for frequent cell 
donation and this reduces the usefulness of the in vitro models developed so far. This 
creates a problem for scaling up high throughput toxicology assays using primary 
human epithelial cells.  
 
Thesis Aim 1:  
The first aim of this project was to develop a primary human nasal epithelial 
cell culture model using a non-invasive technique for harvesting cells. The rationale 
for this subsection of the project was to evaluate whether a primary human nasal 
epithelial cell culture model could be established which would address some of the 
shortcomings listed above, especially in terms of ease of access and non-invasiveness 
of the procedure. Chapter 2 of this thesis provides an in-depth description of the 
methodology and results of this component of the study. 
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1.5.1.2 Insufficient nanoparticle characterisation 
Hypothesis 2: If in vitro nanotoxicity outcomes are related to particle properties then 
information about the key particle characteristics will affect the assay interpretation. 
What happens to NPs once they are synthesised? Do they retain the same 
characteristics as the manufactured state even after they come in contact with in vitro 
cell culture medium which usually contains biomolecules such as proteins? Physico-
chemical characterization of NPs is paramount in order to correlate 
biological/toxicological responses with these properties (83). For example, in a study 
about oxidative damage caused by TiO2 particles on BEAS-2B cells by Gurr et al. 
(84) it was concluded that oxidative and genotoxic potential of nanoparticulate forms 
of TiO2 was superior to that of their larger counterparts. The authors exposed BEAS-
2B cells to 10, 20 and 200 nm anatase TiO2 NPs. The results showed that 10 and 20 
nm NPs in the absence of photoactivation induced oxidative DNA damage, lipid 
peroxidation, and micronuclei formation, and increased hydrogen peroxide and nitric 
oxide production in BEAS-2B cells, whereas 200 nm particles did not induce any 
oxidative damage in the absence of photoactivation. The authors concluded that the 
smaller the particle, the higher potency it had to induce oxidative stress in the absence 
of photoactivation. However, there was no particle characterization study done. The 
authors only mentioned that TiO2 NPs had an approximate size of 200 nm in from the 
information supplied by the manufacturers. However, particles seldom retain their 
‘original’ size in dry state when they are put in cell culture medium. In fact, Murdock 
et al. (85) have shown that the size of 10 nm and 16 nm TiO2 particles in medium 
without serum was 1790 nm and 1810 nm as measured by dynamic light scattering. 
This size was similar to the size of 100 nm TiO2 particles in medium without serum 
which was found to be 2500 nm. This agglomeration in biologically relevant medium 
raises concern about concluding size or surface area dependent toxicity in vitro based 
on particle size measurement either as supplied by manufacturer or measurement in 
dry state (EM) or measurement in PBS. These are just few examples to demonstrate 
the importance of particle characterization in correct interpretation of toxicology data 
obtained from in vitro studies.  
In an article titled ‘How meaningful are the results of nanotoxicity studies in 
the absence of adequate material characterization?’ by Warheit et al. (86) the 
importance of particle characterization in the interpretation of nanotoxicity data 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 38 - 
Chapter 1- Introduction 
obtained from in vitro or in vivo studies has been further highlighted. The author 
raised an important issue with regard to particle characterization data either being 
reported as supplied by the manufacturer without cross checking or being reported as 
size in dry phase or non-biologically relevant medium. As most of the reported studies 
with nanoparticles have been conducted under in vitro cell culture conditions (i.e., in 
the wet phase) wherein the physicochemical characteristics of the particles, including 
particle size, are likely to change from the “just received” (i.e., dry phase) or size in 
PBS this limits the interpretation of cell-nanoparticle interaction data. The author 
concluded that for in vitro toxicity studies, particle size, size distribution, particle 
morphology, particle composition, surface area, surface chemistry, and particle 
reactivity in solution are important factors which need to be accurately characterized 
as prerequisites for implementing nanoparticle toxicity studies. 
 
Thesis Aim 2:  
The second aim of this project was to characterise rigorously a panel of 
nanoparticles spanning a range of physicochemical properties in various biological 
environments (e.g. cell culture media, respiratory tract lining fluid). The rationale for 
this subsection of the project was to avoid problems associated with a lack of particle 
characterisation as highlighted above which should enable robust correlations 
between particle properties and in vitro cytotoxicity results. Chapters 3, 4 and 5 of this 
thesis provide an in-depth description of the methodology and results of this 
component of the study. 
 
1.5.1.3 Shortcomings of current in vitro dosimetry 
Hypothesis 3: If delivered dose (as opposed to administered dose) is determined by 
sedimentation and diffusion then adjusting for the effects of these processes will help 
in estimation of the delivered dose. 
An important question in nanotoxicology relates to the selection of doses, both 
for in vitro and in vivo studies. Many studies are driven by a desire to demonstrate an 
effect and to determine underlying mechanisms, which is most easily achieved with 
high NP doses. These doses may never be reached under realistic exposure conditions 
at the primary point of entry or in secondary organs (87). In vitro studies of NP 
applications and toxicity rely on our ability to quantify the interactions between 
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nanoparticles and cells. In a typical in vitro experiment, cells are immobilized at the 
bottom of a culture plate or on a substrate placed at the bottom of a culture plate, and 
incubated with a suspension of nanoparticles. The nanoparticles are assumed to be 
well-dispersed in the culture medium so the concentration of nanoparticles at the cell 
surface is assumed to be the same as that of the initial bulk concentration. However, 
particles in suspension are not only under the effect of gravity, but also undergo 
diffusion caused by Brownian motion, which means that experimental conditions such 
as nanoparticle size, density, concentration, aggregation, and particle incubation time 
will dictate the number of particles in the suspension which will reach the cells during 
a given in vitro experiment. Limbach et al. (88) Hinderliter et al. (89) and Teeguarden 
et al. (90) have highlighted the importance of distinguishing the administered and 
delivered doses of nanoparticles in vitro. The administered dose is defined as the 
mass, particle number or particle surface area per volume of cell culture medium. In 
contrast, the delivered dose is defined as the mass, particle number or particle surface 
area that reaches the cell monolayer (expressed either as monolayer surface area or 
total cell protein) during the experiment. The delivered dose, therefore, takes into 
account not only initial particle concentration, but also colloidal behavior and 
nanoparticle exposure time, making it a more accurate description of effective 
nanoparticle dose in vitro.  
The relevance of the delivered dose becomes especially important when 
comparing in vitro studies of nanoparticles with very different properties and when 
developing predictive models of nanoparticle toxicity. Limbach et al. (88) measured 
the uptake of 25-50 nm cerium oxide nanoparticles and compared it to the uptake of 
250-500 nm cerium oxide nanoparticles in human lung fibroblasts. After exposing the 
cells to NPs for different times the cells were dried and elemental analysis was 
performed for quantification of NP uptake. They found the uptake by fibroblasts of 
25-50 nm cerium oxide NP was lower as compared to uptake of 250-500 nm cerium 
oxide NP. The cellular dose of 25 nm ceria oxide nanoparticles correlated extremely 
well with the predicted delivered dose (based on Stokes’-Einstein diffusion), while the 
cellular dose of larger particles (320 nm) was lower than the predicted delivered dose 
(hypothesized to be primarily sedimentation-dependent) (88). Teeguarden et al. (90) 
extended this analysis to theoretically show that colloidal behaviour not only affected 
uptake, but might also affect relative toxicity. Their model analyses the colloidal 
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behaviour of the particles whereby the fractions of the administered dose calculated to 
sediment and diffuse towards the cell layer were summated to obtain a single 
delivered dose value for any given set of experimental conditions. The authors 
reanalyzed data for lactate dehydrogenase release post-hoc from a study by Hussain et 
al. (91) who had reported the cytotoxicity (EC50 value) for various nanoparticles 
(1000 nm cadmium oxide NP (CdO), 15 and 100 nm silver NP (Ag) and 30 and 150 
nm molybdenum trioxide NP (MoO3) on rat BRL 3A liver cells). Teeguarden et al. 
were able to show that the EC50 values reported (normalized to the administered dose) 
were 150-1200 fold higher than the values obtained when the results were normalized 
post hoc to the derived delivered dose according to the Teeguarden model. In a further 
paper, the same authors refined the Teeguarden model and modelled the effect of 
sedimentation and diffusion on a particle in the liquid suspension using Matlab
®
 to 
develop a particokinetic model which became known as the In Vitro Sedimentation, 
Diffusion and Dosimetry model or ISDD (89).  
 
Thesis Aim 3:  
The third aim of this project was to develop a user-friendly particokinetics 
program based on that of Teeguarden et al. (90) to calculate the delivered dose of 
nanoparticles used in all cytotoxicity experiments. The rationale for this subsection of 
the project was to provide a means to account for colloidal behaviour of nanoparticles 
in cytotoxicity data through use of delivered dose instead of administered dose values. 
Chapter 3 describes the development of this model using Excel as a user-friendly 
programming format and the validation of the resulting calculated delivered dose 
values against experimental data and ISDD (89). In Chapter 4, in vitro cytotoxicity 
data was generated for a panel of well-characterised nanoparticles with very different 
physicochemical properties. Using the particokinetics programme developed in 
Chapter 3, the results were normalised to both the administered and delivered doses 
and compared. 
 
1.5.1.4 Measuring oxidative stress in vitro under hyperoxic culture conditions 
Hypothesis 4: If cells adapt to hyperoxic environment (21% oxygen) then cells at 
normoxia (13 % oxygen physiological oxygen level at alveioli) will be more 
physiologically relevant. 
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The enhanced surface reactivity of NP and their related ability to generate 
oxidative stress is one of the principal mechanisms hypothesized to drive both NP-
induced inflammation and cellular damage (reviewed by (35, 36)). Based on this 
paradigm, cell cultures in which reactive oxygen species (ROS) production and the 
generation of oxidative stress can be quantified are regarded as valid assay systems 
for comparing the toxicity of manufactured or ambient NP (35, 36, 38, 43, 58). A 
hierarchical model for NP-induced oxidative stress has been proposed in Section 1.4, 
in which cells undergo graded or tiered responses in response to increased insults: 
Tier 1) upregulation of adaptive antioxidant defences, Tier 2) inflammation and Tier 
3) cell death (Fig 1; (38, 43, 58)). What has been overlooked, however, is the fact that 
standard cell culture practices use atmospheric oxygen (i.e. 150 mm Hg, ~21%, O2) 
concentrations that constitutes a hyperoxic environment. With the exception of the 
cornea, epidermis and respiratory tract epithelial layer, cells in vivo typically 
experience 1-10 mmHg oxygen pressure (equating to ~ 1-5% O2). In the respiratory 
tract, small airway epithelial cells and alveolar cells experience approximately 100 
mm Hg oxygen (~ 13% O2) (92). Despite this, most mammalian cells are cultured 
using 21% O2, which promotes increased intracellular production of ROS (93, 94). 
Cultured cells that fail to adapt to this oxidative environment fail to thrive, thus 
leaving only cells that have adopted an adaptive phenotype (94-97). Cellular 
adaptation to the oxidative stress, sometimes termed ‘culture shock’, involves 
enhancement of antioxidant defenses (e.g. upregulation of superoxide dimustases, 
increased glutathione (GSH) synthesis etc.), downregulation of ROS-generating 
enzymes (e.g. cytochrome c oxidase (98)) or alteration of cellular targets of oxidative 
damage (replacement of fumarase A and B with fumarase C in E. Coli (99) and loss 
of aconitase in primates (100)). Logically, this process of adaptation may be 
anticipated to mute oxidative responses in cells cultured using 21% O2, thereby 
masking NP toxicity when measured using oxidative stress-related endpoints and 
making such systems poor predictors of in vivo toxicity outcomes. 
 
Thesis Aim 4:  
The final aim of this project was to assess the impact of cultivating cells at 
atmospheric (21%) vs. physiological (13%) oxygen (O2) on the results of standard 
cytotoxicity assays. The rationale for this subsection of the project was to determine 
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whether hyperoxia (i.e. 21% O2) will induce adaptive changes to the cellular state 
which will ultimately render cultured cells less sensitive to nanoparticle challenge. 
Chapter 5 describes the methodology and results of this component of the study.   
 
Taken together, the aims of this thesis address selected, but important 
limitations of in vitro nanoparticle toxicity assessment and explore methodological 
parameters which may be optimised to improve the data generated by such assays. 
The following chapters provide robust data generated by methods which incorporate 
state-of-the-art recommendations for nanotoxicity studies. The findings will 1) 
contribute to existing knowledge regarding the evaluation of primary nasal cell 
cultures, 2) verify the importance of robust particle characterisation procedures, 3) 
demonstrate why in vitro cell culture studies should all be normalised to the delivered 
dose value and 4) provide new insights into the impact of culture conditions on 
cytotoxicity outcomes. 
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Chapter 2                                                                           
A benign methodology for establishing 
primary human nasal cell cultures 
 
2.1 Introduction 
The respiratory system represents a major portal of entry for xenobiotics into 
the body, whether they are intentionally administered as in the case of drugs and 
anesthetics, or inadvertently taken in by the inhalation of ambient air polluted with 
materials from a wide variety of sources. Nasal inhalation is a major route of entry 
into the body for airborne pollutants, including diesel exhaust particles, dust, pollen 
and nanoparticles used in sprays for both household use and drug delivery. It has been 
reported that upper size limit for nasal inhalation of airborne particles in calm air is 
135 µm (101). Since a large proportion of pollutants exist in the nano-range up to 50 
µm (such as pollen), this means that significant particles deposition can occur in the 
nasal cavity (102). The nasal cavity may provide a port of entry to systemic 
circulation, and particles which are deposited in the nasal cavity might stimulate 
airway epithelial cells to secrete pro-inflammatory cytokines. 
 
2.1.1 Anatomy and physiology of the nose 
The nose is the uppermost portion of the human respiratory system, located in 
the middle of the face and the internal structure lies above the roof of the mouth. The 
shape of the nose is determined by the ethmoid bone and the bony median septum, 
which consists mostly of cartilage and divides the nasal cavity into two non-connected 
parts. While the anterior part of the nasal cavity opens to the face through the nostril, 
the nasal cavity extends posteriorly to the nasopharynx (103).  
The nasal cavity consists of the vestibule, olfactory and the respiratory 
regions. The vestibule consists of the region just inside the nostrils with an area of 
about 0.6 cm
2
. The second region is the olfactory region, situated in the roof of the 
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nasal cavity and covers approximately 3-5% of the total nasal area of 150 cm
2
 in man. 
The respiratory region constitutes the remainder of the nasal cavity and accounts for 
94% of the nasal cavity. It is separated from the vestibule by the atrium and possesses 
lateral walls dividing it into three sections: The superior, the middle and the inferior 
nasal turbinates (Figure 2-1). 
 
The presence of these turbinates creates turbulent airflow through the nasal 
passages which ensures a good contact between the inhaled air and the mucosal 
surface (105). The epithelial cells in the nasal vestibule are stratified, squamous and 
keratinized with sebaceous glands. Due to its nature, the nasal vestibule is very 
resistant to dehydration and can withstand noxious environmental substances. The 
atrium is a transitional epithelial region with stratified, squamous cells anteriorly and 
pseudostratified columnar cells with microvilli posteriorly (105). The respiratory 
region is covered with pseudostratified columnar epithelial cells interspersed with 
goblet cells, seromucus ducts and the openings of subepithelial seromucus glands. 
Furthermore, many of these cells possess actively beating cilia and microvilli. These 
cilia are 4-6 microns long and their thin projections beat with a frequency of 1000 
 
Figure 2-1: Lateral section of the nasal cavity (adapted from reference (104)), showing the 
extensive respiratory region (the turbinate and the olfactory region). 1: olfactory region, 2: 
superior turbinate, 3: middle turbinate, 4: inferior turbinate. 
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strokes per minute. Each ciliated cell contains about 100 cilia, while both ciliated and 
nonciliated cells possess about 300 microvilli each. The mucus flow rate in the 
respiratory region is in the order of 5 mm per min and hence the mucus layer is 













 I                  II                III                IV  
Figure 2-2: Diagrammatic representation of the cell types of the nasal mucosa as seen by 
transmission electron microscopy adapted from reference (106) showing (I) non ciliated 
columnar cell, (II) goblet cell with mucus granules, (III) basal cell, (IV) cilliated columnar cell. 
The epithelium is covered by a 5-10 µm mucus layer (not shown). 
 
The nasal secretions consist mainly of heterogeneous secretory products 
originating from the goblet cells and submucosal glands, with additional contributions 
from lacrimal fluid and the vascular region. Together these secretions form a distinct 
two-layer airway lining fluid. The main function of the mucus is to mediate the 
interactions between the epithelial cells and their environment via processes such as 
lubrication, maintaining water balance and entrapment of particles, including bacteria 
and viruses (103). Approximately 1.5 to 2 L of mucus is secreted daily within the 
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nasal cavity (107). It is continuously cleared by cilia, which extend through the 
periciliary fluid and hook the mucus layer with their tips to transport it towards the 
nasopharynx. The coordination of cilia motility is controlled by neural innervations, 
chemical pacemaking and hormonal stimulation and the effects of ions such as 
calcium and potassium (107).  
The nasal cavity has an essential protective function that it filters, warms and 
humidifies the inhaled air before it reaches lower airways. Any inhaled particles or 
microorganisms are trapped by the hairs in the nasal vestibule or by the mucus layer 
covering the respiratory area of the nasal cavity (103). Due to the mucociliary 
clearance mechanism, the mucus layer will gradually carry deposited particles to the 
back of the throat, down the oesophagus and further into the gastrointestinal tract 
(107). The nasal mucosa also has some metabolic capacity that aids the conversion of 
endogenous materials into compounds that are more easily eliminated (104, 106).  
 
2.1.2 Particle deposition within human nasal airways 
Historically within the field of toxicology the nose has garnered little attention 
as a target for nanoparticle toxicity studies. In addition to their role in olfaction, the 
nasal passages provide some protection to the lower respiratory tract by filtering the 
inspired air. However, little importance has been given to it as a portal of entry of 
environmental toxins and its role in particle capture and removal. Knowledge 
regarding particle deposition processes in the nasal cavity is important in both aerosol 
therapy and inhalation toxicology.  
Aerosol deposition in the nasal cavity has been investigated by a number of 
researchers. Cheng and co-workers (108) measured the total deposition of submicron 
aerosols (5–200 nm) in a nasal cast at constant flow rates between 4 and 50 L/min. 
The deposition efficiency increased with decreasing particle size and flow rate, 
indicating that diffusion was the dominant mechanism. Cheng and co-workers (109) 
also measured submicron particles ranging from 4 to 150 nm at constant flow rates of 
10 and 20 L/min in 10 volunteers. The net deposition efficiency of 4, 8 and 20 nm 
particles varied greatly, although as the following numbers show, particle size had 
more of an influence on deposition rate than air flow: 32-65% (4 nm particles @ 10 
L/min) compared to 26-60% (4 nm particles @ 20 L/min) 18-49% (8 nm particles @ 
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10 L/min) compared to 14-43% (8 nm particles @ 20 L/min), and 8-36% (20 nm 
particles @ 10 L/min compared to 6-29% (20 nm particles @ 20 L/min). The 
deposition efficiencies of 150 nm particles were less than 10% for both flow rates in 
eight out of ten volunteers.  
 
2.1.3 Local particle deposition pattern in the nose 
Although the above study shows that particles do deposit in the nasal cavity, it 
lacks information about detailed local deposition patterns, which is very important in 
studies of aerosol therapy and inhalation toxicology. Wang and co-workers (110) 
compared the deposition pattern of micron and nano-sized particles in a realistic nasal 
cavity. The nasal cavity model used by Wang and co-workers was divided into ten 
separate sections named Zone 1-10 for analysis of local deposition pattern. 
 
 
Figure 2-3: Nasal cavity model used by Wang and co-workers (10). 
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Figure 2-4: Local deposition pattern of 1 nm particles inhaled at a density of 1000 kg/m
3
 
showing even deposition in each zone (as defined in Figure 2-3). Deposition efficiency is 80%. 
The image and data are reproduced from reference (10) 
 
 
Figure 2-5: Local deposition pattern of 22 µm particles inhaled at a density of 1000 kg/m
3
 
showing maximum deposition in Zone 2 (as defined in Figure 2-3), which is the anterior region 
of the nose. Deposition efficiency is 80%. The image and data are reproduced from reference 
(10). 
 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 49 - 
Chapter 2 – A benign methodology for establishing primary human nasal cell cultures 
 
 
Figure 2-6: Deposition patterns of 1 nm and 22 µm particles in different zones as defined in 
Figure 2-3. The image and data are reproduced from reference (10) 
 
This study shows that particle diameter has significant effect on deposition 
patterns for both micron sized particles and submicron sized particles. The major 
regions of deposition of micron sized particles were found to be the nasal valve and 
the middle septum parts in the nasal turbinate, while for submicron sized particles 
there was a uniform distribution of deposited particles. This means that there is a 
uniform and significant particle deposition in of the submicron sized particles inhaled 
by human beings in the nasal cavity. The upper turbinate of the human nose contains 
the olfactory epithelium which serves as an important barrier between the nose and 
the olfactory bulb. Particles which get deposited in this region can be taken up by the 
olfactory system and get into the olfactory bulb. 
 
2.1.4 Nose to brain translocation of particles 
Evidence that nose to brain transport for solid particles takes place in man is 
steadily accumulating. In a review by Sunderman (111) the deposition of heavy 
metals in the olfactory region of the brain was highlighted amongst the workers 
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occupationally exposed to nickel or cadmium containing dusts in alkaline battery 
factory, nickel refineries and cadmium industries. At the autopsy of one such worker 
Badder (112) observed bright yellow staining of the olfactory bulbs, which suggested 
that cadmium entered the brain via the olfactory pathway. Studies in monkeys with 
intranasally instilled gold ultrafine particles (UFPs; <100 nm) and in rats with inhaled 
carbon UFPs suggested that solid UFPs deposited in the nose travel along the 
olfactory nerve to the olfactory bulb. Elder and co-workers (113) exposed groups of 
rats to manganese oxide ultra fine particles (30 nm). They analyzed manganese 
concentrations in lung, liver, olfactory bulb, and other brain regions, and performed 
gene and protein analyses. After 12 days of exposure with both nostrils patent, Mn 
concentrations in the olfactory bulb increased 3.5-fold, whereas lung Mn 
concentrations doubled. There were also increases in striatum, frontal cortex, and 
cerebellum. Lung lavage analysis showed no indications of lung inflammation, 
whereas increases in olfactory bulb tumor necrosis factor-alpha mRNA 
(approximately 8-fold) and tumor necrosis factor-alpha protein (approximately 30-
fold) were found after 11 days of exposure and, to a lesser degree, in other brain 
regions with increased Mn levels. Macrophage inflammatory protein-2, glial fibrillary 
acidic protein, and neuronal cell adhesion molecule mRNA was also increased in 
olfactory bulb. They concluded that the olfactory neuronal pathway is efficient for 
translocating inhaled Mn oxide as solid UFPs to the central nervous system and that 
this can result in inflammatory changes.  
 
2.1.5 Nasal epithelium damage due to particles 
In another study cytological damage to the nasal epithelium of residents of a 
heavily polluted city was analyzed as compared to residents of less polluted city. In 
total 20 residents from each city were studied after environmental (non-deliberate) 
exposure to polluted air containing ozone and PM10. Nasal scrapings were taken from 
the subjects at different time intervals during a month. In total, four scrapings of the 
nasal epithelium were taken from each subject. Control subjects from the less polluted 
city showed no cytological alterations in 30% cases and in the remaining 70% of the 
cases only mild or moderate inflammation could be seen. In contrast all the residents 
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of heavily polluted city showed moderate to severe inflammation. This study showed 
concluded that exposure to inhaled pollutants damages the nasal epithelial cells (114).  
 
2.1.6 Animal models 
The above studies provide evidence that particles deposit in the nose, where 
they may exert an adverse effect on the nasal epithelium and possibly be taken up via 
the olfactory route. At the same time, because of an increased interest in the 
development and use of nanoparticles for drug delivery applications, concerns about 
their toxicity must be addressed. Experiments performed on human subjects are 
limited due to the invasive nature of the procedures such as turbinectomy, corrective 
surgery of the nasal septum or simply an elective surgery and dangers associated with 
toxic aerosols. The use of laboratory animals provide a surrogate for human studies; 
however, the resultant data is often falsely extrapolated due to species-dependent 
differences in airway dimensions, breathing characteristics (66), architecture of the 
upper airway and in the surface epithelial population of the mucosal tissue lining the 
nasal passages. (67). Other disadvantages of the whole animal model are the large 
number of animals and quantities of material required (68) which leads to an increase 
in the cost of research and loss of animal lives. 
 
2.1.7 In vitro models 
Due to the above-mentioned disadvantages there is tremendous pressure to 
find non-animal alternative testing strategies. The development of an appropriate 
human nasal epithelial cell culture would provide a promising system to enable early 
stage predictions of nasal drug transport, metabolism and toxicity in humans. The 
human origin of cells would be of greater clinical relevance compared to studies 
performed with animal models of different species. The use of in vitro cultures of 
nasal epithelial cells in pharmacological and toxicological studies also has several 
advantages: (i) more standardized systems due to control of the experimental 
conditions; (ii) rapid evaluation of permeability, metabolism and toxicity; (iii) in vitro 
exposure of human cells to compounds that could not be investigated in humans in 
vivo, allowing an understanding of the mechanism of drug transport, metabolism and 
toxicity as well as the evaluation of the strategies for their modulation; (iv) limiting 
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the number of experimental animals and amount of research compound required in the 
screening phase (115, 116). Cell culture systems and excised nasal mucosae provide 
meaningful in vitro models to study the toxic potential of nanoparticles on the nasal 
epithelium. Table 1 below gives the summary of primary human nasal epithelial cell 
cultures developed to date for transport, metabolism and toxicity studies. 
 In the studies described in Table 2-1, it has been shown that human nasal 
primary cultures show the potential for the study of nasal drug absorption, metabolism 
and toxicity. It can also be seen that groups working in this domain have used a large 
variety of culture media for establishing the primary cell cultures. It is still not 
conclusive as to which medium is best suited for the culturing of primary human nasal 
cells.  
Cell lines derived from carcinomas of epithelial origin with their extended 
lifespan, improved proliferation and homogeneity may relieve some of the limitations 
of the primary cell cultures. The nasal cell lines most often used in these studies are 
RPMI 2650, BT and NAS 2BL. BT is derived from normal bovine turbinates and 
NAS 2BL is derived from a rat nasal squamous carcinoma. The RPMI 2650 has been 
derived from a human nasal anaplastic squamous cell carcinoma of the nasal septum. 
In culture, RPMI 2650 cells form clusters composed of round and slightly flattened 
cells or show a tendency to spread. RPMI 2650 do not form monolayers and do not 
express goblet and ciliated cells (68, 115, 116). This makes RPMI 2650 cell cultures 
unsuitable for the evaluation of nasal transport. They can be used for metabolism and 
toxicity studies, although results should be interpreted with caution.  
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ALI** Other Information 




DMEM, supplemented with 
1% nonessential amino acids, 
1% glutamine, 10% FCS 










(117) Surgery N/A 
Collagen-
coated 
DIF-1000 Seromed medium 
supplemented with EGF 
(15µg/l), hydrocortisone (725 
µg/l), retinoic acid (30µg/l), 
insulin (10mg/l), transferring 
(10mg/l), BSA (8mg/l) 
N/A  
 









DMEM, 1% nonessencial 
aminoacids, 1% glutamine, 
10% FCS 









supplemented with Ultroser G 
(2%), choleratoxin (10ng/ml) 
N/A    
Ciliary beat 
frequency evaluated 






supplemented with Ultroser G 




   
MTT, LDH, CBF 
studies performed 
* Table 2-1 continued on next page 
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ALI** Other Information 
(121) Surgery N/A No coating 
BEGM in apical and DMEM 
supplemented with 1% 
nonessential aminoacids, 1% 
L-glutamine, 10% FBS, and 
1ng/ml EGF 
800-1200    LCC on Transwells  





1:1 mixture of BEGM and 
DMEM/F-12 supplemented 
with insulin (5µg/ml), 
epinephrine (0.5 µg/ml), 
triiodothyronine(6.5ng/ml), 














Analysis of ICAM-I 
surface expression 


















20% FCS for the first 2 days 
and then serum free media 
N/A     
List of abbreviations: HNE: Human nasal epithelial cells, ALI = Air-liquid interface, DMEM = Dulbecco's modified eagle medium, DMEM/F-12 = Dulbecco's modified eagle 
medium containing Ham’s nutrient, BEGM = Bronchial epithelial growth medium, FCS = Fetal calf serum, EGF = Epidermal growth factor, BSA = Bovine serum albumin, N/A = 
not available,   = performed,  = not perfomred
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2.1.8 Disadvantages of present models 
These cell culture systems listed in Table 2-1 represent the epithelium of the 
middle or superior turbinate area (Figure 2-3) of the nasal cavity. From the local 
deposition pattern of micro and nano-sized particles we know that a vast majority of 
particles are also deposited in the nasal valve comprising of Zones 1 and 2 (Figure 2-
4, 2-5 and 2-6). Another limitation with the methods used for establishing a primary 
human nasal cell culture system is the difficulty in obtaining primary cells from the 
donors as the donor has to undergo painful traumatic method of nasal biopsy, 
brushing or scraping. These methods are not donor-friendly and rely on the 
availability of patients being treated for endonasal surgery for donation. Also, with 
this collection method, the cell pool originates from a limited number of individuals 
so inter-individual variations of response cannot be assessed. On top of this, unlike 
immortalized cell lines, primary cells do not survive for a long time. This means that 
there is a need for frequent cell donation and this reduces the utility of the in vitro 
models developed so far. Since the methods used for obtaining the primary human 
nasal cells are traumatic, this creates a problem of scaling up the primary human nasal 
epithelial cell model.  
In this regard the proposed method to be developed in this current research is a 
simple, atraumatic method for obtaining nasal epithelial cells. This method is 
nonsurgical and is well tolerated; it requires no anesthesia and permits repeated 
isolation from the same source.  
 
2.1.9 Aim 
The aim of this work is to isolate human nasal epithelial cells, characterize 
them and establish cell culture conditions and evaluate the suitability of this technique 
to provide a primary cell culture system for particle transport and toxicological 
studies.  
 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 56 - 
Chapter 2 – A begin methology for establishing primary human nasal cell culture 
2.2 Materials and Methods 
2.2.1 Materials 
Nasal spraying devices were obtained from Apoteket Production & Labaratory 
(Goteborg, Sweden). Dulbecco's Modified Eagle Medium containing Ham’s nutrient 
(DMEM), trypsin-EDTA (2.5 g/l trypsin, 0.5 g/l EDTA), fetal bovine serum (FBS), L-
glutamine (200 mM), penicillin-streptomycin solution (100x), trypan blue solution 
(0.4%) and May-Grunwald Giemsa (MGG) solutions were purchased from Sigma-
Aldrich (Poole, UK). LHC basal medium and bovine serum albumin were purchased 
from BioSource International (Camarillo, CA, USA). Type I bovine collagen was 
purchased from BD Labs. Tissue culture plastic-wares were purchased from Costar 
(High Wicombe, UK). Phosphate buffered saline tablets were purchased from Oxoid 
(Basingstoke, UK).  
 
2.2.2 Methods 
2.2.2.1 Study Population 
The present study was approved by the Biomedical & Health Sciences, 
Dentistry, Medicine and Physical Sciences & Engineering Research Ethics Sub-
Committee, King’s College, London (REC Reference Number: BDM/08/09-82) and 
written informed consent was obtained from all volunteers. Multiple nasal lavaging 
was performed on 25 volunteers. The mean age and standard deviation (SD) of study 
volunteers was 29 ± 9 years and 10 females and 15 male subjects were included in the 
study. Volunteers with (i) nasal infection or disease, (ii) taking nasal medicine, (iii) 
below 18 years old were excluded from the study.  
 
2.2.2.2 Nasal lavage procedure and treatment of recovered fluid 
Nasal lavage (NL) samples were collected according to the method of Harder 
et al. (125) with some modifications. Briefly, 10 x 0.1 ml aliquots of phosphate 
buffered saline (PBS) were sprayed into the nose, with the material draining from the 
nose and collected in a sterile glass beaker after each 1 mL was sprayed. This spray 
and collection procedure was repeated five times into each nostril, i.e. a total volume 
of 5 mL per nostril. Throughout the procedure the glass beaker with the pooled nasal 
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lavage was kept on ice. After the lavage was completed the recovered liquid was 
filtered through a sterile 100 µm-pore nylon filter to remove mucus and cell 
aggregates before centrifugation at 400 x g for 15 minutes at 4°C to pellet the cell 
fraction. 
The cell-free supernatant obtained by this procedure was measured using a 
graduated 10 mL plastic pipette, was removed and discarded. The cells from each 
individual were either 1) re-suspended in 100 µL cell culture medium for seeding in a 
96 well plate, 2) re-suspended in 100 µL cell culture medium for cell counting using a 
Haemocytometer or 3) were re-suspended in 300 µL of cell culture media for staining 
with May-Grunwald Giemsa and subsequent microscopic evaluation.  
 
2.2.2.3 Viable Cell Count 
Trypan blue dye (0.4%) (100 µL) was mixed with 100 µL re-suspended cells. 
The total cell count and viable cell count was performed using a haemocytometer and 
the viability of the cells was assessed by Trypan blue dye exclusion assay. This assay 
is based on the principle that live cells possess intact cell membranes that exclude 
certain dyes such as Trypan blue, eosin or propidium, whereas dead cells do not; thus 
a dead cell will have a blue cytoplasm and a viable cell will have a clear cytoplasm. 
The cells are examined visually to determine whether cells take up or exclude dye and 
the cell number is calculated according to Equation 2-1: 
 
Cell count = Average cell count x dilution factor x 10
4
     
Equation 2-1 
 
Where, average cell count was the sum of cells counted in the four quadrants of 
Haemocytometer divided by four and the dilution factor was the volume of cell 
suspension plus the volume of Trypan Blue added to the cell suspension divided by 
the volume of cell suspension. 
 
2.2.2.4 Differential cell staining for microscopic examination of nasal lavage 
For differential cell counting, cells were re-suspended in 300 µL of cell culture 
medium. Serial dilutions (1:2, 1:3, 1:4) of the re-suspended cells were prepared using 
fresh cell culture medium. 200 µL of cell suspension from each of the serial dilutions 
was added to a Cytospin apparatus and the cells were deposited onto a microscope 
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slide by centrifugation at 450 rpm for 5 min. After the cells had air-dried, they were 
incubated for 5 min with May-Grunwald solution diluted with methanol (2:1). The 
slides were then washed with tap water for 1 min and incubated for 15 min with 
Giemsa solution diluted in distilled water (1:9). After a final rinse with tap water for 
1-2 min, the slides were dried at room temperature and observed under the 
microscope. 
 
2.2.2.5 Optimisation of lavage and culture methods 
The experimental design for establishing a primary human nasal cell culture 
followed a general methodology of performing nasal lavage, filtration of lavage, 
centrifugation of collected lavage at 400g for 15 min, removal of cell-free 
supernatant, re-suspension of pelleted cells in cell culture medium and then seeding of 
cells into a 96-well cell culture plate. The plate was kept in a sterile, humidified 
incubator maintained at 37ºC and 5% CO2 / 95% air and cells were cultured until 
confluent. The cell culture medium was changed every 24-48 h.  
 
Phase I Effect of seeding volume 
The diagram in Figure 2-7 illustrates the first set of experiments, termed Phase 
I experiments, investigating the effect of cell seeding volume on cell confluency at 96 
h post seeding. Due to a limited amount of cells gathered from each lavage, a cell 
count was not performed before plating. Instead, all cells from the lavage were 
suspended in either 100µl of CCM1 (SV1), 300 µl of CCM1 (SV2) or 500 µl of 
CCM1 (SV3). The composition of CCM1 is listed below in Table 2-3. After seeding, 
the cell culture medium was changed every 24 h and the number of cells present in the 
well were observed under the microscope at t = 96 h after seeding to see which 
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Phase II Effect of cell culture medium 
Having arrived at suitable seeding density value a further study was carried 
out to determine the effects of collagen coating and cell culture medium composition 
on adherence of cells at 96 hours post seeding. The diagram in Figure 2-8 illustrates 
the second set of experiments, termed Phase II experiments. Cells from the lavage 
were suspended in 100 µl of either CCM1 or CCM2 and seeded onto collagen-coated 
plates as described below. The compositions of CCM1 and CCM2 are listed below in 
Table 2-3. The cell culture medium was changed every 24 h and the confluency of 




Figure 2-8: Diagram of the design for experiments in Phase II experiments. 
 
Phase III Effect of lavage technique 
From the previous two studies it was concluded that SV1, collagen coating 
and CCM2 gave better results in terms of cell growth and adherence after t = 96 h 
post seeding. A third group of experiments was carried out to evaluate a new method 
of nasal lavage to determine its effect on the volume of lavage collected, total number 
of cells collected, the proportion of viable cells collected and cell confluency at t=96 
h. Further, the filtration of the nasal lavage was investigated to determine whether it 
had an effect on the contamination rate of the cultured cells. The diagram in Figure 2-
9 illustrates the third set of experiments, termed Phase III experiments. The 
procedures are described in more detail below. However, all cells harvested in this 
experimental group were resuspended in 100 µl of CCM2 and seeded onto collagen-
coated plates. The cell culture medium was changed every 24 h and the confluency of 
cells was evaluated qualitatively under the microscope at t = 96 h after seeding. 
Figure 2-7: Diagram of the design for experiments in Phase I experiments.*SV: Seeding 
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Figure 2-9: Diagram of the design for experiments in Phase III experiments. 
 
The system was optimised in three phases. In Phases I-III the following 
variables were optimised (Table-2-2). 
 




Dependent Variable Description 
Variable 1 Head back vs. Head forward 
1. Volume of lavage 
2. Cell count 
Variable 2 Filtration vs. Non-filtration 
1. Microscopic observation of 
nasal debris vs. no debris 
2. Contamination rate 
Variable 3 
Collagen coating vs. No-
collagen  
1. Microscopic observation of 
cell attachment 
2. Confluency at 96 h 
Variable 4 CCM1 vs. CCM2 
1. Confluency at 96 h 
2. Viability at 96 h 
Variable 5 Seeding volume 1. Confluence at 96 h 
*CCM: Cell Culture Medium 
 
Variable # 1: Nasal lavage technique 
Head back: In this method, the volunteer was asked to tilt their head back at 
~30 degrees, press one nostril closed and self-administer the PBS spray to the open 
nostril. During the spraying process the patient was asked neither to breathe nor 
swallow. After 10 metered aliquots of ~ 0.1 mL were sprayed into the nostril the 
volunteer was asked to tilt their head forward and allow the fluid to drip into a sterile 
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Head forward: In this method, the volunteer was asked to tilt their head 
forward, press one nostril closed and whilst taking a deep breath spray the PBS into 
the open nostril. The intake of breath whilst spraying creates a negative pressure 
which prevents the PBS from dripping out of the nostril. After 10 metered aliquots 
were administered, the fluid was collected in a beaker glass as described in 3.2.2. 
 
Variable # 2: Filtration of nasal lavage fluid 
In phases I-II, collected lavage samples were processed immediately without a 
filtration step. During phase III experiments, the collected lavage fluid was passed 
through a nylon filter by pouring the lavage on a nylon filter with a pore size.of 100 
µm to remove nasal debris and reduce contamination upon culturing.  
 
Variable # 3: Collagen coating of growth surface  
The cell-support materials and coatings most commonly used for culturing 
human nasal epithelial cells can be seen in Table 2-1. Collagen coating has been used 
by a number of research groups to enhance the attachment of cells. 
In phase I cells were seeded directly onto plastic tissue culture 96 well plates. In 
phases II and III plates were coated by preparing a solution containing 17.6 mL of 
Laboratory of Human Carcinogenesis (LHC) basal medium of Lechner and LaVeck 
(126), 2.0 mL of bovine serum albumin suspended in double distilled water at a 
concentration of 1 mg/ml and 0.4 mL of collagen I suspended in double distilled 
water at a concentration of 2.9 mg/ml. Collagen coating solution (100 µl) was then 
added to each well of the 96-well plate. The plate was stored in an incubator at 37°C 
overnight. After incubation, all the coating solution was removed from each well and 
the plate was allowed to dry under aseptic conditions for at least one hour. 
 
Variable # 4: Cell culture medium  
The medium and its supplements are primary factors affecting the viability, 
proliferation and differentiation of the cells in culture. A wide range of cell culture 
media and medium supplements have been used in culturing of primary human nasal 
epithelial cells (Table 2-1). Since no preference for a particular medium composition 
can be derived from Table 2-1, two simple media were chosen initially for practical 
and economic reasons. The primary difference lies in the quantity of fetal bovine calf 
serum used in each medium. Table 2-3 summarises each of the components. 
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Table 2-3: Contents of cell culture medium used 
 Cell Culture Medium 1 (CCM1) Cell Culture Medium 2 (CCM2) 
Name 
Dulbecco's Modified Eagle 
Medium containing Ham’s 
nutrient (DMEM/F12) 
Dulbecco's Modified Eagle 
Medium containing Ham’s 
nutrient (DMEM/F12) 
Supplements 
Fetal bovine serum (FBS) 10% 
L-Glutamine 1% 
Non-essential amino acids 1% 
Penicillin-Streptomycin solution 
Fetal bovine serum (FBS) 20% 
L-Glutamine 1% 
Non-essential amino acids 1% 
Penicillin-Streptomycin solution 
 
Variable # 5: Cell seeding volume  
Seeding volumes: After lavage, the centrifuged cells were re-suspended in 
different volumes either 100 µl (SV1), 300 µl (SV2) or 500 µl (SV3) of cell culture 
medium immediately before seeding. Cell multiplication was evaluated after 96 h by 
qualitative assessment of the area covered by the cells in each well using microscopy. 
 
2.3 Results 
2.3.1 Nasal lavage 
The lavage procedure took about 5 min to complete. In total 90 nasal lavages 
were performed on a volunteer population of 25 subjects. Of these 36 lavages were 
performed according to the Head Back technique and 54 were performed according to 
the Head Forward technique. The mean age and standard deviation of study was 29 ± 
9 years. There were 10 females and 15 male subjects. There was no pain or 
discomfort experienced by any volunteer. There was no bleeding observed in any 
volunteer although red blood cells were observed in 18 lavage samples after 
centrifugation.  
 
2.3.2  Lavage collection and cell viability 
The mean volume of lavage fluid collected, total cell count and cell viability 
data from each lavage technique is compiled in Table 2-4.  
 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 63 - 
Chapter 2 – A begin methology for establishing primary human nasal cell culture 
 
Table 2-4: Nasal lavage volumes and cell counts according to each lavage technique. Values listed 
are the mean ± SD. 
Lavage 
Technique 







Head Back 18 4.0 ± 0.4 
157941 ± 
47311 
76212 ± 28968 47.5 ± 6.5 
Head 
Forward 





53.0 ± 7.0 
*There is a significant difference in the volume of lavage collected, total cell count and the viable 
cell count between the Head Back technique and Head Forward technique with P<0.001 for all 
three variables. 
 
As it can be seen from Table 2-4, the Head Back lavage technique led to a loss 
of sprayed PBS as some quantity always hit the back of the throat and was swallowed. 
The Head Forward technique led to a better recovery of lavage fluid, with a fairly 
consistent volume of lavage of 5-6 mL collected each time. The number of cells 
collected by the Head Forward technique was also higher, while the percentage of 
viable cells collected by each method was equivalent between 40-60%.  
 
2.3.3 Differential cell staining for microscopic examination of 
nasala lavage 
MGG staining was performed and cells identified by their structure as 
epithelial cells, neutrophils, eosinophils, lymphocytes, basophils, mast cells and 
erythrocytes. MGG staining was performed in 6 samples from phase III which filtered 
and all the samples showed the presence of a substantial amount of epithelial cells in 
the lavage fluid (Figure 2-10 A). In some cases, neutrophils could be seen under the 
microscope after MGG staining (Figure 2-10-B).  
The Figure 2-10 below shows microscopic images of MGG-stained cytospin 
preparations of fresh nasal lavage as observed under Olympus X50 microscope at 
200X magnification.  
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The differential count of MCG-stained cell samples (filtered and using head 
forward nasal lavage technique) showed that 90% of the cells were epithelial in nature 
(Table 2-5). 
 
Table 2-5: Differential count performed on cells recovered from the nasal cavity of human 


















1 6 2.5 41 97 3 0 
2 5 3.2 49.5 86 14 0 
3 6 4 39.3 72 28 0 
4 5.5 3.3 61.2 94 3 3 
5 6.5 1.8 48.5 94 6 0 
6 5.5 2.5 49.3 93 7 0 
Mean 5.8 2.8 48.1 89.3 10.2 0.5 




Figure 2-10: MGG-stained nasal lavage sample showing presence of squamous epithelial cells, 
red blood cells and neutrophils. Samples were observed under observed under Olympus X50 
microscope at 200X magnification. 
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2.3.4 Optimization of lavage and culture methods 
A summary of results for Phases I-III of the study to establish cell harvesting 
and culturing conditions is provided in Table 2-6. In Phase I it was determined 
qualitatively that a lower seeding volume (and thus a higher seeding density) led to 
better cell adherence, although cells did not grow to confluency during this 
experimental phase. In Phase II, a similar qualitative assessment of cell growth 
suggested that collagen coating of the growth surface led to better cell adherence and 
multiplication. This study also showed that cell culture medium two was better for 
cell multiplication, although confluency was not achieved. In Phase III it was 
determined that the Head Forward lavage technique resulted in the recovery of a 
significantly larger volume of nasal lavage fluid (Table 2-4) and a significantly 
greater number of collected nasal cells. In a further innovation, it was shown in Phase 
III that filtration of the lavage fluid reduced nasal debris, although it was not 
eliminated completely. This step was shown to significantly reduce the number of 
cultures that developed microbial contamination compared to unfiltered cultures. 
Confluence of cells in phase III was not achieved either and attempts to passage cells 
when seeded at confluence failed. 
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Table 2-6: Compiled results from phase I – III of the cell harvesting and culture conditions optimisation experiments. 
Variable 
1 
Outcome Variable 2 Outcome Variable 3 Outcome 
Variable 
4 












































SV3 (n=6) 0/6   (0%) 
SV2 (n=6) 0/6   (0%) 
SV1 (n=6) 0/6   (0%)  
Result: Seeding Density 1 showed better multiplication of cells at t=96 hrs although confluency was not reached at 96 h 





























SV1 (n=6) 0/6   (0%) 
Result: Coated surface showed better cell adherence and CCM2 showed better cell multiplication at t=96 hrs though confluence was not reached 












































Result: Filtration leads to reduction in the amount of debris in the seeded cells, reduces contamination rate but complete debris removal was not possible 
using 100 µm nylon filters. *CCM = cell culture medium, SV = seeding volume. 
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2.4 Discussion 
This study aimed to optimise and characterise a primary nasal epithelial cell 
culture system involving atraumatic collection of nasal cells. Nasal cells or tissue 
sampled from the nasal cavity may originate from four different domains (127): (i) 
the vestibular area, covered by a stratified, keratinized and squamous epithelium 
including strong hairs which filter particles; (ii) the atrium, representing an 
intermediate zone lined with transitional epithelium, squamous at the anterior part 
and with microvilli at the posterior part; (iii) the three turbinates located on the 
lateral nasal walls and (iv) the olfactory epithelium which is above the medium 
turbinate consisting of specialized olfactory cells.  
Fundamentally, there are three different groups of technique to sample nasal 
epithelial material for the development of human nasal primary cell culture systems, 
i.e. atraumatic methods, traumatic methods and post mortem biopsy (115). Main 
advantages of the traumatic method and the post mortem method is usually the high 
number of cells harvested. The major disadvantage is that traumatic sampling can 
rarely be repeated. As primary cell culture passaging is limited to a maximum of 
about three subsequent passages (128) per sample repeated sampling from the same 
subject and from the same area may be required.  
Some of the atraumatic methods can meet this requirement. Pipkorn and 
Karlsson (129, 130) gave an overview on the atraumatic methods used for obtaining 
specimens from the nasal mucosa. Such techniques include nasal smears, blow 
secretion, nasal lavage, scraping from nasal mucosa, brush techniques and imprints. 
These techniques are easy to perform but suffer from the low amount of cells 
obtained which might be insufficient to allow the culture of confluent cell layers. By 
utilizing a fairly large volume for nasal lavage which covers a large surface area it is 




 cells per sampling (129, 130). Thus the nasal 
lavage technique may provide enough cells for cell culturing but the shortcomings of 
these methods are: an exact sampling site can not be standardized and mainly 
superficial cells are obtained (115).  
For the successful development of a primary cell culture model in general 
many factors have to be considered, namely method of procuring the cells, seeding 
density, support membrane (e.g. polyester, collagen and polycarbonate membranes), 
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medium composition (to improve cell growth and differentiation), feeding regimen, 
culture time, cell heterogeneity, cell viability, reproducibility and costs involved. No 
specific approach in the culturing of primary human nasal epithelial cells is generally 
superior to another, and the method selection depends on the scientific goal of the 
study (131).  
The pre-optimization studies performed showed the importance of each 
variable. Studies to optimize the technique developed in this chapter showed that: 
Lavage Technique: Different methods have been proposed to perform nasal 
lavage (132-135). The number of cells obtained may be low depending on the 
method used for nasal lavage (135, 136). The analysis of cells obtained by nasal 
lavage presents some problems such as mucus aggregates or broken cells interfering 
in the assessment of total and differential cell counts and this might lead to 
misrepresentation of results. The results in Table 2-4 indicate that the lavage 
technique is extremely important in determining not only the volume of recovered 
lavage fluid, but also the total number of cells collected. Interestingly, the percentage 
of viable cells did not significantly differ according to the lavage method and ranged 
between 47% and 52%, irrespective of the lavage technique used. These results are in 
good agreement with results obtained by Prat and co-workers (137, 137, 138). They 
analysed cells obtained by nasal lavage by instilling 5 ml of sterile saline solution in 
each nostril with the subject's head tilted backwards at a 30º angle. They reported an 
average total cell count of 1.27 x 10
5
 ± 0.41 x10
5





 cells/ml in this study using a similar technique). Although they did not 
report the viable cell count, they observed that cell viability was low and ranged 
between 60% and 70%. The total number of cells increased considerably when using 
the head forward technique (Table 2-4; P<0.001). This can be explained by the fact 
that with the head tilted backwards a proportion of PBS was lost from the nose to the 
back of the throat. This is reflected by the difference in the volume of lavage 
collected by the two different methods employed (Table 2-4; P<0.001).  
Prat and coworkers also reported that their nasal lavage samples contained 70 
± 7 % epithelial cells, 26 ± 7% neutrophils and 0.56 ± 0.3% eosinophils. In this 
study, microscopic examination of the nasal lavage fluid, using MGG staining to 
differentiate the cell types, confirmed the presence of epithelial cells and neutrophils. 
However, eosinophils were not detected in any of the samples investigated in this 
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study. Differential cell count performed on the 6 samples (filterd) stained using 
MGG staining technique showed that 90% of the cells were epithelial in nature and 
10% were neutrophils (Table 2-5). 
Filtration: Mosler and co-workers (124) performed a microbiological 
investigation on samples of nasal epithelial cells obtained by brushing technique. 
They cultured the aliquots of the centrifuged medium on horse blood and chocolate 
blood agar and identified S. aureus, S. pmeumoniae, H. Influenza, streptococci, 
staphylococci, Neisseria species and Corynebacterium species. The pre-optimization 
study showed that filtration of the lavage sample before centrifugation leads to a 
cleaner debris free sample and reduces the chances of contamination. It can be seen 
from the results in Table 2-6 that the percentage of contamination came down to 44% 
(n=18) from 60% (n=30). This can be attributed to the fact that filtration helped in 
removing mucus aggregates and other nasal debris in the nasal lavage which may 
contain the infection causing organisms. The presence of bacteria in nasal mucus was 
analyzed by Park and co-workers (139). They sampled mucus from 36 individuals 
and found that only 6 were sterile while the remaining 30 were non-sterile. This 
finding suggests that filtration will play a very important role in reducing the chances 
of contamination. In this study a 100 µm pore size nylon filter was used but we were 
not able to remove all the debris. Other groups (120, 140) have used 60-70 µm pore 
size nylon filters. Reducing the pore size of the nylon filter might further help in 
reduction of nasal debris. This hypothesis needs to be analyzed further.  
Collagen coating: Dissociated nasal epithelial cells have been grown on 
plastic tissue culture dishes, glass or plastic cover slips, microporous inorganic 
membranes, collagen treated culture dishes and inorganic membranes, collagen 
matrices, floating collagen gels and full collagen membranes. The type of surface on 
which the cells grow influences the preservation of specific phenotypic 
characteristics (141) and the development of specialized epithelial functions such as 
barrier formation and vectorial transport of solutes (142). In this study, we also 
showed the importance of collagen coating which can be explained by the fact that 
being a part of the lamina propria, collagen may improve cell attachment efficiency 
(128, 143), cell proliferation (128), and cell differentiation (144). On the other hand 
Werner and Kissel (68) found no differences in cell growth and proliferation between 
untreated and collagen treated supports. This may be difficult to explain knowing the 
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fact that nasal epithelial cells which do not have hemidesmosomes and attach to the 
basement membrane only by cell-adhesion molecules like laminin and fibronectin 
(106). In this study the use of collagen I showed better attachment of cells which can 
be explained by the fact that the respiratory basement membrane is composed of 
mainly collagen fibres (106). Consequently, biological matrix such as collagen is 
important to obtain a stable and reproducible nasal culture system.  
Cell culture medium: The medium and its supplements are primary factors 
affecting the viability, proliferation and differentiation of cells in culture. A wide 
range of cell culture medium and medium supplements has been used in human nasal 
epithelial cell cultures (Table 2-1). The media that been proven to be the best for 
culturing of freshly isolated human nasal epithelial cells are; Dulbecco’s modified 
Eagle’s medium (DMEM); Ham’s F-12; Bronchial epithelial growth medium 
(BEGM); and the 1:1 mixtures of DMEM:Ham’s F-12 and BEGM:DMEM. Results 
from the study by Mattinger and co-workers (145) indicate that BEGM medium with 
added supplements provided optimal conditions for growth, expansion, viability and 
morphology of primary human nasal epithelial cells and their passages. From the 
abundance of information on cell culture medium suitable for primary human nasal 
cell culture (Table 2-1) it cannot be concluded which medium is best suited. 
Therefore, for this study we started with the use of a very simple cell culture medium 
for practical and economic reasons. Wu and co-workers (128) identified three 
substances improving the in-vitro culture of human nasal epithelial cells: 
hydrocortisone, cholera toxin, T3 and epidermal cell growth supplement. Insulin was 
also identified to be critical for multiplication of cells.  
 Insulin initiates its action by binding to a glycoprotein receptor (insulin 
receptor) on the surface of the cell. Binding to this receptor generates a signal that 
eventually results in insulin's action on glucose, lipid and protein metabolism. The 
growth-promoting effects of insulin appear to occur through activation of receptors 
for the family of related insulin-like growth factors (IGFs) (146-149). In cell culture, 
insulin is a component of serum-free media formulations for all primary cells and 
cell lines so far examined. In addition to the stimulation of cell growth, classical 
insulin responses such as increased fatty acid and glycogen synthesis are seen in 
serum-free medium. 
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Four agents known to increase the level of cellular cAMP by different means 
(cholera toxin, dibutyryl cAMP, methyl isobutyl xanthine and isoproterenol) increase 
the growth of colonies of cultured human epidermal cells and of keratinocytes 
derived from other stratified squamous epithelia. This effect is due to an increase in 
the overall rate of cell proliferation in the colonies. The increased proliferation in the 
presence of the toxin is associated with an increased proportion of small cells known 
to include the multiplying fraction. The use of the toxin makes the cultivation of 
keratinocytes from epidermis and other stratified squamous epithelia much easier and 
prolongs the culture life of the cells (150). 
As it can be seen from Table 2-1, a number of research groups have used 
serum-free culture medium which offers several advantages as compared to serum-
supplemented culture medium. Serum-free culture medium does not have any 
qualitative or quantitative variabilities of the additives caused by serum and the 
microbiological contaminations can be omitted (145). Furthermore they found that 
supplementation with epinephrine caused increased viability, short population 
doubling time and increased passages. They also found that use of epidermal growth 
factor and bovine pituitary extract increased the viability. The essential and 
synergistic effects of EGF with insulin on human keratinocyte spreading and 
proliferation have been described by other authors (151, 152). This may be attributed 
to the fact that insulin or insulin like growth factor I (IGF-I) increase cell surface 
EGF receptors and this effect in part may be responsible for the synergism (153).  
Heme toxicity: Some of the lavage samples collected showed the presence of 
red blood cells. This was more often seen during the dry summer season when the 
nose was dry. Nasal drying is a common cause of nose bleeds. In the cases where 
RBC was present in the lavage collected, epithelial cell growth could not be seen as 
the lysis of RBC leads to the release of free heme in the cell culture medium which 
might be toxic for cells. Iron-derived reactive oxygen species (ROS) are implicated 
in the pathogenesis of numerous vascular disorders including atherosclerosis, 
microangiopathic hemolytic anemia, and vasculitis and reperfusion injury. One 
abundant source of redox-active iron is heme released from intracellular heme 
proteins. Free heme damages lipid, protein, and DNA through the generation of 
ROS. Heme and heme proteins have been implicated in a variety of toxic effects 
through oxidation of lipid (154-158). Heme in the aqueous phase frequently 
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aggregates in the membrane and promotes oxidation, which leads to the enhancement 
of permeability and membrane disorder. Oxidation of membrane components may 
promote cell lysis and death (159, 160). The red blood cells could be removed by 
changing the cell culture medium at t=6 h after seeding based on the hypothesis that 
RBC and epithelial cells would have differential adherence rates. 
Seeding density: From the literature review (Table 2-1) it can be seen that 
most of the research groups cultured the primary human nasal epithelial cells on air-
liquid interface. It has also been reported that cells were seeded at 20,000 to 35,000 
cells per cm
2
 at ALI by Auger and co-workers (122) and they reported confluent 
monolayer formation. Other research groups have generally seeded the cells at a 






. Mosler and co-workers (124) used 
brushing technique to collect nasal epithelial cell samples from infants and they 
found that a minimum seeding density of 50,000 viable cells/cm
2
 was necessary for 
successful culturing of cells. The seeding density according to the head forward 





A procedure was established for the atraumatic collection of nasal epithelial 
cells. These cells morphologically appear to be squamous epithelial cells in nature. 
These cells can be cultured to confluence but not passaged. However, this method 
will require further adaptations and verifications (especially characteristics of the cell 
type) before it can be successfully used as a model for studying nanoparticle toxicity 
in the nose. 
This model offers the opportunity to investigate an important question: to 
what extent do inhaled nanoparticles cause inflammation to the nasal epithelium. 
This model potentially provides the opportunity of scaling up the data from results 
based on 8 to 10 individuals at the maximum (Table 2-1) to a statistically significant 
number of human beings. However, to grown the cells successfully further 
modifications are required to the culturing technique. Although primary human nasal 
cells are readily obtained, the capacity offered by this system to perform extensive in 
vitro toxicity is currently much less than that of immortalised cell lines, which are 
utilised in subsequent chapters.  
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Chapter 3                                          
Particle kinetics in assay systems: 
Delivered dose 
3.1 Introduction 
Our interest in identifying, understanding, and addressing potential risks to 
human health and the environment due to NPs has increased because of the rapid 
expansion of engineered nanomaterials designed for use in consumer products. To 
understand these risks, controlled laboratory toxicology experiments are conducted 
on a variety of biological systems ranging from simple cell culture systems to more 
complex animal or human models. The usual aim of these experiments is to obtain 
biologically relevant information which might help in predicting potentially harmful 
effect in human beings upon exposure to nanomaterials. When cell culture models 
are used in the laboratory for toxicological experiments it would be ideal to use doses 
of NP which reflect particle deposition in the human respiratory tract (which may or 
may not be possible depending on the analytical technique used) for a more robust 
extrapolation of results from in vitro experiments to in vivo experiments. However, 
NPs in cell culture medium are in a dynamic state where they are settling, diffusing, 
aggregating based upon the NP properties and the characteristics of the medium (88). 
This affects their transport to the cells which makes the definition of dose for NP in 
an in vitro system more complicated (88, 90). The aim of this chapter is to 
understand the colloidal behaviour of NP in suspension and improve the 
understanding of NP dose in an in vitro system. 
 
3.1.1 Dosimetry 
The search for the appropriate dose metric for evaluating biological effects of 
NPs has been central to addressing the toxicity of nanomaterials. Oberdorster (161) 
highlights three areas which are significant in understanding nanomaterial toxicity 
compared with that of macroscale materials and/or constituent chemicals: dose, 
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biokinetics, and the significance of physicochemical properties. Evidence has 
emerged that, for some materials, the use of mass concentration alone as a dose 
metric can obscure associations between the material and biological behaviour (161), 
as can be seen from Figure 3-1. Other authors have highlighted the use of surface 






Figure 3-1: Dose response relationship for instilled ultrafine (20 nm primary particle size) and 
fine (250 nm primary particle size) titanium dioxide particles 24 h after intratracheal 
instillation in rats. (A) Correlation between particle mass and lavaged polymorphonuclear 
neutrophils (PMN’s) and (B) correlation between instilled particle surface area and lavaged 
PMN’s. Figure reproduced from Oberdorester et al. (165, 166).  
 
However, Wittmaack et al. (167) challenged the findings of Oberdorester et 
al. (165, 166) and Stoeger et al. (164) by recalculating the data presented by the 
authors and suggesting that particle number rather than surface area is a more 
suitable dose metric for evaluating dose-response relationships for particle-induced 
inflammation particularly for differently prepared carbon nanoparticles. The 
discussion of appropriate dose metric in vitro was started by Limbach et al. (168) 
who debated that uptake of oxide NPs by human lung fibroblast cells were affected 
by particle size, density and agglomeration state and due to diffusion and 
gravitational settling of particles this would impact delivery of particles to cell 
monolayers. Figure 3-2 shows the three ways which people have generally used to 
quote dose – one is nominal dose in terms of mass, surface area or particle number 
which basically is the amount of particles put on the system, second is the delivered 
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dose which is basically the amount of NPs actually reaching the cells and third is the 
cellular dose which is the amount of NPs internalized by the cells.  
 
 
Figure 3-2: Definitions of dose metrics for accurate assessment of in vitro particle-cell 
interactions (Khanbeigi et al. (169)) 
 
In a typical in vitro experiment, cells are immobilized at the bottom of a 
culture plate or on a substrate placed at the bottom of a culture plate, and incubated 
with a suspension of NPs. The NPs are assumed to be well-dispersed in the culture 
medium so the concentration of NPs at the cell surface is assumed to be the same as 
that of the initial bulk concentration. However, particles in suspension are not only 
under the effect of gravity but also undergo diffusional movements (driven by both 
Brownian motion and regional concentration gradients), which means that not all the 
particles in the suspension will reach the cells.  
Limbach et al. (88) and Teeguarden et al. (90) have identified discrepancies between 
the amount of a material introduced to in vitro cell cultures, i.e. the administered 
dose, and the amount of material cells are able to interact with after a given exposure 
time, i.e. the delivered dose. As particles form a dynamic concentration gradient 
within the suspension medium, there are indications that over short incubation 
periods actual doses of material interacting with cells may be orders of magnitude 
lower than assumed. Limbach et al. (88) measured the cellular dose of internalized 
25-50 nm cerium oxide nanoparticles and compared it to the cellular dose of 250-500 
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nm cerium oxide nanoparticles in human lung fibroblasts. Separately, they calculated 
the delivered dose by assuming that small particles reached the cell layer by diffusion 
only and larger particles reached the cell layer via sedimentation. They then 
compared their predicted delivered dose values with measured cellular doses (i.e. 
after exposing the cells to the NPs for different exposure times, the cells were dried 
and elemental analysis was performed for quantification of NP uptake). The cellular 
dose of 25 nm ceria oxide nanoparticles correlated extremely well with the predicted 
delivered dose (based on Stokes’-Einstein diffusion). A number of mechanisms 
explain the effective internalization of these relatively small particles (especially at 
low particle doses). One such mechanism is the endocytic pathways with small 
vesicle structures, which is an especially prevalent pathway in fibroblast cells (170) 
and can be found during calveolae-mediated endocytosis (vesicle size 60-80 nm) 
(171). On the contrary, particles of large sizes (320 nm) are excluded from these 
pathways and therefore show a limited uptake rate compared to small particles. This 
results in discrepancies between the delivered vs cellular dose (88).  
In the case of small or low density particles, diffusion-limited transport 
dominates whereas for large or high density particles, the transport is mainly driven 
by gravitational settling. The results of Limbach et al. indicate that the computed 
delivered dose values are realistic for particles of different sizes, densities and 
agglomerate states (88). Using the same mathematical model, Teeguarden et al. (90) 
theoretically showed that the process of particle transport not only affected the 
particle uptake but also the relative toxicity. In the study, Teeguarden et al. 
calculated separate values for particles that reach the cell layer by either 
sedimentation (gravity) or diffusion (Brownian motion) and summated the two 
values to obtain delivered does for a given experiment. Teeguarden et al. (90) then 
re-analyzed published data of lactate dehydrogenase release from a study by Hussain 
et al. (91), who had reported the cytotoxicity (EC50 value) for various nanoparticles 
(1000 nm cadmium oxide NP (CdO), 15 and 100 nm silver NP (Ag) and 30 and 150 
nm molybdenum trioxide NP (MoO3)) on rat BRL 3A liver cells. The analysis by 
Teeguarden provided EC50 values as normalized to the delivered dose of particles 
(0.005 to 0.66 cm
2
/ml). The post hoc analysis contrasted dramatically with the EC50 
value range calculated by Hussain et al. (0.005 to 89.3 cm
2
/ml), who normalized 
their results to the administered surface area dose (Table 3:1).  
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The purpose of the Teeguarden et al. study was to highlight the discrepancy 
in the administered surface area dose and transport adjusted (delivered) surface area 
dose. The study shows the relevance of normalizing in vitro results to the delivered 
dose when reporting the cytotoxicity data. The consequence of reporting data 
normalised to the administered dose is that artificially high values may be reported, 
biasing the results of efficacy and safety studies.  
 
Table 3:1: Recalculation of EC50 values by Teeguarden et al. (90) after taking into account the 
particle transport.  
Particle Type EC50 Administered Surface 




EC50 Particle Transport 





CdO-1000 nm 0.005 0.005 
Ag 100-nm 1.37 0.02 
Ag 15-nm 19.0 0.272 
MoO3 150-nm 21.3 0.262 
MoO3 30-nm 89.4 0.663 
 
Hinderliter et al. (89) further refined the study by Teeguarden et al. (90). The 
improved model is based on a parabolic partial differentiation equation (Equation 1), 
which was independently developed by both Smoluchowski (172) and Mason and 
Weaver (173). The equation (Equation 3-1) calculates the particle movement through a 
fluid (i.e. towards the cell layer) under a set of defined boundary conditions. The 
resulting particokinetic model by Hinderliter became known as the In Vitro 
Sedimentation, Diffusion and Dosimetry model or ISDD (89). The improved model 
calculates both sedimentation and diffusion simultaneously for the same particle and 
therefore excludes the drawback of the model by Teeguarden et al. (90) of 
potentially counting particles twice in the delivered dose calculation. Using the ISDD 
model, Hinderliter et al. (89) theoretically demonstrate the dramatic effects of 
altering not only nanoparticle composition, density, incubation time and particle size 
distribution, but also the influence of different cell culture medium volumes and 
agglomerate fractal densities. 
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 n: particle concentration (number or mass/mL) 
 t: time (s) 
 D: Stokes-Einstein diffusion rate (m2s) 
 x: distance travelled (m) 
 V: Stoke’s sedimentation velocity (ms-1) 
 
The focus of the studies presented is based on the theoretical aspects of the 
colloidal behaviour in a suspension, however provide limited in vitro cell culture data 
to demonstrate a robust use of the model in practice. In addition, particokinetic 
modelling in drug delivery and nanotoxicity research has not been explored and may 
prove a useful technique in assessing the safety of NPs with regards to in vitro-in 
vivo correlation. Further the ISDD model developed above requires expensive 
programming platform Matlab
®
 to calculate delivered dose value.  
Thus the aim of this work was to develop an easy-to-use model taking into 
consideration the non-agglomerate particle size polydispersity. 
 
3.1.2 Theory of sedimentation and diffusion 
In contrast to soluble chemicals, particles can settle, diffuse and aggregate in 
fluids. It is thus important to understand their physical behaviour in fluids to 
understand the dynamics of dosing. Nanoparticles in suspension are under the 
influence of gravity and undergo diffusion which is the net migration of particles 
from regions of high to low concentration (Figure 3-3). To understand the dynamics 
of particle transport in fluids a simple model describing particle sedimentation and 
particle flux is derived. 
A video by Clift et al. (174) of live imaging of J774.A1 cells treated with 
fluorescently labelled polystyrene nanoparticles of 20 and 200 nm for 60 min clearly 
demonstrates the gravitational and diffusional influenced movement of NPs. The 
forces acting on a particle in suspension are illustrated in Figure 3-4. 
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Figure 3-3: Diagramatic summary of nanoparticle behavior in suspension in traditionally used 
in vitro toxicity testing experimental setup. Nanoparticles in suspension are under the influence 
of gravity and diffuse from regions of high concentration to low concentration. The colloidal 
behavior of the particle suspension will have an important impact on the effective dose of 
particles to interact with cells and elicit a response (e.g. internalization, membrane damage, 
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Figure 3-4: Illustration of forces acting on a particle in suspension. 
Gravitational Settling: Gravitational settling can be determined by the 
balance of forces acting on a particle in suspension. The forces which act on the 
particle in suspension are buoyancy and drag forces resisting the movement of the 
particle under the influence of gravity as illustrated in Figure 3-4. 
The gravitational force acting on the particle is a function of its mass which is 
dependent upon the density and the size of the particle. Buoyancy is equal to the 
mass of fluid medium displaced which is equivalent to the volume of the particle 
(size) and the density of the fluid medium. The only other force remaining is drag 
force which is dependent upon the size of the particle, the viscosity of the fluid and 
the particle velocity. Terminal velocity or settling velocity is reached when there is a 
steady-state situation where this velocity becomes constant. This terminal velocity 
can be derived using Stoke’s law: 
 
    






 Vs is the particle’s settling velocity (m s
-1
), 
 g is the gravitational acceleration (m s
-2
), 
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 ρs is the mass density of the particles (kg m
-3
),  
 ρmis the mass density of the fluid (kg m
-3
), 
    is the fluid's viscosity (kg m-1 s-1), 
 r is the radius of the particle (m). 
 
Diffusional Motion: Diffusion is the random movement of particles from 
regions of higher concentration to regions of lower concentration (Figure 3-3). There 
is no net transport by diffusion when a system is at equilibrium. However, in an in 
vitro cell culture setup the cells internalize the particles thus making them 
unavailable in the suspension. This creates a concentration gradient at the medium 
layer immediately above the cells which drives the diffusion process. This transport 





    




 c is the particle’s concentration (kg m-3), 





 t is the time (s) 
 z is the spatial coordinate (from bottom to top of the culture well) (m). 
 














 T is the temperature (K) 
 N is the Avogadro’s number  
   is the fluid's viscosity (kg m-1 s-1), 
 r is the radius of the particle (m). 
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Further the Equation 3-4 and Equation 3-4 mathematically relate the 
sedimentation velocity and diffusion coefficient both to the hydrodynamic radius of 
the particle. Thus, prior to modelling the particle behaviour in suspension it is 
essential to characterize the particle size in the relevant medium. In the ISDD model 
the authors utilized the equations developed by Smoluchoski (172) and Mason and 
Weaver (173) to understand the behaviour of small articles settling in fluid and using 
Matlab
®
 to solve the Equation 3-1 the authors calculated the predicted deposited 
dose. 
 
3.2 Aims and objectives 
The aim of this chapter was to develop an Excel program for the calculation 
of delivered dose based on Stoke’s law of sedimentation and Fick’s second law 
(describing diffusion), and to verify output of this model by comparing it to the 
ISDD model developed by Hinderliter et al. (89). Further, the delivered dose values 
produced by the Excel model will be compared with experimental data from 
Khanbeigi et al. measuring uptake of 50, 100, 200, 700 and 1000 nm polystyrene 
beads by murine macrophages (J774.1).  
 









3.3.2.1 Theoretical elements of the particokinetics program developed 
Calculating the number of particles reaching the bottom of the well due to 
gravitational settling 
For the purpose of developing the program, we must know the shape and 
dimension of the vessel in which the particles diffuse. Typically cells are cultured in 
tissue culture plates which are cylindrical in nature as illustrated in Figure 3-5. 
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Figure 3-5: Typical cell culture plate which is cylindrical in nature and cells are at the bottom 
of the well. 
After culturing the cells for 24 h in the incubator, equal volumes of NP 
suspension prepared in the same media in which the cells were cultured are added to 
the cells. At this time point (t = 0 h) the particles are assumed to be homogeneously 
distributed through the medium (Figure 3-6).  
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 84 - 
Chapter 4 – In vitro nanoparticle toxicology incorporating particokinetic modelling of dose 
 
To calculate the number of particles reaching the cells by sedimentation we 
divide the total volume occupied by the cell culture medium into cylinders which are 
1 µm high and have the same surface area as that of the tissue culture plate. Let’s say 
the total number of such cylinders is ‘b’. Since we have assumed homogeneous 
distribution of particles we can calculate the number of particles contained in each of 
these 1 µm high cylinders by dividing the total number of particles ‘a’ by the total 
number of cylinders ‘b’. Now we can calculate the total distance travelled ‘l’ (m) by 
a given particle by multiplying the gravitational settling velocity Vs (m/s) with 
exposure time of the experiment ‘t’ (s) . In the end, the total number of particles 
reaching the cell layer would be equal to the number particles contained in all 1 μm-
thick cylinders that can be contained within a height equal to the maximum distance 
a particle with a given size may sediment i.e. ‘l’ (m). So the number of particles 
reaching the bottom of the well can be calculated by Equation 3-5. 
 
     






    
 
Figure 3-6: Calculation of particles reaching the bottom of the well by gravitational settling. 
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Equation 3-5 
 
Calculating the number of particles reaching the bottom of the well due to 
diffusion 
For calculation of the rate of diffusion, particles were assumed to diffuse in 
the liquid toward the cells in one dimension (top to bottom of the culture well). This 
is a reasonable assumption because diffusion is a concentration-driven phenomenon. 
Under the experimental conditions we have assumed uniform distribution of particles 
in each of the 1 µm cylinders (Figure 3-6). The only direction where concentration 
gradient exists is along the z- axis as particle internalization by cells at the bottom of 
the plate maintain constant sink conditions. However, along the x-axis and y-axis 
there is no concentration gradient (due to uniform particle distribution) so there will 
be no diffusion along these axes. Net diffusional movement driven by Brownian 
motion is regarded as zero in this model, due to the fact that Brownian motion occurs 
in all directions and therefore cancels itself out. This concentration gradient-driven 
















Figure 3-7: Typical cell culture plate which is cylindrical in nature and cells are at the bottom 
of the well. The particles are added at t = 0 h.  
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At time point (t=0) the particle suspension has just been added to the well. 
This means that the particle concentration throughout the media at any position (i.e. 
any given z along the vertical axis) is the initial concentration of particles (Cinitial) 
(Figure 3-7). 
Equation 3-3 was solved according to the method by Cussler et al. (175). To 
solve Fick’s second law of diffusion the authors applied the following experimental 
boundary conditions which are based on an assumption of very short contact time: 
Assumption: t+Δt reflects the assumption of very short contact times. At such early 
time points, the particles barely have a chance to diffuse through a given cross 
sectional area and reach the cell monolayer surface (defined as the interface; position 
z = 0). 
Therefore, at time point t+Δt, we assume that particles didn’t have a chance 
to diffuse. So the concentration at position z=0 would still be 0 and at any other 
given position z (z = ∞) would be equal to the initial concentration of particles Cinitial. 
 
t=0, all z: C=Cinitial 
t+Δt, z=0: C=0 
t+Δt, z=∞: C=Cinitial 
Using the above boundary conditions, Cussler (175) provided the solution for 




) across the interface (z=0): 
 
    
 
  






After the exposure period (t = t) some particles would have reached the cells 
while others might still be suspended in the media (Figure 3-8). 
After calculating the number of particles reaching the bottom of the well by 
sedimentation and diffusion using Equations 3-5 and 3-6, respectively, we can 
calculate the total number of particles reaching the bottom of the well by adding the 
two values. A similar approach was taken by Teeguarden et al. (90) but they used a 
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different equation to calculate the time required to diffuse a given distance in one 
dimension (Equation 4 in the paper).  
 Total particles reaching the bottom of the well = Nsed + Ndiff 
 
Figure 3-8: Illustration to show the situation after the exposure period t (h) where some 
particles would have reached the bottom of the well and others would still be suspended in the 
medium. 
 
3.3.2.2 ISDD model 
The Matlab
®
 code for the ISDD model was kindly provided by Justin G. 
Teeguarden (Biological Sciences Division, Pacific Northwest National Laboratory, 
Richland, WA, USA). The cell culture experiments were performed in 24-well plate 
with 200 µl of cell culture medium at 37°C. Dynamic viscosity of the cell culture 
medium was 0.736 mPa.s. The following variables were input into the ISDD model 
for calculating the delivered dose: Mean particle size (nm) = measured HD in 
DMEM/FBS10%; administered dose (μg/mL); and incubation time (h).  
 
3.3.2.3 Cell culture medium and particle size characterization 
All experimental work reported in this chapter was performed by Raha 
Ahmad Khanbeigi. The experimental conditions are described in detail here to 
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provide sufficient information to understand the verification and validation of the 
particokinetics model developed in this chapter. 
  The viscosity of the cell culture medium supplemented with 10% FBS 
(CCMFBS10%) was measured at 37°C using an AMVn Automated Micro Viscometer 
(Anton Parr). Briefly, the samples were loaded into the microcapillary and the 
viscosity was determined according to Höppler's falling ball principle.  
The polystyrene particles were characterized in two different media – water 
and cell culture medium with 10% serum (CCMFBS10%). The hydrodynamic 
diameters (HD) of fluorescent labelled polystyrene beads at particle sizes of 50, 100, 
200, 700 and 1000 nm were measured using photon correlation spectroscopy 
(Nanosizer, Malvern Instruments, UK) at a scattering angle of 173°. Suspensions (2 
mL) of each particle size were prepared in purified water (to verify manufacturer 
data) or DMEM without phenol red supplemented with 10% (v/v) FBS,1% sodium 
pyruvate, 1% penicillin/ streptomycin, 1% HEPES buffer and 1% L-glutamine 











 particles/200 μL for 50, 100, 200, 700, 1000 nm particles, respectively. The 
instrument parameters used for measurements in cell culture media were: Refractive 
index of particles=1.590, refractive index of DMEM /FBS10% = 1.337 (176), 
temperature = 37°C, dynamic viscosity of DMEM/FBS10% = 0.738x10
-3
 Pa s. The 
suspensions were incubated for 4 hours at 37°C with particle size measurements 
taken every 15 minutes. 
 
3.3.2.4 Macrophage cell culture 
J774.1 murine macrophage-like cells were cultured in DMEM supplemented 
with 10% fetal calf serum (FCS), 100 µM sodium pyruvate, 100 g/mL penicillin/ 
streptomycin, 100 µM HEPES buffer and 100 µM L-glutamine. (FCS was obtained 
from Gibco and all other supplements from Lonza). Cells were passaged twice 
weekly by scraping cells and splitting 1:10. 
 
3.3.2.5 Polystyrene nanoparticle uptake by macrophages 
J774A.1 cells were seeded in 24-well plates at a density of 1x10
6
 cells/well 
and incubated overnight in cell culture medium (DMEM supplemented with 10% 
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(vol/vol) FBS, 1% sodium pyruvate, 1% penicillin/ streptomycin, 1% HEPES buffer 
and 1% L-glutamine) in a humidified 5% CO2 incubator at 37°C. For treatment, the 
cell culture medium was removed and replenished with 200 μL fresh cell culture 
medium containing different concentrations of polystyrene beads (i.e. administration 
doses) according to the selected experimental conditions chosen for each particle 
size. To ensure uniform mixing, all latex bead suspensions were mixed vigorously 
prior to addition to cells. Negative controls comprised of cells treated with 200 μl 
fresh cell culture medium were included in all experiments. Depending on the 
selected experimental conditions, plates were incubated for 0.25, 0.5, 1 or 4 h, after 
which the medium was removed, cells were washed three times with PBS (37°C) and 
the plate was left exactly 18 h at room temperature to air dry under light exclusion. 
The dried monolayer was dissolved in 1mL N-methyl-pyrrolidone/ 25 mM Tris 
buffered saline pH 8.1 (1:3) and fluorescence was measured as described below. The 
number of latex beads associated with the cell monolayer was calculated from the 
corresponding calibration curve. For each exposure time and concentration the 
experiment was repeated six times using cell passage numbers 3-20. 
To determine the amount of particles taken up by macrophages, calibration 
curves were produced for each particle size, showing number of particles in 
suspension against the fluorescence measured. The cells for the uptake experiment 
were dissolved in 500L N-methylpyrrolidone/25mM Tris Buffer Saline pH 8.1 
(3:1), and after scraping were transferred to a 1.5mL microcentrifuge tube. This was 
repeated twice so that the final volume of liquid collected was 1000 L. The 
fluorescence in 1mL of the collected cell lysate was measured (Cary Eclipse 
Fluorescence Spectrophotometer-Varian) using a quartz cuvette (104F-QS 10mm) at 
excitation maxima of 468nm and emission maxima of 508nm (PMT = high (800 V), 
slit width of 5). 
 
3.4 Results 
3.4.1 Cell culture medium and particle characterization 
The viscosity of cell culture medium at 37 °C was found to be 0.736 ± 0.002 
mPa.s. Unmodified polystyrene beads were shown to remain stable in size over the 
duration of the four hour experimental period when suspended in DMEM/FBS10% 
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and incubated at 37°C (Figure 3-9); reproduced from (169)). However, a look at the 
particle size distribution data (Figure 3-10) showed that all the particles with the 

















Figure 3-9: Top panel: Particle size measurements of polystyrene beads in ultrapure water (A) 
and DMEM/FBS10% (B) over 4 h. The table includes HD values measured at the 4h time point, 
zeta potential and endotoxin content. All values listed represent the mean ± SD of n=3 
experiments. Figure reproduced from Khanbeigi et al. (169). 
 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 91 - 
Chapter 4 – In vitro nanoparticle toxicology incorporating particokinetic modelling of dose 
 
 
Figure 3-10: Examples of hydrodynamic diameter (intensity) distribution of polystyrene 
particles in DMEM/FBS10% (A) 50nm , (B) 100nm, (C) 200nm, (D) 700nm, (E) 1000nm. The 
measurements were taken every half an hour over 4h and traces are representative of n=3 
individual experiments. Figure reproduced from Khanbeigi et al. (169). 
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3.4.2 Comparison of Excel®- and ISDD-derived delivered dose 
values and experimentally derived cellular doses 
A comparison of the Excel
®
-based (abbreviated as EXCEL) and ISDD-
derived delivered dose values was carried out for polystyrene beads of 50, 100, 200, 
700 and 1000 nm particles after 4 h exposure to the macrophages (Figure 3-11). It 
can be seen that the EXCEL predicted delivered dose values had very little 
discrepence from the ISDD predicted delivered dose values. The error bars on the 
EXCEL model represents the variance in the frequency distribution data obtained 
from particle sizing experiment conducted three times. The size of the error bars 
represent the polydispersity index of the particles so for PS 50, 700 and 1000 nm we 
get large error bars which confirms with the large PDI (>0.4) observed during 
particle characterization (Figure 3-9). Further, the contribution of sedimentation and 
diffusion separately to the total delivered dose has been plotted which shows that for 
PS particles less than or equal to 200 nm the transport is diffusion dominated 
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Figure 3-11: The measured cellular dose (particle #/cm
2
) versus predicted delivered doses 
(particle #/cm
2
) from the EXCEL (sedimentation + diffusion), EXCEL (sedimentation only), 
EXCEL (diffusion only) and ISDD models after exposing non-activated J774A.1 macrophages 
for 15 min to 240 min to 50, 100, 200, 700 and 1000 nm PS beads. The data for measured 
cellular dose has been taken from Khanbeigi et al. (169). 
 
The Table 3:2 shows that the comparison of EXCEL model prediction for the 
delivered dose - sedimentation + diffusion, sedimentation only and diffusion only as 
percentage of ISDD predicted delivered dose values. It shows that the EXCEL model 
prediction shows little discrepancy from the ISDD predicted values. However, if we 
were to take into consideration only sedimentation or only diffusion then the EXCEL 
model would either underpredict (PS 50, 100 and 200 nm) or overpredicted (PS 700 
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Table 3:2: The EXCEL predicted delivered dose value as percentage of ISDD predicted 









only) % of ISDD 
EXCEL (Diffusion 
only) % of ISDD 
PS 50 129.63 5.65 123.98 
PS 100 90.08 3.07 87.01 
PS 200 79.34 10.97 68.37 
PS 700 130.30 87.72 42.99 
PS 1000 139.90 109.25 30.99 
 
3.5 Discussion  
The aim of this study was to develop an EXCEL model as a quick and easy 
tool to calculate administered dose values for a corresponding delivered dose. The 
EXCEL-based platform offers greater flexibility and ease of access in comparison to 
the ISDD model which is run through Matlab
®
, a program which is expensive and 
unfamiliar to many biologists. However, the development of each model requires 
certain assumptions and these may explain the deviation between the EXCEL and 
ISDD model. As mentioned earlier in the introduction both the models take into 
account only the downward vector of diffusion. This is a reasonable assumption 
because diffusion is concentration driven phenomenon. Under the experimental 
conditions we have assumed uniform distribution of particles in each of the 1 µm 
cylinders (Figure 3-6). The only direction where concentration gradient exists is 
along the z- axis as the cells at the bottom of the plate act as a constant sink 
condition. However, along the x-axis and y-axis there is no concentration gradient 
(due to uniform particle distribution) so there will be no diffusion along these axes. 
We can also ignore the advective force as under normal cell culture conditions the 
plates are held at a constant temperature and are left undisturbed so the effect of 
advective forces would be negligible.  
The primary reason for the minor discrepancy between the two models lies in 
the mathematical capability of the programs. Since Matlab is capable of high 
numbers of simultaneous calculations, it is possible for this program to solve 
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Equation 1, whereby gravitation settling and diffusion are calculated simultaneously 
for a single particle. In contrast, due to the computational limitations of Excel
®
, the 
gravitational effect and diffusion are applied separately on each particle and added 
together at the end. What is fascinating, is the particle size polydispersity 
dependency in the differences between the EXCEL and ISDD models. This 
polydisperisty of particle size distribution leads to the variance observed in the 
EXCEL predicted deposited dose. Taking the polydispersity into account the EXCEL 
predicted delivered dose as percentage of ISDD predicted dose show little 
discrepencey PS 50 (129% ± 23), PS 100 (90% ± 6), PS 200 (79% ± 6), PS 700 
(130% ± 32) and PS 1000 (140% ± 36) which shows that the EXCEL predicted 
delivered dose values are approximately equal to the ISDD predicted delivered dose 
values.  Does this factor make the EXCEL better or equivalent to ISDD? Yes, to a 
certain extent, the EXCEL model is equivalent, as the EXCEL predicted deliverd 
dose is equivalent to the ISDD predicted delivered dose values. However, the 
differences between the two programs are insignificant when put into the context of 
the comparisons to administered dose values. According to Khanbeigi et al. (169), 
ISDD predicts that ~8-15% of the administered dose of polystyrene beads 50-1000 
nm actually reached the cell layer over the course of a 4 h incubation time period. 
With EXCEL this value range becomes ~7-21%. Thus, it may be clearly seen that 
researchers unable to access Matlab
®
 to run ISDD predictions of the delivered dose 
would benefit from normalizing their data to the delivered dose using the EXCEL 
program, despite its limitations. 
 A drawback of the ISDD program is the reliance on mean hydrodynamic 
diameters, which can vary considerably depending on the selected measurement 
technique and conditions. The EXCEL program developed here takes into 
consideration the polydisperisty index of the particles in the relevant medium. Thus, 
the characterization of particle size in cell culture medium was important as the 
hydrodynamic diameter of the particle in the relevant medium was required to run 
both the models. The particle size measurements showed that there was a large 
increase in size for the 50 and 100 nm particles (Figure 3-9) as compared to the 
increase in size of 200, 700 and 1000 nm particles. This phenomenon may be 
explained by widespread particle aggregation for the 50 nm particles and limited 
aggregation for the 100 nm particles. Further, there is evidence for all particles that 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 96 - 
Chapter 4 – In vitro nanoparticle toxicology incorporating particokinetic modelling of dose 
formation of protein corona had occurred which causes stearic hindrance thus 
preventing the aggregation of particles (42, 177, 178). However, since the protein 
corona will affect the colloidal behaviour of the particles, it is very important to 
measure the hydrodynamic diameter in cell culture medium and use this diameter for 
input into particokinetic models of the delivered dose. 
Some engineered nanomaterials may not necessarily undergo widespread 
aggregation, but may nonetheless show significant polydispersity. It was identified in 
this study that the ability to model the delivered dose for a non-aggregated, but 
polydisperse particle sample would increase the accuracy of the predicted delivered 
dose. This can be achieved using both programs by dividing the particle size 
distribution data into a frequency histogram. The corresponding delivered dose 
values can then be calculated separately for each fraction of the total particle 
population with a given particle size (following the size distribution curve; see 
Figure 3-12) and summated manually at the end. Using ISDD, this is a lengthy, 
multiple-step process. The advantage of the EXCEL program is that this process can 





Figure 3-12: Corresponding delivered dose values calculated separately for each fraction of 
the total particle population with a given particle size following the size distribution curve. 
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As per recommendation of the examiners both data setsbased on gravity only 
and gravity + diffusion modelling of particle behavious in suspension are presented 
below (Figure 3-13) for comparison – the data from the original model which 
modelled the particle movement based on both gravity and diffusion and the new 
model as per examiner’s recommendation which models the movement of particle 
based on gravity only. 
Gravity Only vs. Gravity + Diffusion 
 
 
Figure 3-13: The graph shows a comparison of the measured particle uptake in J774.1 
macrophage cells (black bars), the predicted delivered dose based on gravity + diffusion 
(dark grey bars) and the predicted delivered dose based on gravity only (light grey bar) of 
PS 50, PS 100, PS 200, PS 700 and PS 1000 nm particles at four different total exposure 
times of 15, 30, 60 and 240 minutes. The error bars on the observed data indicate mean ± 
SD of n = 6 individual experiments. The error bars on the modelled data represent the 
range of deposited dose obtained from three different particle size distribution data 
(obtained from particle characterization studies) input into the modelling program. 
 
The graphs in Figure 3-13 depict two different models (Gravity + Diffusion 
vs. Gravity Only) for calculating a delivered dose value and compare these with 
measured particle uptake in macrophage cells. A discrepancy between the two 
models is observed, whereby the delivered dose value calculated by the Gravity Only 
model is lower than that of the Gravity + Diffusion model.  The discrepancy between 
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the two model outputs is greater for smaller nanoparticles (i.e. PS 50, PS 100 and PS 
200 nm) than for larger particles (700 and 1000 nm). The Stoke’s Law of 
Sedimentation shows that sedimentation velocity is proportional to the square of the 
particle radius, meaning that the larger the particle, the greater number will sediment 
to the bottom of the cell culture dish within a given time period (e.g. 1-4 h in this 
study).  Thus, the model of Gravity Only is suitable for particles with a large radius, 
a high density and longer incubation periods, as particle movement to the cell layer is 
defined primarily by sedimentation alone. 
Table 3:3: Calculation of the percentage particle uptake in cells of PS 50 nm when 
normalised to delivered dose values calculated by two different methods: Gravity + 




































15 1.03 x 10
10
 2.88 x 10
10
 6.14 x 10
8
 36 1677 
30 1.51 x 10
10
 4.11 x 10
10
 1.23 x 10
9
 37 1227 
60 1.95 x 10
10
 5.88 x 10
10
 2.45 x 10
9
 33 796 
240 2.28 x 10
10
 1.23 x 10
11
 9.82 x 10
9
 18 232 
  
Figure 3-13 and Table 3:3 show that cells exposed to 50, 100, and 200 nm 
particles took up a significantly higher number of particles than the Gravity Only 
delivered dose value predicted would reach the cell layer.  Therefore, one or more 
further transport processes must be enabling small, low density particles to reach the 
cell layer during the short time periods covered in this study.  For the purposes of this 
thesis, it was hypothesized that the published models (89, 90, 168) for delivered dose 
calculations, which incorporated gravity + diffusion, provide a good working 
approximation of a more accurate delivered dose value when compared to the 
Gravity Only delivered dose (and certainly when compared to the administered 
dose).  Although these published models require assumptions to be made regarding 
particle diffusion, as discussed in (89, 90, 168), independent experimental evidence 
for the role of diffusion in small nanoparticle uptake into cells was provided by a 
recent study in Nature – ‘The effect of sedimentation and diffusion on cellular uptake 
of gold nanoparticles’ (179). In this study, the authors cultured the cells in two 
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different configurations – upright position which is what we commonly use in cell 




Figure 3-14: Schematic of upright (left) and inverted (right) configurations for 
measuring cellular uptake of gold nanoparticles as used by Cho et al. Image 
reproduced from Cho et al. (179). 
 
The hypothesis of the authors was that cells in an inverted position would 
only take up gold nanoparticles (15, 54, and 100 nm) which would reach the cells by 
the process of diffusion. They found that while more NPs were taken up in the 
traditional configuration as compared to the inverted configuration, uptake was still 
observed in the inverted position. Notably, the uptake value of 15 nm gold 
nanoparticles was essentially the same for both configurations, which means that the 
transport of NP was predominantly diffusion driven. They also showed that 
increasing particle size from 15 nm to 54 nm to 100 nm led to an increase in disparity 
in particle uptake in the two positions. This disparity was thought to be due to the 
increased number of particles reaching the cell surface through sedimentation in the 
traditional upright well position. The disappointing aspect of this very creative 
approach, was that the authors did not try to predict the delivered dose in both 
configurations and evaluate the correlation with their experimental data. 
Thus, comparison of our own uptake and modelling data with that reported in 
the relevant literature (89, 90, 168, 169, 179-181), indicates that the movement of 
particles in cell culture medium is governed by a transport process additional to 
gravity only movement. 
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3.6 Conclusion 
In summary, this chapter describes the development of an EXCEL model to 
demonstrate that this predicts the deposited dose comparable to the ISDD model. 
Further refinements in the EXCEL model may be possible to improve it. However, 
this does not mean that the model in its current form cannot be used. Compared to 
the discrepancies with the administered dose values (especially for small or low 
density NPs), the deviations between the EXCEL and ISDD programs are very small. 
Since it is an easy and flexible program it can be more widely accessible to 
researchers and allow for greater variety of use, such as the easy calculation of 
delivered doses from non-aggregated, polydisperse particle size distribution data. 
The application of the particokinetics principal in vitro would give us a better 
understanding of the actual amount of NPs coming into contact with the cells and 
causing an effect. Just like physiologically-based pharmacokinetic modeling has led 
to better understanding of biological and toxicological effects of a drug and helped in 
promoting more accurate study design through better interpretation of data, 
particokinetics could lead to a better interpretation of toxicological data and the 
identification of the true biologically relevant dose of the particles coming in contact 
with the cell surface. This could improve the accuracy and scalability of in vitro 
systems. It might also lead to better correlation between in vitro and in vivo data thus 
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Chapter 4                                                       
In vitro nanoparticle toxicology 
incorporating particokinetic modelling of 
dose 
 
4.1 Introduction  
There has been a rapid growth in the application of nanotechnology to 
consumer products which according to one estimate is projected to grow from $18 
billion industry in 2008 to a $3 trillion industry by 2015 (5). Due to the special 
properties namely size, surface area and chemical reactivity; nanoparticles have been 
shown to be more toxic than their counter bulk materials. These findings have been 
reviewed in numerous publications (16, 28, 42, 161, 182). The traditional approach 
of using whole animal exposure models to assess the safety of all nanomaterials via 
all exposure routes will not be feasible given the rapid rate of development in the 
materials science sector (69, 70). Instead, the development of predictive in vitro 
models of nanotoxicology based on robust paradigms linking nanoparticle (NP) 
physicochemical properties and in vivo outcomes is the way forward to avoid the 
backlog. A number of studies (56, 61, 183, 184) have tried to develop inexpensive 
toxicological screening tools to correlate nanoparticle properties such as size, shape 
and surface area to biological activity observed in vivo. However, as outlined in a 
review article in Nature by Thomas Hartuang the most important point for any 
alternative (non animal based) testing method is the predictive power, reliability and 
the usefulness of these model systems (69). Despite all the research going on in the 
area of nanomaterial toxicity no conclusive information can be drawn. For example a 
search on PubMed for ‘carbon AND nanotube AND toxicity’ gave 664 results 
(PubMed accessed on 17
th
 July 2012). A recent review by Kaiser et al. (185) 
performed a similar search and then analysed the paper identified according to their 
rigour. The results demonstrated a high number of publications with either 
incomplete information or contradictory results. It was highlighted that this was due 
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to lack of material characterization in many studies, different methods for 
preparations of nanomaterial suspensions, different duration of assays, different 
assay design, just to name a few factors. Importantly, it is often observed that crucial 
information regarding the applied concentrations is often missing which is important 
to reproduce the experiments in another laboratory. Thus, there is an obvious need 
for harmonization in characterization, suspension, application and assay of test 
particles. 
 
4.2 Importance of particle characterization 
A number of reviews have concluded that pulmonary exposures in rats to 
ultrafine/nanoparticles (i.e., defined here as <100 nm) produce enhanced lung 
toxicity when compared to equivalent mass doses of larger particle types of similar 
or identical composition (186, 187). In support of this hypothesis, one can compare 
the results of two 90-day inhalation studies that were conducted in three rodent 
species using pigment grade/fine (particle size ~380 nm; surface area = 6 m
2
/g) or 
ultrafine/nano (particle size reported as 25 nm; 53 m
2
/g) titanium dioxide particle-
types. In the first study, rats, mice, and hamsters were exposed to fine TiO2 particles 
at aerosol concentrations of 10, 50, or 250 mg/m
3
 (188). In a second study, the same 
rodent species were exposed to ultrafine (i.e., nano) TiO2 particulates at exposure 
concentrations of 0.5, 2, or 10 mg/m
3
 (189) and evaluated at several time points 
postexposure. The results of the two studies demonstrated that (1) rats were the most 
sensitive rodent species for lung effects and (2) the effects measured at 250 mg/m
3
 in 
the fine particle study were not dissimilar from those observed at 10 mg/m
3
 in the 
ultrafine/nanoscale TiO2 study. Accordingly, comparing the results of both studies 
would suggest that, on a mass basis, the effects measured following 
ultrafine/nanoscale TiO2 exposures were ~25 times greater than those observed for 
the fine/pigment-grade TiO2 particle types. However, a number of other factors 
require consideration before drawing this conclusion. These include the following 
issues: 
(1) Surface area indices of the ultrafine/nanoscale TiO2 particle-types were 
significantly greater compared to the fine-sized TiO2 particulates used in 
the study (53 m
2
/g vs 6 m
2
/g). 
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(2) The crystal structure of the ultrafine/nano TiO2 particles was composed of 
80% anatase and 20% rutile, whereas the fine TiO2 samples were 100% 
rutile. 
(3) The measured surface reactivity index (i.e., delta b* -using the vitamin C 
assay) of the nanoscale TiO2 particle types was substantially enhanced 
compared to the pigment-grade TiO2 samples (delta b* values of 23.8 vs 
0.4, (190)).  
This is just one example to demonstrate the importance of robust particle 
characterization in correct interpretation of toxicology data obtained from both in 
vitro and in vivo studies. In an interesting article by Warheit et al. (86) the 
importance of particle characterization in the interpretation of nanotoxicity data 
obtained from in vitro or in vivo studies was further highlighted. In subsequent 




The effective size of the NP species becomes a crucial parameter in the lung 
because it directly influences their clearance and bio-distribution. It has been shown 
that the clearance by alveolar macrophages is dependent on particle size. Thus, when 
investigating size-dependent effects (191-193) the size distribution of the NPs in 
relevant biological media needs to be described (61, 193, 194). In a study 
investigating oxidative damage caused by TiO2 particles on BEAS-2B cells by Gurr 
et al. (84) it was concluded that oxidative and genotoxic potential of nanoparticulate 
forms of TiO2 was greater than that of their larger counterparts. The authors exposed 
BEAS-2B cells to 10, 20 and 200 nm anatase TiO2 NPs. The results showed that 10 
and 20 nm NPs in the absence of photoactivation induced oxidative DNA damage, 
lipid peroxidation, and micronuclei formation, and increased hydrogen peroxide and 
nitric oxide production in BEAS-2B cells, whereas 200 nm particles did not induce 
any oxidative damage in the absence of photoactivation. The authors concluded that 
the smaller the particle, the higher potency it had to induce oxidative stress in the 
absence of photoactivation. However, there was no particle characterization 
performed in this study. The authors only mentioned that TiO2 NPs had an 
approximate size of 200 nm from the information supplied by the manufacturers. It is 
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a known fact that particles seldom retain their ‘original’ size in dry state when they 
are put in cell culture medium (195). In the study by Murdock et al. it was observed 
that the size of 10 nm and 16 nm TiO2 particles in medium without serum was 1790 
nm and 1810 nm. This size was similar to the aggregate size of 100 nm TiO2 
particles in medium without serum (2500 nm). This agglomeration in biologically 
relevant medium raises concern about concluding size- or surface area-dependent 
toxicity in vitro. One of the most commonly used particle size analysis techniques is 
dynamic light scattering (DLS) also known as photon correlation spectroscopy. It is a 
non-invasive, useful technique to evaluate particle size and size distribution of NPs 
in solution. However, DLS cannot distinguish between mixed particle population nad 
is biased towards larger size as the amount of light diffracted from a larger particle 
will be considerably more. These shortcomings have been highlighted by Filipe et al. 
(196) who used polystyrene beads of 100 and 400 nm mixed in different proportions 
(3:1, 6:1, 15:1, 150:1 and 300:1) to demonstrate that DLS was unable to resolve 
peaks of polydisperse samples and it was not possible by DLS to separate the two 
bead sizes. Another relevant technique used for particle size analysis is nanoparticle 
tracking analysis (NTA) which was compared against DLS by Filepe et al. (196) to 
demonstrate the better resolution power of NTA when polydisperse samples are 
being analyzed. However, the analysis by NTA is dependent upon the ability to 
resolve the video and track each particle individually. This usually means that a NTA 
could be used for low concentrations of particle suspension as for the study by Filepe 
et al. the PS 100 nm supplied by the manufacturer had to be diluted 1:100,000. In 
case of characterizing particles prior to in vitro toxicity testing it would be more 
relevant to measure particle size at a concentration corresponding to that applied on 
the cells. Other relevant techniques are scanning electron microscopy, transmission 
electron microscopy and atomic force microscopy. However, manual measurements 
from thousands of micrographs need to be done before gaining statistically 
significant information. Another limitation is the extensive preparation and fixation 
which could result in morphological change in the nature of the particle also this 
preparation may not represent the true state of particle in a biologically relevant 
medium.  
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4.2.2 Surface area 
 The choice of dose metric (mass dose, surface area dose or number dose) has 
been under debate as highlighted by Oberdorester et al. (197). In a study by 
Oberdorster et al. (166) the authors exposed rats for 24 h to fine (~ 250 nm) and 
ultrafine (~20 nm) TiO2 NPs by intratracheal instillation and the results demonstrated 
the significantly greater inflammatory potency (as measured by polymorphic nuclear 
cell (PMN) recruitment) by of the ultrafine particles. The same group analysed the 
data in a subsequent study (165) and expressed the PMN recruitment in terms of 
particle surface area. When the instilled doses were expressed in terms of surface 
area the responses of the ultrafine and fine TiO2 particles fell on the same dose-
response curve as seen in Figure 3-1.  
In another study by Hohr et al. (198) the authors exposed rats for 16 h to fine 
(180 nm) and ultrafine (20-30 nm) TiO2 NPs by intratracheal instillation at four 
different surface area dose of 100, 500, 600 and 3000 cm
2
 and equivalent mass dose 
of 1 or 6 mg. The surfaces of the particles were modified by methylation to achieve a 
hydrophobic surface or left unmodified and hydrophilic. The acute inflammatory 
response in the rat lung was measuring the PMN recruitment in the brochoalveolar 
lavage fluid. The results showed that PMN influx correlated with the surface area 
dose. It also showed that at low doses (1mg or < 500 cm
2
) methylation (hydrophobic 
surface) seemed to suppress inflammatory activation although this was not 
statistically significant. The authors concluded that surface area of the instilled TiO2 
NPs determined the acute pulmonary inflammation. However, it must be noted that 
the authors did not present any experimental data to confirm the surface 
modification. 
 
4.2.3 Surface charge/ zeta potential 
 In a recent study by Ruenraroengsak et al. (65) the authors exposed human 
alveolar epithelial type-1 cells for 4 h or 24 h to polystyrene NPs of 50 nm and 100 
nm. The surface of these particles were amine modified (positively charged), 
carboxyl modified (negatively charged) or unmodified. The amine modified 50 nm 
particles were found to be consistently more cytotoxic followed by unmodified and 
then carboxyl modified particles. The cytotoxicity was measured by MTT assay, 
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LDH release, Capsase-3/7 activation and activation of cytokine release (IL-6). The 
authors suggested that the increased cell death and apoptosis observed in TT1 cells 
exposed to 50 nm amine-modified NPs in the present study may be due to increased 
depletion of significant medium nutrients. A unique finding was that the toxic effect 
of the amine-modified nanoparticles was associated with severe membrane damage 
and the formation of holes in the alveolar epithelial cells. The authors suggested that 
the alteration in cell membrane structure may be caused by electrostatic attraction 
between amino surface groups of the particles and phospholipids of cell membranes, 
possibly causing transformation of the lipid bilayer of the cell to the liquid phase.  
However, in another study by Mura et al. (199) the authors exposed Calu-3 cells 
to surface modified (positive using chitosan, neutral using PVA or negative using 
PF68 stabilizer) PLGA NPs for 4 and 24 h. The particles were characterized for their 
size and zeta potential in serum supplemented cell culture medium. The cell viability 
and cytokine release from the Calu-3 cells were used as cytotoxicity markers. The 
authors found no influence of surface chemistry or surface charge on the cytotoxicity 
of PLGA NPs. It must be noted that the particle used by Mura et al. (197) was 
manufactured using poly(lactic-co-glycolic acid) (PLGA) and chitosan coating was 
applied for providing the particle with a positive charge whereas Ruenraroengsak et 
al. (65) used amine modified polystyrene particles to provide the positive charge 
with no chitosan coating. This difference in the nature of the particles does nto allow 
for direct comparison between the results of the two studies.   
 
4.2.4 Surface reactivity 
Recently Sayes et al. (200) studied the catalytic properties of anatase and 
rutile nano-TiO2 and correlated these properties to the in vitro cytotoxic responses of 
different nano-TiO2 crystal structures on both human dermal fibroblasts and human 
lung carcinoma cells using various biochemical endpoints (MTT, LDH, IL-8 
production). These investigators concluded that nano-TiO2 particles in the anatase 
crystal phase were superior catalysts, generators of reactive species, and more 
cytotoxic when compared to the rutile particle-types tested. The investigators 
determined the reactive species formation ex vivo by two different methods – first the 
chemiluminescence of luminol was used to qualitatively probe the production of 
reactive species over 20 min and second the decay of photograde organic dye Congo 
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Red was followed via absorption spectroscopy and correlated to rate constants for 
radical production in water. The differences in the cytotoxic response of the nano-
TiO2 tested were due to the anatase nano-TiO2 being more reactive as measured by 
the production of reactive species ex vivo, and not because of differences in surface 
area. However, since the particles aggregated increasingly in the cell culture medium 
as suggested by the investigators, size of the particle influencing the cytotoxic 
endpoints measured cannot be completely ruled out. In another study by Warheit et 
al. (190) the authors exposed rats to three different types of ultrafine TiO2 particles. 
UF-1 and UF-2 were rutile type and differed in the surface coating. UF-1 was coated 
with alumina where as UF-2 was coated with silica and alumina. The third type 
designated as UF-3 consisted of 80% anatase/20% rutile and were not coated with 
anything. The particle sizes as determined in a 0.1% tetrasodium pyrophosphate 
buffer using DLS of UF-1, UF-2 and UF-3 were 136, 149.4 and 129.4 nm 
respectively. The average surface areas in dry state as determined by BET of UF-1, 
UF-2 and UF-3 were 18, 35.7 and 53.0 m
2
/g respectively. The chemical reactivity of 
the samples was measured using an ascorbic acid depletion assay. This assay 
measures the chemical reactivity of the sample toward an anti-oxidant, specifically 
ascorbic acid. With greater chemical reactivity, the yellowing of the test sample will 
increase providing a higher surface reactivity index (Δb*). The chemical reactivity 
order of the three particle type was UF-3>UF-1>UF-2. The authors examined BAL 
fluid after intratracheal instillation of the particles for PMN influx, LDH and 
microprotein value (as an indicator of enhanced cellular permeability) after 24 h, 1 
week, 1 month and 3 months post exposure. Further cell proliferation and 
histopathological examination was carried out on the rat lungs. UF-1 or UF-2 did not 
produce sustained adverse pulmonary effects in any of the endpoints utilized in this 
study. However, exposures to uf-3 TiO2 particles produced inflammation and 
cytotoxicity responses through 1 month post-exposure as well as enhanced cell 
proliferative labeling and histopathologically adverse lung tissue effects when 
compared to PBS vehicle controls. The authors suggested the difference in chemical 
reactivity to be the reason behind this observation. The chemical reactivity assay 
basically represents an indirect measure of the number of active sites (sites on the 
particle's surface which can initiate the chemical transformation of molecules). Given 
this reactivity, UF-3 TiO2 particles are likely to produce more reactive species than 
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either of the UF-1 or UF-2 TiO2 particle-types, thus possibly contributing to the 
sustained in vivo cytotoxicity and inflammation measured through 1 month post-
exposure. However, the authors have not taken into account the measured difference 
in the specific surface areas of the three particles. For the same mass of particles the 
UF-3 type has almost 3 times the surface area of UF-1 and 1.5 times the surface area 
of UF-2. Given this difference in surface area, it would be difficult to conclude if 
surface reactivity was the only contributing factor towards the difference seen in 
cytotoxicity.  
The above mentioned examples highlight the importance of particle 
characterization in correct interpretation of in vivo toxicity and in vitro cytotoxicity 
data. Thus one of the aims of this chapter was to rigorously characterize the panel of 
model nanomaterials prior to cytotoxicity testing. 
 
4.3 Need for nanoparticle toxicity testing 
In 1990 two important papers were published in the Journal of Aerosol 
Science demonstrating on a mass for mass basis, titanium dioxide and aluminum 
dioxide NPs eliciting a significantly greater inflammatory response in the lungs of 
rats as compard to larger particles with the same chemical composition (201, 202). 
These two studies challenged the long held assumption that response to particulate 
exposure could be understood in terms of chemical composition and suggested 
unusual biological activity associated with NPs. As research began to focus on the 
potential risk associated with NP, the term ‘nanotoxicology’ was formalized in an 
editorial in Occupational and Environmental Medicine by Donaldson et al. (19). 
 
4.3.1 Cell-based assays for evaluating nanotoxicology 
There are many assays used in vitro for evaluating the toxicity of NP. The 
assays used for assessing cell viability are MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay (203) and variations of of this assay (e.g. MTS, 
XTT, WST-1, etc.). These assays principally determine cell viability through 
determination of mitochondrial function by measuring the activity of mitochondrial 
enzymes such as succinate dehydrogenase. Another equally common measure of 
cytotoxicity is the lactate dehydrogenase (LDH) assay. LDH is an enzyme that is 
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normally found within the cell cytoplasm. Reduced cell viability leads to an increase 
in the leakiness of the plasma membrane and therefore release of the LDH enzyme 
into the cell culture medium. Trypan Blue exclusion has been used in a small number 
of studies to assess the toxicity induced by particles. Trypan Blue is a large 
negatively charged molecule. Cells with an intact cell membrane are able to prevent 
Trypan Blue uptake and therefore appear clear by light microscopy. In contrast, dead 
cells, which are unable to maintain an intact plasma membrane, are colored blue 
within seconds of exposure to the dye. The fluorescent dye propidium iodide (PI) 
works in a similar way to Trypan Blue, staining the DNA/nucleus of dead cells due 
to the heightened plasma membrane permeability. This staining is used as an 
indicator of cell death via necrosis. It is relatively common to combine PI staining 
with annexin V–FITC (fluorescein isothiocyanate). Annexin V (AV) binds to 
phosphatidyl serine on the surface of apoptotic cells. Using flow cytometry of dual-
stained cells allows the identification of both apoptotic and necrotic cell death within 
the same cell population. Another way of assessing cytotoxicity is by the assessment 
of cellular adenosine triphosphate (ATP) content. This is a relatively sensitive 
assessment of cell viability and kits using luminescence to assess the ATP content of 
cell extracts are available, and the assay can be conducted in a 96-well plate format. 
Apart from cell viability the toxicity from NP can also be quatified using 
assays to measure oxidative stress in the cells. The fluorescent dye 2,7-
dichlorofluorescin (DCFH) or dihydrorhodamine-123 can be used to measure ROS 
inside the cells after exposure to NP and the fluorescence can be measured by 
fluorimetric or by flow-cytometric techniques. Other method for measuring oxidative 
stress is to measure redox sensitive antioxidants such as glutathuione (GSH) using 
the o-phthalaldehyde (OPA) method (204) where the GSH in the cellular extract 
forms a fluorescent GSH-OPA adduct that can be quantified by fluorimetry. 
Measurement of mRNA expression changes of oxidative stress-dependent genes has 
also been put forward as a sensitive marker of oxidative stress induced by particles 
and nanoparticles; among these, the best-described is heme oxygenase-1 (HO-1) 
(38).  
Another way to quantify NP toxicity is to measure inflammatory cytokine and 
chemokine release from the cells after exposure to NP. Examples of cytokines and 
chemokines associated with inflammation include tumour necrosis factor alpha 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 110 - 
Chapter 4 – In vitro nanoparticle toxicology incorporating particokinetic modelling of dose 
(TNFα), interleukin (IL)-IL8, IL1α, IL1β and IL6. After exposure to NP the cells 
release cytokine protein into the cell culture medium. The medium can then be 
extracted, and centrifuged to remove cellular debris and particles, and then the 
cytokine protein content assessed by enzyme linked immunosorbent assay (ELISA). 
ELISA techniques are well-established, reliable, and usually relatively sensitive. 
Alternatively, cytokine mRNA expression can be measured as an indicator of 
alterations at the gene expression level.  
 
4.3.1.1 MTT assay 
The MTT assay (203) is a colorimetric assay which is used to measure the 
metabolic activity of the cells. The mitochondrial reductase enzyme reduces the 
yellow MTT salt to formazan dye which has a purple colour. This allows the 
investigator to assess the viability and proliferation of cells. In this case, it is used to 
determine the cytotoxicity of nanoparticles, since these nanoparticles are thought to 
interfere with cell viability and growth. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide), a yellow tetrazole, forms purple formazan when it is 
reduced in living cell). Sodium dodecyl sulphate (SDS), a solubilising agent, is then 
used to dissolve the insoluble purple formazan, which yields a coloured solution. A 
spectrophotometer is then used to measure the absorbance of this coloured solution at 
570 nm.  
Although this is one of the most commonly used assays for cell viability it is 
important to include appropriate controls to prevent the interference of particles or 
cell debris from spectrophotometric analysis. In the final stage of MTT assay the 
cells are solubilised using SDS or DMSO which generates a suspension containing 
cell debris, NP and formazan. It has been suggested by Stone et al. (205) to 
centrifuge the test plate, transfer the supernatant into another test plate for 
measurement of absorbance. Another possible problem may be the interaction of NP 
with the dye as demonstrated in the cytotoxicity evaluation of single-walled carbon 
nanotubes (SWCNTs) by Worle-Knirsch et al. (206). The authors showed that the 
SWCNTs attached to the MTT-formazan crystals that were formed after the 
reduction of MTT and stabilized their chemical structure so that the crystals were not 
soluble in the solvents used to dissolve the MTT-formazan, such as 2-propanol, 
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hydrochloric acid, sodium dodecylsulfate or acetone. As a result, reduced cell 
viability was observed in the MTT test.  
 
 
Figure 4-1: Schematics of MTT reaction (207). 
 
4.3.1.2 LDH assay 
Cell death or cytotoxicity is classically evaluated by the quantification of cell 
membrane damage. The LDH assay is based on the measurement of activity of 
lactate dehydrogenase (LDH) released from damaged cells. LDH is a stable 
cytoplasmic enzyme present in all cells and rapidly released into the cell culture 
supernatant upon damage of the plasma membrane. The loss of intracellular LDH 
and its release into the culture medium is an indicator of irreversible cell death due to 
cell membrane damage. This assay, therefore, is a measure of the membrane 
integrity. LDH activity can be determined by a coupled enzymatic reaction: LDH 
oxidizes lactate to pyruvate which then reacts with tetrazolium salt INT to form 
formazan. The increase in the amount of formazan produced in culture supernatant 
directly correlates to the increase in the number of lysed cells. The water-soluble 
formazan dye is detected by spectrophotometry (490 nm).  
However, as with MTT assay NPs could interfere with the LDH assay. In a 
recent study by Han et al. (208) copper (Cu-40, 40nm), silver (Ag-35, 35nm; Ag-40, 
40nm), and titanium dioxide (TiO2-25, 25nm) NPs were examined for their potential 
to interact with LDH assay. The authors found that Cu NP and Ag NP interacted with 
LDH assay by inactivating LDH and caused a decrease in LDH activity over time 
whereas TiO2 NP did not inactivate LDH. 
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Figure 4-2: Schematics of LDH reaction (209). 
 
The choice for the use of a particular cytotoxicity assay is dependent upon the 
toxic effect of interest. Apart from choosing the correct assay one has to take into 
account all the potential interferences to avoid obtaining false-positive or false-
negative results. If these potential interferences are controlled for, the MTT or LDH 
assay can be used successfully to address nanoparticle-induced toxicity (210).  
For the present work MTT assay and LDH assay were chosen and the 
experiments were performed according to the plate design shown in Figure 4-3. 
These assays have been widely used, sample preparation is not tedious, are quick and 
inexpensive. In contrast, the cost of screening six different NPs on two different cell 
lines using two different exposure times using a more sensitive assay such as PI 
staining with annexin V, inflammatory cytokine and chemokine analysis and 
oxidative stress generated was beyond the budget of the project. 
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Figure 4-3: Plate design for NP toxicity testing experiments. The row D of the 96-well plate 
contained no cells and helped in accounting for interaction between NP and dye. 
 
Thus MTT and LDH assay were used with appropriate controls to assess the 
toxicity of NPs. 
 
4.4 Aims and objectives 
The aim of this chapter was to apply particokinetic modelling (developed in 
Chapter 3) to the assessment of in vitro cytotoxicity of rigorously characteried 
reference metal oxide nanoprticles, reference drug delivery like polystyrene 
nanoparticles and in-house developed lipid nanocapsules (LNCs) on the human 
alveolar epithelial cell line, A549, and the human nasal epithelial cell line, RPMI 
2650.  
4.5 Materials and methods 
4.5.1 Nanomaterials 
Polystyrene microsphere aqueous suspensions (Thermoscientific; 1% solids 
by weight and a density of 1.06 g/mL) were purchased with manufacturer reported 
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diameters of 50 and 200 nm. Reference metal oxide nanoparticles composed of CuO 
and TiO2 were purchased from NanoScale Material Inc., USA with manufacture 
reported properties shown in Table 4-1.  
 






Appearance/Color Black Powder White Powder 
Specific Surface Area(BET) (m
2
/g) ≥ 65 ≥ 500 
Crystallite Size (nm) ≤ 8 Amorphous 
Average Pore Diameter (Å) 85 32 
Total Pore Volume (cc/g) ≥ 0.1 ≥ 0.4 
Bulk Density (g/cc) 1.65 0.6 
True Density (g/cc) 5.7 3.7 
Mean Aggregate Size, d0.5 (μm) 6 5 
Moisture Content (%) ≤ 4 ≤ 4 
Loss on Ignition (%) ≤ 4 ≤ 12 
Content (Based on Metal) (%) > 99.6 > 99.999 
 
LNCs were prepared at two sizes (50 and 150 nm) by Dr. Marie-Christine 
Jones using a phase-inversion process developed by Heurtault et al. (211). In brief, 
Labrafac (Gattefossé, Saint-Priest, France), Lipoid S75-3 (Lipoid, Ludwigshafen, 
Germany), Solutol HS15 (BASF, Ludwigshafen, Germany) and a 3% w/w NaCl 
solution were stirred at room temperature (for composition see Table 4-2). The 
resulting coarse emulsion was heated to 85˚C under constant stirring then cooled 
back to 60˚C. This heating-cooling cycle was repeated twice more (85-60-85) before 
adding ice cold water to the emulsion maintained at 72˚C. The LNCs were then left 
under stirring at room temperature for 5-10 minutes. Excess Solutol HS15 was 
removed from LNC preparations using dialysis in combination with BioBeads
®
 
(BioRad Laboratories, USA) until the residual concentrations were: LNC 50 1.5 
mg/mL and LNC 150 <0.5 mg/mL. 
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LNC 50 17 1.75 17 64.25 2x volume 
LNC 150 25 1.5 8.5 65 3.5x volume 
*Prior to purification 
 
4.5.2 Methods 
4.5.2.1 Cell culture medium (CCM) and respiratory tract lining fluid (RTLF) 
characterization 
Total Protein Content: RTLF samples were kindly provided by Dr Anders 
Blomberg of the University Hospital, Umea. Ethical approval for the study 
examining different modes of airway sampling was provided by the local research 
Ethics Committee (University of Umea), in accordance with the Declaration of 
Helsinki, and the written informed consent of all volunteers. These samples were 
generated form large volume BAL-fluid samples obtained from each of the subjects and 
concentrated using both 9K iCON and 3K microcon protein concentrators. RTLF and CCM 
were characterized by measurement of total protein content using the method of 
Smith et al., 1985 adapted for use on a microplate reader. Briefly, total protein was 
measured by reaction with bicinchoninic acid and 4% copper (II) sulphate, following 
the method of Smith et al., 1985. 
Dynamic Viscosity: The viscosity of RTLF and CCM supplemented with 2% 
FBS was measured at 37°C using an AMVn Automated Micro Viscometer (Anton 
Parr). Briefly, the samples were loaded into the microcapillary and the viscosity was 
determined in triplicate according to Höppler's falling ball principle. 
 
4.5.2.2 Particle size measurement in water, CCM and RTLF 
 Particle size was measured in four different medium – water, CCM without 
serum, CCM with 2% serum and concentrated (1.2 mg/ml total protein) human 
RTLF. The particles were prepared at a concentration of 0.17 mg/ml in the respective 
medium and probe sonicated at 40Hz for 5 min to break up any aggregates. The 
particle size was then measured using dynamic light scattering (ZetasizerNano, 
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Malvern, UK), every 30 minutes, at 37°C for a period of 6 h. The samples were 
prepared in water, CCM without phenol red supplemented with 2% (v/v) FBS, 1% 
(v/v) non-essential amino acids, 0.1% (v/v) gentamicin, and 1% (v/v) L-glutamine 
(CCMFBS2%) and CCM without phenol red supplemented with 1% (v/v) non-essential 
amino acids, 0.1% (v/v) gentamicin, and 1% (v/v) L-glutamine (CCM) at a 
concentration of 0.17 mg/ml. The instrument parameters used for measurements in 
cell culture media were: refractive index of CCMFBS2% = 1.337 (176), temperature = 
37°C, dynamic viscosity of CCMFBS2%= 0.734x10
-3
 Pa s. 
 
4.5.2.3 Zeta potential measurement in water and CCM 
The zeta potential of particle was measured in water and CCM supplemented 
with 2% v/v serum. The particles were suspended in the respective medium at a 
concentration of 0.17 mg/ml and the zeta potential was measured using laser Doppler 
anemometry (ZetasizerNano, Malvern, UK) at 37°C. Zetasizer Software 6.20 was 
used to analyse the data. 
 
4.5.2.4 Oxidative potential measurement 
Preparation of chelex – resin treated water: 60g of Chelex® 100 sodium 
form were mixed in 2L of 18.2Ω ultra-water, covered and stirred at room 
temperature. The contaminated Chelex
®
-resin was removed by vacuum filtration 
through a Wattman 0.45 µm cellulose nitrate membrane and the water adjusted to 
pH7 with 1M HCl. To avoid further metal contamination which is likely to occur 
during the use of laboratory glassware the treated water was routinely stored in a 
sealable plastic container and finally stored in the fridge for up to 1 month. 
NP dilution: NP stock solutions were prepared at 150 µg/ml in 5% MeOH in 
chelex water pH7 and vortexed for 10 minutes and probe-sonicated for 30 seconds. 
Then the solutions were diluted with Chelex water to a concentration of 12.5 µg/ml. 
Ascorbate solution preparation: A concentrated 2mM ascorbate solution 
was prepared by the addition of 70.44mg of ascorbate to 180ml of Chelex
®
-treated 
water, pH7. The pH of the solution was then adjusted to pH7 with the use of 1M 
NaOH. The solution was then made up to a final volume of 200ml with Chelex
®
-
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treated water (pH7) using a volumetric flask. Aliquots of 2.5ml were then stored at –
80°C until day of exposure.  
NPs exposures: All NPs exposures were performed in triplicate in UV-
transparent 96 well flat-bottomed plates (Greiner bio-one) at a final volume of 200 
µl. 160 µl of the diluted NP suspensions (12.5 µg/ml) were added to the plate in 
triplicate and a further 20 µl of Chelex-treated water was added to each. Immediately 
prior to the addition of the ascorbate to each assay well, the plate was pre-incubated 
for 10 minutes at 37°C in a plate reader (Spectra Max 190) and during the exposure 
the plate was maintained at this temperature. Exposure was initiated by the addition 
of 20 µl of the ascorbate stock (2mM) into each well of NP, giving a final 
concentration of 200 µM ascorbate and 10 µg/ml NPs. After addition of ascorbate, 
the concentration remaining in each well was monitored and recorded every 2 
minutes for a period of two hours by measuring the absorbance at 265nm with the 
use of Softmax Pro software. The rate of ascorbic acid depletion was then 
determined by performing a linear regression through the initial part of a 
concentration verses time plot using Prism (version 5.0). This was performed for 





 depletion of ascorbate ± standard deviation. 
AA depletion assay using inhibitors: The mechanisms driving the oxidative 
activity can also be examined by use of the ascorbate depletion assay by the addition 
of the transition metal chelators and free radical scavengers.  
All NP exposures with inhibitors are performed in triplicate in UV 96 well 
flat-bottomed plates (Greiner bio-one) at a final volume of 200 l. 160 l of the 
diluted PM suspensions are added to the plate in triplicates. NP samples are pre-
incubated in the presence or absence of inhibitor by the addition of 20 l of 2mM 
DTPA inhibitor stock to one set of triplicates. Immediately prior to the addition of 
the ascorbate to each assay well, the plate was pre-incubated for 10 minutes at 37°C 
in a plate reader (Spectra Max 190) and during the exposure the plate was maintained 
at this temperature. Exposures were initiated by the addition of 20 l of the ascorbate 
stock (2mM) into each well NP, giving a final concentrations of 200 M ascorbate 
and 10g/ml NP and final concentrations of inhibitors of 200 M DTPA. The rate of 
ascorbate depletion was determined as above. 
 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 118 - 
Chapter 4 – In vitro nanoparticle toxicology incorporating particokinetic modelling of dose 
4.5.2.5 Culture of A549 and RPMI 2650 
 Human alveolar epithelial cells (A549, ATCC, USA) and human nasal 
epithelial cells (RPMI-2650, ATCC, USA) were cultured in CCMFBS10% in a 
humidified incubator at 37°C and 95% air and 5% CO2. All experiments were 
performed on cells seeded at a density of 30,000 cells/cm
2
 in CCMFBS2%.  
 
4.5.2.6 Nanoparticle preparation and exposure 
 For all cell culture experiments, particles were sterilized by dry heat 
sterilization at 180°C for 20 minutes (Memmert, Schwabach, Germany) and then 
suspended at 1.7 mg/mL in CCMFBS2%. The suspension was sonicated for five 
minutes using a probe sonicator at 40 Hz (Vibra Cell Sonics Material Inc. Danbury, 
CT, USA) and immediately diluted with CCMFBS2% to the desired administration 
dose. The choice of mass-based administration dose range (0.00526, 0.0526, 0.526, 
5.26 and 52.6 µg/cm
2
 ≈ 0.0017 to 17 µg/100 μl corresponds to the following 





on particle type. These concentrations were chosen based on the findings of Faux and 




 is a critical threshold dose at 
which particle-induced inflammation occurs in both in vitro systems (as IL-8 
production) and in vivo systems (as neutrophil recruitment). Although pro-
inflammatory outcomes are not measured in this study, the use of this dosing scheme 
will allow for direct comparison of the study results with the wider nanotoxicology 
literature. 
 
4.5.2.7 Cell viability assay using MTT 
 MTT Calibration Curve: The MTT assay was used to assess the effects 
of exogenously applied compounds on the cell layer metabolism. To compare the 
metabolic activity of cells seeded in 10% FBS supplemented CCM and 2% FBS 
supplemented medium, RPMI-2650 and A549 cells were plated at a range of seeding 
densities from 150 to 40,000 cells/well in two the two different cell culture medium 
in a 96-well plate and MTT assay was performed. The plates were incubated for 24h 
under standard conditions. After 24h, the cell culture medium was removed and 
replaced with fresh cell culture medium and 50 µl of MTT solution (5 mg/ml in PBS) 
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was added to each well. After 4h this medium was removed by gentle inversion and 
tapping onto paper. Any formazan crystals generated within the adherent cell layers 
were solublised with 100 µl of a surfactant solution (10% v/v SDS in DMF:water 
(1:1)). Upon complete solubilization of the crystals after incubating overnight under 
standard conditions, the absorbance of each well was measured by 
spectrophotometry using a wavelength of 570 nm and correcting for background 
absorbance using a wavelength of 650 nm. A calibration curve was produced using 
absorbance as a function of cell number/well and the calibration curve obtained from 
cells seeded under two different cell culture medium conditions were compared and 
the metabolic activity of cells grown in both the conditions was found to be similar. 
 Cytotoxicity: Nanoparticle toxicity as measured by a reduction in metabolic 
activity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay. Cells were seeded in a 96-well plate and, after 24 h, were 
exposed to 100 µL of particles suspended in CCMFBS2% at concentrations of 52.6, 
5.26, 0.526, 0.0526 and 0.00526 µg/cm
2 
or CCMFBS2% alone (negative control) and 
incubated for 6 and 24 h. After the exposure period, the particle suspensions were 
aspirated and replaced by 200 µL fresh CCMFBS2%. 50 µL MTT (5 mg/mL) was then 
added to the wells and the plate was incubated for a further 4 h. The medium was 
then removed and the resulting intracellular formazan crystals were dissolved over 
24 h in 100 µL of 10% SDS prepared in 1:1 water:DMF, after which the absorbance 
from the solubilized formazan was measured spectrophotometrically (SpectraMax, 
UK) at an absorbance wavelength of 560nm. 
The relative cell viability (% viability) was calculated as follows: 
 
               
   
    
     
 
Equation 4-1 
Where A is the absorbance obtained for each concentration of the test substance, S is 
the absorbance obtained for positive control (1% v/v Triton-X) and CM is the 
absorbance obtained for untreated cells (incubated with CCMFBS2% alone). The 
latter reading was defined as 100% cell viability. 
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4.5.2.8 Membrane damage study using LDH 
 Cells were seeded in a 96-well plate and, after 24 h, were exposed to 100 µL 
of particles suspended in CCMFBS2% at concentrations of 52.6, 5.26, 0.526, 0.0526 
and 0.00526 µg/cm
2 
or CCMFBS2% alone (negative control) and incubated for 6 and 
24 h. LDH assay was performed according to manufacturer’s guidelines (Cytoscan-
LDH assay kit was purchased from G-Biosciences, Maryland, USA). Briefly, after 
the exposure period, 50 µl of supernatant from each exposure well was removed into 
a new 96-well plate and 50 µl of reconstituted reaction mixture was immediately 
added to each well. The plate was covered in foil and put on a shaker for thorough 
mixing at 37°C. After mixing for 20 minutes, the plate was removed and 50 µl of 
stop solution was added to all wells. The absorbance of the wells was measured by 
spectrophotometry (SpectraMax, UK) at an absorbance wavelength of 490 nm, using 
a reference wavelength of 680 nm. 
All samples, positive, negative, and media controls are run in triplicate. The 
relative cell LDH release (% LDH release) was calculated as follows: 
 
                 
    
    
     
Equation 4-2 
Where A is the absorbance obtained for each concentration of the test substance, CM 
is the absorbance obtained for untreated cells (incubated with CCMFBS2% alone) and 
S is the absorbance obtained for positive control (1% v/v Triton-X). The latter 
reading was defined as 100% LDH release. 
 
4.5.2.9 Conventional Cytotoxicity vs. Particokinetics and Cytotoxicity 
The particokinetic modelling program, EXCEL developed in Chapter 3 was 
applied to calculate the amount of particles reaching the cells. Cytotoxicity of the 
particles calculated from administered surface area dose was reanalysed and the 
cytotoxicity was recalculated using the delivered surface area dose. The half-
maximal effective concentration derived from the administered surface area dose and 
delivered surface area dose were compared. 
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4.6 Results 
4.6.1 CCM and RTLF characterization 
Total Protein Content: The RTLF obtained from healthy human lungs and 
concentrated had the total protein content of 1.2 mg/ml and the total protein content 
in cell culture medium supplemented with 2% v/v FBS was determined as 0.8± 
mg/ml using BCA assay. 
Dynamic Viscosity: The dynamic viscosity of the RTLF and cell culture 
medium supplemented with 2%FBS at 37°C was 0.696±0.039 mPa.s and 
0.734±0.002 mPa.s. 
 
4.6.2 Particle size in water, CCM and RTLF 
Size in Water: The size of the NPs was measured in water every 30 minutes 
for a period of 6 hours as seen in Figure 4-4 A. The size of LNC 50 and LNC 150 
remained stable over 6 h with the average size being 68 and 147 nm respectively. 
The size of PS 50 and PS 200 remained stable over 6 h with the average size being 
57 and 248 nm respectively. The size of CuO NP increased from 850 ± 290 nm at 
t=0 h to >1500 nm at t=6 h. The size of TiO2, NP remained over 1500 nm for the 
whole duration of particle size measurement.  
Size in CCM: All the particles showed some degree of aggregation in CCM 
without serum as seen in Figure 4-4 B. The size of LNC 50 increased from 76 ± 2 nm 
at t=0 h to 113 ± 4 nm at t=6 h. The size of LNC 150 increased from 150 ± 3 nm at 
t=0 h to 157 ± 2 nm at t=6 h. The size of PS 50 increased from 205 ± 75 nm at t=0 h 
to 1127 ± 380 nm at t=6 h. The size of PS 200 increased from 254 ± 8 nm at t=0 h to 
> 1500 nm nm at t=6 h. The size of CuO and TiO2 NP started at around 750 nm at 
t=0 but increased rapidly (within 1 h) to over 1500 nm and remained so for the 
remaining duration of particle size measurement.  
Size in CCMFBS2%: The particles remained stable in CCMFBS2% as seen in the 
size distribution profile in Figure 4-4 C. The size of LNC 50, LNC 150, PS 50, PS 
200, CuO and TiO2, remained stable over the period of 6 h with the average size 
being 91 ± 17, 162 ± 3, 95 ± 8, 243 ± 8, 267 ± 13 and 356 ± 90nm respectively.  
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The data in Figure 4-4 show average particle size values of n=3 
measurements at each hour over 6 h. The values are based on calculated Z-average 
values obtained from the Zetasizer Nano; however it can also be informative to look 
at the intensity distribution graphs of the particles suspended in different media. 
Figure 4-5 shows that the LNC 50 and PS 50 suspended in CCM gave a multi-modal 




Figure 4-4: Particle size measurements of TiO2, CuO, PS 50, PS 200, LNC 50 and LNC 150 in 
ultrapure water (A), CCM (B) and CCMFBS2% (C) over 6 h. All values listed represent the 
mean ± SD of n=3 experiments.  
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Figure 4-5: Particle size measurements PS 50, PS 200, LNC 50 and LNC 150 in ultrapure 
water, CCM and CCMFBS2% over 6 h based on intensity distribution obtained from Zetasizer 
Nano. 
 
Size in RTFL: The amount of RTLF available was very limited so all the 
particles could not be measured in RTLF. With future studies in mind, a decision was 
made to characterize CuO particles in RTLF. A look at size based on intensity 
distribution gives a better picture of the protein and particle agglomerate size in the 
system. The graphs in Figure 4-6 show that (a) CCMFBS2% blank has peak intensity at 
173 nm whereas (b) RTLF blank has peak intensity at 408 nm and (c) CuO NPs are 
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suspended in RTLF the peak intensity reduced to 237 nm. However, a look at time 
course of particle size in Figure 4-6 D shows that RTLF blank had a consistent size 
of about 300 nm where as the particle size of CuO decreased from 400 nm at t =0 h 











Figure 4-6: Average intensity distribution measurement of blank CCMFBS2% (A), blank RTLF 
(B), CuO (0.017 mg/ml) in RTLF (C) and size of blank RTLF and CuO in RTLF (D) as measured 
by dynamic light scattering over a period of 6 h at 37°C.  
  
4.6.3 Zeta potential in water and CCMFBS2% 
The zeta potential of particles was measured at 37°C in water and CCMFBS2%. 
All the particles had negative zeta potential in water. In CCMFBS2% all the particles 
except LNC 50 and LNC 150 seems to have approximately the same zeta potential of 
about -12 ± 2 mV (Figure 4-7). LNC 50 and LNC 150 had a ZP of -3 and -2.6 
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respectively. The ZP should ideally be measured in low ionic salt solutions line (10 
nM NaCl) instead of water as measurement in water would lead to increase in the 
thickness of double layer due to lack of ions in the solution.  
 
 
Figure 4-7: Zeta potential of particles in water and CCMFBS2%. The data represent mean ± 
SD; n=3. 
 
4.6.4 Oxidative potential in water 
Only copper oxide particles had a biologically significant oxidative potential, 
with an initial ascorbic acid depletion rate of 11.1 ± 0.7 nM/sec. All the other 
nanoparticles tested had a similar oxidative potential to that of water (initial ascorbic 
acid depletion rate) 1.4 nM/sec. In the presence of metal chelator DTPA the ascorbic 
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Figure 4-8: Rate of ascorbic acid depletion in presence of PS 50, PS 200, LNC 50, LNC 200, 
TiO2 and CuO at pH=7 at 37
o
C. Depletion was determined in the absence and presence of 
metal chelator DTPA spectrophotometrically at a wavelength of 265 nm for 2 hours and 
readings taken at intervals of 2 minutes. The data represents the mean ± SD; n=3. 
 
4.6.5 Culture of A549 and RPMI 2650 – MTT calibration 
 MTT Calibration Curve: The metabolic activity of A549 cells in CCM 
supplemented with 2% FBS was compared to the metabolic activity of RPMI 2650 
after 24h incubation. A linear relationship was found for absorbance vs. cell number 
over the range of 1250 -40,000 cells/well, indicating seeding density over this range 
did not affect the rate of uptake or biotransformation of the MTT salt by individual 
cells. The coefficient of variation (R
2
) value for both the calibration curves was 
greater than 0.97 (Figure 4-9). This allowed for the accurate analysis of loss in cell 
viability in subsequent experiments where cells were seeded at a density of 10,000 
cells/well.  
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Figure 4-9: Calibration curve of A549 and RPMI 2650 cell number vs. absorbance after 
incubation with MTT for 4 h. The data represent mean ± SD of n=3 (3 different passages); each 
experiment performed in triplicate. 
 
4.6.6 Cell viability and membrane damage 
 First the reference metal oxide nanoparticles were tested on A549 and RPMI 
2650 cells for cytotoxicity and the particokinetics principal was applied to see if re-
interpretation of data based on delivered dose made a difference in the cytotoxicity 
profile of the particles. In further tests more pharmaceutically relevant carrier 
systems were tested for cytotoxicity. 
 
4.6.7 Reference CuO and TiO2 metal oxide nanoparticle 
cytotoxicity 
 The reference metal oxide nanoparticles showed a dose and time dependent 
toxicity profile. The delivered dose was ~50% of the administered dose value for 
CuO NP after 3 h (Table 4-3) where as for TiO2 NP all the administered particleshad 
reached the cells. This is due to the fact the TiO2 has more density and a bigger 
particle size compared to CuO so the particles reach the cells primarily by 
gravitation. At 6 h and 24 h time points the delivered dose value for both the NP was 
the same as the administered dose value (Table 4-4). In the MTT assay the CuO 
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particles produced a greater inhibition of cellular metabolism than TiO2 which only 
impaired cell activity at the overload concentration. In both the cases of copper oxide 
and titanium dioxide nanoparticle the delivered surface area dose was equal to the 
nominal surface area dose as these particles are heavy and almost all the particles 
(>97%) reach the bottom of the 96-well plate in 6 h. Hence no difference in nominal 
and delivered surface area dose was observed. The measurement of lactate 
dehydrogenase release after particle exposure could not be performed for CuO NPs 
as the particles interfered with LDH positive control supplied by the manufacturers 
(Figure 4-12). However, TiO2 particles did not interfere with the LDH assay and the 
results of LDH release correlated will with MTT data.The cytotoxicity testing on 
RPMI 2650 indicated similar results. The metal oxide particles showed dose and time 
dependent toxicity. CuO NP showed more toxicity than TiO2 NP at all the time 
points tested. In comparison the TiO2 NPs did not show as much toxicity as the CuO 
particles (Figure 4-10 and Figure 4-11). 
 
































0.020 0.009 0.016 0.016 
0.101 0.048 0.083 0.083 
0.202 0.096 0.167 0.167 
1.012 0.484 0.837 0.837 
2.025 0.969 1.675 1.675 
10.129 4.846 8.375 8.375 
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Table 4-4: Administered and delivered dose values of CuO and TiO2 NP after 6 h exposure. The 





























0.0002 0.0002 0.0001 0.0001 
0.0020 0.0018 0.0016 0.0016 
0.0208 0.018 0.016 0.016 
0.104 0.094 0.083 0.083 
0.208 0.189 0.167 0.167 
2.080 1.890 1.675 1.675 
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Figure 4-10: The effect of copper oxide on A549 and RPMI 2650 cell lines after 3 (green), 6 
(blue) and 24 h (red) exposure. Cellular metabolic activity was measured 
spectrophotometrically at 570 nm and viability calculated as a percentage of the control (assay 
medium alone) over a particle concentration range. Effect of particles on cell viability as 
determined by conventional cytotoxicity (administered dose) was compared to effect of particles 
on cell viability after applying partico-kinetics principles (delivered dose). The data represent 
the mean ± SD; n=3 
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Figure 4-11: The effect of titanium dioxide on A549 for 3 (green), 6 (blue) and 24 h (red) 
and on RPMI 2650 cell lines after 6 (blue) and 24 h (red) exposure. Cellular metabolic activity 
was measured spectrophotometrically at 570 nm and viability calculated as a percentage of the 
control (assay medium alone) over a particle concentration range. Effect of particles on cell 
viability as determined by conventional cytotoxicity (administered dose) was compared to effect 
of particles on cell viability after applying partico-kinetics principles (delivered dose). The data 
represent the mean ± SD; n=3 
 
 The LDH assay was unavailable for the CuO particles as the test material 
interfered with the assay, but LDH release after exposure to TiO2 showed a negative 
correlation with effects in the MTT assay with Pearson’s correlation coefficient of 
value -0.94 (Figure 4-12). 
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4.6.8 PS 50 and PS 200 Cytotoxicity 
 Polystyrene nanoparticles did not show any toxicity in any of the cell lines 
tested at 6 h or 24 h. LDH release could not be measured at any of the particle 
concentration tested. The maximum LDH release was 5% of the control after 
exposure of A549 cells for 24 h to PS 50 at the maximum concentration. The 
particles were tested for interference with LDH using the standard LDH supplied by 
the manufacturer and showed no interference. This might mean that the particles 
were not membrane active. The effect of polystyrene nanoparticles on the viability of 
cell in the two cell lines tested A549 and RPMI 2650 were similar (Figure 4-13). 
None of the particles at any given concentration reduced the cell viability by less 










Figure 4-12: The effect of copper oxide and titanium dioxide on LDH positive control (A) and the 
correlation between cellular metabolic acitivity and lactate dehydrogenase release from the A549 
and RPMI 2650 cell lines after exposure to TiO2 NP for 6 and 24 h (B). The data represent the 
mean ± SD; n=3 
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4.6.9 LNC 50 and LNC 150 Cytotoxicity 
 The in-house developed lipid nanocapsules (LNC 50 and LNC 150) of 50 and 
150 nm showed a time and dose-dependent toxicity. The effects of LNC 50 and LNC  
 








Figure 4-13: The effect of PS 50 and PS 200 on A549 and RPMI 2650 cell lines after 6 (blue) and 
24 h (red) exposure. Cellular metabolic activity was measured spectrophotometrically at 570 nm 
and viability calculated as a percentage of the control (assay medium alone) over a particle 
concentration range. Effect of particles on cell viability as determined by conventional 
cytotoxicity was compared to effect of particles on cell viability after applying portico-kinetics 
principles. The data represent the mean ± SD; n=3 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 134 - 
Chapter 4 – In vitro nanoparticle toxicology incorporating particokinetic modelling of dose 
 
150 were similar in both cell lines. The administered surface area doses of LNCs 
were much higher than those tested for CuO and TiO2 NP because these particles 
have been prepared for incorporation of pharmaceutically active molecule in them 
and they will be inhaled deliberately which might lead to higher deposited dose in 


















(Table 4-5 and Table 4-6). 
 


































0.33 0.012 0.196 0.005 
1.65 0.060 0.98 0.029 
3.3 0.121 1.9 0.058 
16.5 0.605 9.8 0.29 
33 1.21 19.6 0.58 
165 6.05 98 2.9 
330 12.1 197 5.8 
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0.33 0.025 0.196 0.013 
1.65 0.125 0.98 0.068 
3.3 0.25 1.9 0.136 
16.5 1.25 9.8 0.68 
33 2.5 19.6 1.4 
165 12.5 98 6.8 
330 25 197 13.6 




The results show that particles only showed toxicity only at overload dose 
concentration (Figure 4-14 and Figure 4-15).This overload concentrations is based on 




 is a 
critical threshold dose at which particle-induced inflammation occurs in both in vitro 
systems (as IL-8 production) and in vivo systems (as neutrophil recruitment). 
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Figure 4-14: The effect of LNC 50 on A549 and RPMI 2650 for 6 (blue) and 24 h (red). Cellular 
metabolic activity was measured spectrophotometrically at 570 nm and viability calculated as a 
percentage of the control (assay medium alone) over a particle concentration range. Effect of 
particles on cell viability as determined by conventional cytotoxicity (administered dose) was 
compared to effect of particles on cell viability after applying partico-kinetics principles 
(delivered dose). The data represent the mean ± SD; n=3 
 
 
    Nanoparticle toxicokinetics in the nose: an assessment of risk 
 
 - 137 - 
Chapter 4 – In vitro nanoparticle toxicology incorporating particokinetic modelling of dose 
 
Figure 4-15: The effect of LNC 150 on A549 and RPMI 2650 for 6 (blue) and 24 h (red). Cellular 
metabolic activity was measured spectrophotometrically at 570 nm and viability calculated as a 
percentage of the control (assay medium alone) over a particle concentration range. Effect of 
particles on cell viability as determined by conventional cytotoxicity (administered dose) was 
compared to effect of particles on cell viability after applying partico-kinetics principles 
(delivered dose). The data represent the mean ± SD; n=3. 
 
LDH release after exposure to LNC 50 and LNC 150 did not show a good 
negative correlation with effects in the MTT assay with Pearson’s correlation 
coefficient of value -0.91 (Figure 4-16). This means that cytotoxicity of the LNC has 
a different mechanism of action rather than membrane disruption. However, our 
experiments did not provide us with a good hypothesis for this mechanism. 
Further the data showed that LNC 50 caused more LDH release as compared to LNC 
150 after 24 h exposure (Figure 4-17). At 6 h both LNC 50 and LNC 150 showed 
LDH release which was less than 10% of control in both the cell lines. However, at  
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24 h the LDH release from both the cell lines after exposure to LNC 50at delivered 




 was 28% (A549) and 33% (RPMI) of control. The 
cell viability after 24 h exposure at the same delivered dose concentration was 45% 
(A549) and 52% (RPMI) of control. LNC 150 even at the heighest tested 




 did not give more than 10% (of control) LDH release.  
 
Figure 4-16: The correlation between cellular metabolic acitivity and lactate dehydrogenase 
release from the A549 and RPMI 2650 cell lines after exposure to LNC 50 and LNC 150 NP for 6 
and 24 h (b). The data represent the mean ± SD; n=3. 
 
Figure 4-17: LDH release from the A549 (grey) and RPMI 2650 (black) cell lines after exposure to 
LNC 50 and LNC 150 NP for 6 and 24 h. The data represent the mean ± SD; n=3. 
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4.6.10 Re-calculation of response based on delivered dose and 
comparison to administered dose 
 The half-maximal effective concentration (EC50) values were calculated using 
a sigmoidal dose-response curve. The EC50 values were calculated for both 
administered and delivered surface area doses. The EC50 value for PS 50 and PS 200 
could not be calculated as the particles did not reduce the viability below 80% at any 
of the tested concentration. Similarly, the EC50 value for 6 h exposure could not be 
calculated for LNC 50 and LNC 150 as not even at the heighest administered 
concentration the cell viability was reduced below 50% of control. The administered 
SA dose EC50 was usually lower than the delivered SA dose EC50 except for CuO 
and TiO2 NP. Comparison of IC50 value of LNC 50 and LNC 150 value showed that 
there was no size dependency of toxicity. In case of CuO and TiO2 all the particles 
reached the bottom of the well by the end of 24 h so the administered dose was equal 
to the delivered dose. However, in case of LNC 50 and LNC 150 less than 10% of 
the particles administered reached the bottom of the well so the delivered dose was 
less than 10% of the administered dose. This is in agreement with findings of 
Khanbeigi et al. who found that for low density particles such as polystyrene beads 
less than 0.3% of the particles administered were able to interact with the cells.  
 
Table 4-7: EC50 values for nanoparticles exposed to A549 cells for 24 h calculated using 
conventional nominal surface area dose and after applying particokinetics to calculate 
delivered surface area dose. 
Particle Type 












CuO 1.60 1.60 
TiO2 5.09 5.09 
Purified LNC 50 289.70 13.86 
Purified LNC 150 266.90 11.78 
 
4.7 Discussion  
In order to understand the interaction of nanomaterials with biological 
systems it is essential to systematically and accurately define particle characteristics 
(212). In the present study the size of particles was measured using dynamic light 
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scattering over a period of 6 h in four different media – water, CCM without serum, 
CCM with 2% v/v serum and in reconstituted concentrated RTLF. The results in 
Figure 4-4 indicate that particles aggregate in water and CCM without serum and this 
aggregation is a dynamic process. Coating of the particles with stabilizers such as 
poly(vinyl alcohol), Tween-80, Fluonic 127, Fluonic 68, Solutol
®
 HS 15 etc. 
prevents this aggregation by adhering to the nanoparticle surface and causing stearic 
hinderance (213-217). However, particles remained stable in CCM supplemented 
with serum (Figure 4-4) which may be due to opsonisation of serum protein onto the 
surface of the particles which provide steric hinderance and thus prevent the particles 
from agglomeration. These results are in agreement with reports from Murdock et al. 
(195), Allouni et al. (177) and Ji et al. (218) who have also observed aggregation of 
particles in water and non-supplemented cell culture medium. They also observed 
size stabilization in cell culture medium supplemented with serum. Murdock et al. 
tested the particle size in F-12K and RPMI-1640 media supplemented with either 
10% (v/v) or 20% (v/v) FBS, Allouni et al. measured TiO2 size in RPMI-1640 
supplemented with 10% (v/v) FBS and Ji et al. used six different types of cell culture 
medium each supplemented with a range (0.5% to 10% v/v) of FBS to measure the 
particle size of TiO2. 
To understand the colloidal stabilisation of particles suspended in 
supplemented media we have to consider the forces operating at the nanoparticle and 
liquid interface. Typical forces operating between the particles suspended in a liquid 
would be van der Waal’s (VDW), electrostatic interactions, steric interactions and 
solvation forces (219). Typically in water the particles have a net attractive VDW 
force and a repulsive electrostatic force. The balance between the attractive and 
repulsive forces would determine the aggregation of particles. The zeta potential of a 
particle is the potential difference between the stationary layer of fluid attached to the 
particle and the dispersion medium (220). A value of 25 mV (negative or positive) 
can be considered an arbitrary value that separates the low-charged surfaces particles 
from the high-charged surface particles (American Standard, 1985). Nanoparticles 
with a high zeta potential are electrically stabilised due to the repulsion between 
adjacent and similarly charged particles. So the non-aggregation of PS 50 and PS 200 
particles in water can be explained by the high zeta potential of the particles 
measured in water (-58.5 mV and -27.1 mV, respectively). For LNC 50 and LNC 
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150, the size stability in most media can be explained by steric stabilization of the 
particles conferred by the polyethylene glycol (600 Da) component of the particle 
shell, which is composed of Solutol
®
 HS15 (polyethylene glycol (600)-
hydroxystearate). 
When the particles are suspended in cell culture medium without serum we 
observed an aggregation of particles. The CCM is highly ionic due to presence of a 
number of salts with an ionic strength usually greater than 100 mM (218). According 
to Derjaguin, Landau, Verwey, and Overbeek (DLVO) theory, the stability of a 
colloidal suspension is based on the net balance of two forces: the electrostatic 
repulsion which prevents aggregation and a universal attractive van der Waals force 
which acts to bind particles together (219). In dilute electrolyte solutions, the 
counterion zone formed around the charged surface of nanoparticles extends causing 
interaction between the double layers of the two particles at long range. The van der 
Waals attraction is calculated by:  
 




where VA is van der Waal’s attractive force (Newton), A is the Hamaker constant 
(Joule) and D is the particle separation (meters). Since VA is inversely proportional to 
distance between the particles, it is relatively weak at long-range, hence electrostatic 
repulsion between the double layer dominates and a stable nanoparticle suspension 
results. However, high ionic strength compresses the electrical double layer and the 
magnitude of the repulsive barrier decreases, thereby van der Waals attraction 
dominates. Therefore, the net interaction potential becomes purely attractive leading 
to nanoparticle agglomeration as observed in the CCM. The zeta potential of the 
particles in CCMFBS2% was approximately the same for CuO, TiO2, PS 50 and PS 200 
which may be due to the adsorption of albumin from the FBS onto the surface of the 
particles. This result is in agreement with the results from other authors who have 
observed similar trend for metal oxide NPs (168, 177, 218). The study by Limbach et 
al.(168) investigated the changes to zeta potential values of metal oxide NPs (SiO2, 
TiO2, Fe2O3, CuO, Al2O3, ZrO2, CeO2) of 20-70 nm in water and cell culture medium 
with 10% FBS. In pure water, the zeta-potential measurements of oxide dispersions 
cover a wide range from -25 to 55 mV. Once these dispersions were mixed with cell 
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culture medium, protein adsorption strongly affected the surface charge distribution 
of oxides and shifted the zeta potential to around -18 mV. The zeta potential of 
LNC’s was much lower compared to other particles tested in CCMFBS2% which might 
mean that due to PEG coating of the LNC’s the adsorption of serum around the 
particles is not the same which may explain the deviation from the trend. 
For nanoparticles that are inhaled, the respiratory tract lining fluid (RTLF) is 
the first physical interface between the body and the outside environment, with a 
crucial physiological and protective role for the underlying epithelial cells from nasal 
to alveolar passages. The understanding of the interactions between/coating of 
inhaled particles that deposit in the lung with the RTLF is important in understanding 
the interactions between particles with respiratory cells. This is why the colloidal 
stability of nanoparticles in RTLF was investigated in this study. The major protein 
constituents of the RTLF are albumin, transferrin, lysozyme and immunoglobulins A, 
G, M and surfactant protein A, which constitute more than 75% of the total protein 
component of RTLF (221). In comparison, the primary constituents of FBS are 
albumin and alpha globulins (Supplier Information). In this study, the total protein 
content measured in CCMFBS2% and RTLF was 0.8 mg/ml and 1.2 mg/ml, 
respectively. It should be noted that the concentrations in these samples are not as 
high as the total protein content in RTLF in vivo (17.9 ± 8.6 mg/ml) (219); however, 
inherent limitations of dynamic light scattering techniques limit the ability to 
generate useful particle size data in media with high protein concentrations due to 
significant background scattering caused by biomolecule agglomerates. Particle 
tracking analysis is a more robust technique for polydisperse suspensions or particle 
suspension in biological medium (222), but was not available during this study. The 
measurement of blank CCMFBS2% and RTLF showed interesting differences in the 
protein agglomeration profiles (Figure 4-6). In CCMFBS2% there is an initial peak 
between 8 to 20 nm which is representative of un-agglomerated albumin and over 
time (approximately 3 h) it agglomerates and stabilizes at about 150 nm. However, 
for blank RTLF there are peaks at ~20 nm and ~400 nm which might be 
representative of the respective protein aggregates and lung surfactant-containing 
liposomes formed in RTLF after lavage. The particle size measurements of CuO NPs 
in different media revealed that they aggregated in water and CCM without serum, 
but remained stable in CCMFBS2% and RTLF. This might be due to opsonization of 
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proteins onto the surface of the particles. The increase in particle size from dry state 
to the size measured in CCMFBS2% and in RTLF might be attributed to the 
opsonization of proteins on the particle surface. The decrease in particle size 
observed in RTLF might be attributed to the fact that at the beginning some 
agglomerates of both particles and large surfactant containing liposomes might cause 
a bias of intensity distribution towards large particles due to their scattering 
thousands of times more light than smaller particles (85). Over the period of time 
these particle agglomerates settle down and are not present in suspension any more to 
cause the bias thus causing the decrease in particle size over time. 
Importance of measuring reactive oxygen species ex vivo: In a study by 
Sayes et al. (200) the authors showed that simple ex vivo tests of nanotitania 
photoactivity could thus prove useful as a comparative screen for cytotoxicity in this 
important class of materials. The authors measured the reactive oxygen species 
generation ex vivo of nano-TiO2 (dry state size 3-10 nm, anatase, rutile and 
anatase/rutile 60/40) and measured the cytotoxicity in human dermal fibroblasts and 
human lung carcinoma cells using various biochemical endpoints (MTT, LDH, IL-8 
production). The investigators determined the reactive species formation ex vivo by 
two different methods – first the chemiluminescence of luminol was used to 
qualitatively probe the production of reactive species over 20 min and second the 
decay of photograde organic dye Congo Red was followed via absorption 
spectroscopy and correlated to rate constants for radical production in water. The 
differences in the cytotoxic response of the nano-TiO2 tested were due to the anatase 
nano-TiO2 being more reactive as measured by the production of reactive species ex 
vivo, and not because of differences in surface area. The authors found that the 
differences in the cytotoxic response of the nano-TiO2 tested were due to the anatase 
nano-TiO2 being more reactive as measured by the production of reactive species ex 
vivo, and not because of differences in surface area.  
Ascorbic acid depletion as a valid model for assessing oxidative potential 
ex vivo:Nanoparticle toxicity in many cases has been attributed (35-38, 223) to their 
capacity to generate oxidative stress due to the production of reactive oxygen species 
(ROS). The characterization of NPs by measurement of their oxidative potential was 
performed using a well established method of ascorbic acid depletion. This method 
was described systematically by Seiffert and co-workers (224) in her doctoral thesis. 
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2+) with the subsequent formation of superoxide (•O2
−
) and redox cycling (224). 
The rate of ascorbic acid oxidisation can be measured and provides an indirect value 
for the oxidative potential of the sample. Figure 4-8 shows that CuO NP had the 
highest oxidative potential (as measured by ascorbic acid depletion rate), which 
might be due to the CuO being highly redox active metal. This result is agreement 
with the findings of Seiffert and co-workers (224) who found similar ascorbic acid 
depletion rates for CuO and TiO2 NPs. The lack of oxidative potential of LNC’s 
affirmed that the in-house manufacturing process did not contaminate the surfaces of 
these particles with reactive species, as the components of the LNC are not expected 
to be reactive in themselves (unless degraded).  
A comparison of nanoparticle cytotoxicity covering a wide range of 
materials, as conducted in this study, showed very interesting results. First, it should 
be mentioned that a true comparison of cytotoxicity for these different nanomaterials 
may only be performed when the cell viability and membrane integrity assay results 
are normalized to the delivered dose (modeled using EXCEL as discussed in Chapter 
3). The reason for this is that the different nanoparticle properties, especially particle 
size distribution, aggregation potential and density, will mean that each particle type 
will exhibit a very different colloidal behavior during particle exposure. Thus, if cells 
are exposed to particle suspensions at similar administered doses (as was done in this 
study), particle-specific colloidal behavior will dictate that delivered dose values will 
differ by order of magnitude for the same exposure times.  
 In this study, CuO NP proved to be most toxic as compared to other NPs, as 
expected. This can be explained by the high oxidative potential of CuO. These results 
are in agreement with Karlsson et al. (225) who tested different metal oxide particles 
(CuO, TiO2, ZnO, CuZnFe2O4, Fe3O4, Fe2O3) and multiwalled carbon nanotubes on 
A549 cells. Cytotoxicity was analysed using trypan blue assay. DNA damage and 
oxidative lesions were determined using the comet assay and intracellular production 
of reactive oxygen species (ROS) was measured using the oxidation-sensitive 
fluoroprobe 2',7'-dichlorofluorescin diacetate (DCFH-DA). CuO nanoparticles were 
most potent regarding cytotoxicity and DNA damage, and were the only particles to 
induce significant increase in intracellular ROS generation. Interestingly, it should be 
noted that, due to the high density of CuO, the administered and delivered dose 
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values are very similar, especially after 24 h exposure time. Interesting differences 
can be seen when the same delivered doses came into contact with the cells, yet 
different cytotoxicity outcomes were achieved because the overall incubation times 
are different. This might be due to a longer accumulative intracellular residence time. 









 for PS 200 after 6 h exposure) we 
can see that the cell viability in case of TiO2 was reduced to 30% of control in 
contrast to 97% cell viability for PS 200 particles. This may be partly explained by 
the fact that TiO2 particles being heavier will reach the cells faster and in effect the 
cumulative cell surface residence time of TiO2 particles will be much greater than the 
cumulative cell surface residence time of PS 200 particles. This means that more 
TiO2 could be internalised as compared to PS 200 particles. This also shows that the 
particokinetic model can be further improved such that it reflects the cumulative 
cellular surface residence time.  
The assessment of cytotoxicity of LNC 50 and LNC 150 showed that particle 
size did not influence toxicity, when similar surface area doses are administered 
(Figure 4-14, Figure 4-15 and Table 4-5). This is in agreement with the results 
obtained by Oberdorester et al. (165) (Figure 3-1).It should be noted that the toxicity 
of LNC particles when compared to PS particles at similar delivered dose levels was 
greater (Figure 4-13, Figure 4-14 and Figure 4-15). This was unexpected as the 
LNC’s are manufactured from biocompatible components for drug delivery 
applications. One reason might be that there is still some excess surfactant stabilizer, 
Solutol HS15, present in the particle suspension which may be causing this toxicity. 
Indeed, previous studies showed that LNC particles which are not subjected to a 
rigorous purification procedure exhibited IC50 values similar to copper oxide 
nanoparticles (data not shown). Thus, the residual surfactant stabiliser is likely to 
play a role in cytotoxicity observed in this study. 
 
4.8 Conclusion 
The application of particokinetic model to normalise the results to delivered 
dose values allowed for a highly robust comparison of nanoparticle cytotoxicity. This 
is in agreement with Teeguarden et al. (90) who described a model of colloidal 
behaviour whereby the fractions of the administered dose calculated to sediment and 
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diffuse towards the cell layer were summated to obtain a single delivered dose value 
for any given set of experimental conditions. By applying the particokinetic model 
post hoc to an experimental data set examining nanoparticle influence on membrane 
integrity (i.e. half-maximal effective concentrations (EC50) for lactate dehydrogenase 
release (91), Teeguarden et al. were able to show that the EC50 values reported 
(normalized to the administered dose) were 150-1200 fold higher than the values 
obtained when the results were normalized post hoc to the particokinetic derived 
delivered dose. In this study, the differences in EC50 values for cell viability 
(comparison administered vs. delivered dose) were not as drastic, but still showed at 
least one order of magnitude difference for the LNC particles. In this study 
particokinetic modelling was applied to cytotoxicity studies to determine the impact 
of dosimetry on common cytotoxicity values such as cell viability and membrane 
integrity. The differences in nominal and delivered dose EC50 values for LNC 50 and 
LNC 150 demonstrates that normalization of in vitro results to administered dose 
values may lead to reporting of effective toxic or minimum active doses that are 
artificially higher than they should be in safety studies. This study thus provides an 
example of using particokinetic modeling in designing in vitro cell-based assays that 
more accurately assess dose-response effects of nanoparticle systems. 
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Chapter 5                                                             
Standard cell culture conditions promote 
hyperoxia-induced cellular adaptations that 




One of the primary drivers for the growth in nanotoxicology research is the 
rapid expansion of engineered nanomaterials designed for use in consumer products. 
According to the Project on Emerging Nanotechnologies, there are currently more 
than 1300 consumer products that incorporate nanomaterials and this number is 
expected to grow to 10
4
 materials within a decade (6). The traditional approach of 
using whole animal exposure models to assess the safety of all nanomaterials via all 
exposure routes will not be feasible given the rapid rate of development in the 
materials science sector (69, 70). Instead, the development of predictive models of 
nanotoxicology based on robust paradigms linking nanoparticle (NP) 
physicochemical properties and in vivo outcomes is underway. The enhanced surface 
reactivity of NP and their related ability to generate oxidative stress is one of the 
principal mechanisms hypothesized to drive both NP-induced inflammation and 
cellular damage (reviewed by (35, 36)). Based on this paradigm, cell cultures in 
which reactive oxygen species (ROS) production and the generation of oxidative 
stress can be quantified are regarded as valid assay systems for comparing the 
toxicity of manufactured or ambient NP (35, 36, 38, 43, 58). A hierarchical model for 
NP-induced oxidative stress has been proposed, in which cells undergo graded or 
tiered responses ind response to increased insults: Tier 1) upregulation of adaptive 
antioxidant defences, Tier 2) inflammation and Tier 3) cell death (Figure 1-3; (38, 
43, 58)). 
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For the evaluation of ROS production in the presence of cells, various 
methods are available – using fluorescent probes like 2',7'-dichlorfluorescein-
diacetate (DCFH-DA), dihydrorhodamine-123, dihydroethidium or using 
electroparamagnetic resonance. Each method has its advantages and disadvantages 
which have been reviewed here (226). What has been overlooked, however, is the 
fact that standard cell culture practices use atmospheric oxygen (i.e. 150 mm Hg, 
~21%, O2) concentrations that constitutes an hyperoxic environment. With the 
exception of the cornea, epidermis and respiratory tract epithelial layer, cells in vivo 
typically experience 1-10 mmHg oxygen pressure (equating to ~ 1-5% O2). In the 
respiratory tract, small airway epithelial cells and alveolar cells experience 
approximately 100 mm Hg oxygen (~ 13% O2) (92). Despite this, most mammalian 
cells are cultured using 21% O2,which promotes increased intracellular production of 
ROS (93, 94). Cultured cells that fail to adapt to this oxidative environment fail to 
thrive, thus leaving only cells that have adopted an adaptive phenotype (94-97). 
Cellular adaptation to the oxidative stress, sometimes termed ‘culture shock’, 
involves enhancement of antioxidant defenses (e.g. upregulation of superoxide 
dimustases, increased glutathione (GSH) synthesis etc.), downregulation of ROS-
generating enzymes (e.g. cytochrome c oxidase (98)) or alteration of cellular targets 
of oxidative damage (replacement of fumarase A and B with fumarase C in E. Coli 
(99) and loss of aconitase in primates (100)). Logically, this process of adaptation 
may be anticipated to mute oxidative responses in cells  
 
cultured using 21% O2, thereby masking NP toxicity when measured using oxidative 
stress-related endpoints and making such systems poor predictors of in vivo toxicity 
outcomes. 
The implications of ‘culture shock’ for the in vitro assessment of 
nanoparticle-induced generation of intracellular ROS, especially as such studies are 
under investigation as predictors of in vivo outcomes, must be carefully considered. 
If standard cell culture conditions are exposing cells to artificially high oxygen levels 
thus forcing adaptation in surviving cells, such adaptive mechanisms may mask the 
true toxicity of nanomaterials under investigation and result in poor correlations to in 
vivo results. Therefore, the aim of this study was to investigate whether standard 
culture conditions in atmospheric oxygen (21% O2; termed hyperoxia in this study) 
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produce adaptation to oxidative stress compared to cells cultured at 13% O2 (termed 
normoxia in this study). Further, the impact of hyperoxia vs. normoxia on the results 
of standard in vitro nanoparticle toxicity assays (i.e. generation of ROS, intracellular 
glutathione and cell metabolism) were evaluated to assess the importance of this 
parameter for the robust interpretation of in vitro nanotoxicity data. 
 
 
5.2 Materials and methods 
5.2.1 Materials 
5.2.1.1 Test materials and cell culture media 
Reference nanocomposite copper oxide (CuO) particles (nanocrystallite form 
with a diameter of 2-10 nm according to the manufacturer’s data) were procured 
from NanoScale Material Inc. (USA). Physicochemical characterization of the 
particles in suspension was carried out in house as described below. 
Three variations of cell culture media were used in the study. Cell culture media 
without FBS (CCMFBS-) was used in selected physicochemical characterisation 
experiments and was comprised of minimum essential medium (phenol red-free) 
supplemented with 10% v/v fetal bovine serum (FBS), 1% v/v non-essential amino 
acids (NEAA), 1% v/v L-glutamine (L-Glu) and 0.1% v/v gentamicin (all from 
Sigma Aldrich, UK). Cell culture media with 10% FBS (CCMFBS10%) was used to 
culture cells and was comprised of minimum essential medium (with phenol red) 
supplemented with 10% v/v FBS, 1% v/v NEAA, 1% v/v L-Glu and 0.1% v/v 
gentamicin. Cell culture media with 2% FBS (CCMFBS2%) was used for selected 
assays and was comprised of minimum essential medium (phenol red-free) 




5.2.2.1 Nanoparticle characterization 
The particle size of a 0.017 mg/mL suspension was characterized over 6h in 
three different media, deionised water, CCMFBS- and CCMFBS2% using dynamic light 
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scattering. Measurements were taken every 30 min with a Zetasizer Nano ZS 
(Malvern, Worcestershire, UK). The zeta potential was also measured in deionised 
water and CCMFBS2% at the same particle concentration using the same instrument. 
All measurements were carried out at 37°C.  
 
5.2.2.2 Nanoparticle dispersion and dosing scheme 
For all cell culture experiments, particles were sterilized by dry heat 
sterilization at 180°C for 20 minutes (Memmert, Schwabach, Germany) and then 
suspended at 1.7 mg/mL in CCMFBS2%. The suspension was sonicated for five 
minutes using a probe sonicator at 40 Hz (Vibra Cell Sonics Material Inc. Danbury, 
CT, USA) and immediately diluted with CCMFBS2% to the desired administration 
dose. The choice of administration dose range (0.00526, 0.0526, 0.526, 5.26 and 52.6 
µg/cm
2
) corresponds to the following theoretical particle surface area doses: 0.0002, 




. These concentrations were chosen based on the 




 is a critical 
threshold dose at which particle-induced inflammation occurs in both in vitro 
systems (as IL-8 production) and in vivo systems (as neutrophil recruitment). 
Although pro-inflammatory outcomes are not measured in this study, the use of this 
dosing scheme is will allow for direct comparison of the study results with the wider 
nanotoxicology literature. 
5.2.2.3 Respiratory epithelial cell culture 
Human alveolar epithelial cells (A549, ATCC, USA) were cultured in an 
oxygen cabinet (Don Whitely Scientific, UK) under normoxic conditions (13% O2) 
and in a separate standard incubator under hyperoxic conditions (21% O2). The cells 
were cultured in CCMFBS10% in a humidified incubator at 37°C and 5% CO2. The 
cells were thawed and cultured at 21% O2 for at least two passages. Cells were then 
transferred and cultured at their respective pO2 (13% or 21%) for 72 h before being 
trypsinization and plating. All experiments were performed on cells seeded at a 
density of 30,000 cells/cm
2
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5.2.2.4 Measurement of endogenous glutathione level 
The original method described by Neuschwander-Tetri et. al. (204) was 
modified for measurement of intracellular GSH (extraction of GSH was done in 
13%). The flask of cells were transferred to 13% oxygen chamber and left for 72 h 
and then trypsinized and were seeded in 6-well plates. They were left in the 6-well 
plate for 24 h for the cells to adhere and were then exposed to 1) CCMFBS2% (baseline 
GSH control), 2) 100 µM (final concentration) diethylmaleate (DEM; Sigma Aldrich, 
UK) or 3) CuO nanosuspension (52.6 to 0.00526 µg/cm
2 





). Cells exposed to the positive control, DEM, were incubated for 2, 4 or 8 h 
with the compound, after which the supernatant was removed and the cells washed 
twice with ice cold PBS before addition of 6.5% v/v trichloroacetic acid (TCA) for 
10 min on ice. The TCA extract was collected for glutathione (GSH) measurement, 
mixed with O-phthaldialdehyde (OPA) and the fluorescence from the GSH-OPA 
adduct was measured using a Hidex Chameleon fluorometer (Hidex, Turku, Finland) 
at a λexcitation of 350nm and λemission of 420nm. The cells were then lysed by incubation 
with 0.5M sodium hydroxide (NaOH) for 1 h at room temperature and the NaOH 
extract was collected for total protein measurement. Total protein was measured 
using the bicinchoninic acid method (228). The fluorescence per mg protein was 
calculated and the results were plotted as nmol intracellular GSH per mg protein. 
Intracellular glutathione levels were determined at 2, 4, and 8 h following 




 CuO nanoparticle suspension. Intracellular glutathione 









 of CuO nanoparticle suspension. At each time point, cells were processed as 
described above and also plotted as nmol intracellular GSH per mg protein. 
 
5.2.2.5 Measurement of intracellular reactive oxygen species 
Dihydrorhodamine-123, a redox-sensitive probe, was used to determine 
intracellular ROS generation induced by either hydrogen peroxide (positive control) 
or CuO nanoparticles. The methods described by Henderson et al. and Royall et al. 
(229, 230) were used in a slightly modified format. The flask of cells were 
transferred to 13% oxygen chamber and left for 72 h and then trypsinized and were 
seeded in a clear-bottom black 96-well plate. They were left in the 96-well plate for 
24 h for the cells to adhere and after 24 h the cells were loaded dihydrorhodamine-
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123 at a final concentration of 20 µM (DHR-123 Sigma Aldrich, UK) prepared in 
Hank’s balanced salt solution (HBSS). After 30 min incubation with DHR-123 the 
cells were washed twice with cell culture medium. The cells were then exposed to 
hydrogen peroxide (H2O2; 2.5, 25, 250 and 500 µM), CuO nanoparticles (2, 0.2, 




) or CCMFBS2% (negative control) for 1, 2, 3 and 4 h. 
Live cell fluorescence was measured using an atmospheric controlled fluorescence 
plate reader (BMG Labtech, Aylesbury, UK) every hour at a λexcitation of 490nm and 
λemission of 530nm. The cells were then lysed by incubation with 0.5M sodium 
hydroxide (NaOH) for 1 h at room temperature and the NaOH extract was collected 
for total protein measurement. Total protein was measured using the bicinchoninic 
acid method (228). The fluorescence per mg protein was calculated and the results 
were presented as % ROS generated relative to the medium control for each 
concentration of H2O2 and CuO. The area under curve (AUC) of each graph was 
calculated using GraphPad Prism software to provide a single value reflective of the 
cumulative % ROS generated over the exposure period of 4 h at different 
concentrations of challenge. 
 
5.2.2.6 Measurement of metabolic activity using the MTT assay 
Nanoparticle toxicity as measured by a reduction in metabolic activity was 
assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay (203). The flask of cells was transferred to 13% oxygen chamber and 
left for 72 h and then trypsinized and were seeded in a 96-well plate. They were left 
in the 96-well plate for 24 h for the cells to adhere and after 24 h, were exposed to 





or CCMFBS2% alone (negative control) and incubated at hyperoxia or 
normoxia for 24 h. After the exposure period, the particle suspensions were aspirated 
and replaced by 200 µL fresh CCMFBS2%. 50 µL MTT (5 mg/mL) was then added to 
the wells and the plate was incubated for a further 4 h. The medium was then 
removed and the resulting intracellular formazan crystals were dissolved over 24 h in 
100 µL of 10% SDS prepared in 1:1 water:DMF, after which the absorbance from 
the solubilized formazan was measured spectrophotometrically (SpectraMax, UK) at 
an absorbance wavelength of 560nm. 
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The relative cell viability (% viability) was calculated as follows: 
 
               
   
    
     
Eq.: 5:3 
 
Where A is the absorbance obtained for each concentration of the test 
substance, S is the absorbance obtained for positive control (1% v/v Triton-X) and 
CM is the absorbance obtained for untreated cells (incubated with CCMFBS2% alone). 
The latter reading was defined as 100% cell viability.  
 
5.2.2.7 Data analysis 
A Student’s t-test and one-way ANOVA were used to perform the statistical 
analysis. All analyses were performed using GraphPad Prism statistical program 
(Version 4, GraphPad Software, USA). 
 
5.3 Results 
5.3.1 Test material characterization 
CuO nanoparticles could only be dispersed as large aggregates in deionized 
water and CCMFBS-, with both suspensions increasing steadily in agglomerate size 
over the 6 h measurement period (Figure 4-4A, 4-4B). Dispersion in CCMFBS2% 
showed an initial particle size of ~280 nm and remained stable in size over the same 
measurement period (Figure 4-4C). A look at the particle size distribution by 
intensity (Figure 5-1) shows that particle size remained stable with peak intensity of 
~242 nm. The zeta potential of CuO particles in media without serum 
supplementation was highly negative (-31±3 mV), which was reduced to only a 
moderately negative charge of -11±1 mV in the presence of 2% serum. 
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Figure 5-1: Particle size measurements CuO in CCMFBS2% over 6 h based on intensity 
distribution obtained from Zetasizer Nano. 
 
5.3.2 GSH levels in A549 cells cultured in 21% oxygen and 13% 
oxygen 
Intracellular GSH levels measured over 8 h in A549 cells cultured at 21% O2 
were on average 81% higher than those measured in cells cultured at 13% O2 (47 ± 2 
versus 26 ± 7 nmol GSH/mg protein, respectively; Figure 5-2).  
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Figure 5-2: Intracellular glutathione (GSH) levels in cells cultured under physiological versus 
standard atmospheric conditions, 13% and 21% oxygen (O2) concentration, respectively. GSH 
in cells cultured under 13% O2 for 0, 2 and 4 h (* P < 0.05 compared to 21% O2) was 
significantly lower compared to cells cultured at 21% O2. Data represent mean ± SEM, n = 4. 
 
The exposure of A549 cells cultured at 13% O2 to 100 μM DEM reduced 
GSH levels by approximately 30% during the first 2 h of exposure followed by a 
rebound phase during which GSH levels steadily increased to baseline concentration 
level (Figure 5-3a). In contrast, cells cultured at 21% O2 exhibited no change in GSH 







) resulted in a time-dependent decrease in GSH (26 ± 10 
nmol GSH/mg protein at t=0 h and 17 ± 3 nmol GSH/mg protein at t=8 h in cells 
cultured in 13% O2, but no change in cells cultured at 21% O2 (Figures 5-3a and 5-
3b). This dose was chosen because no reduction in GSH level was seen at 21% when 
cell were exposed to CuO NP in a dose-dependent manner. The reduction in GSH in 
cells exposed to CuO NP was dose-dependent in cells cultured in 13% O2 (Figure 5-




) in cells 
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Figure 5-3: Change in intracellular glutathione (GSH; nmol per mg protein) levels in A549 cells 
cultured under oxygen concentrations of 13% (left) and 21% (right) when challenged by (a & b) 




 data represent the mean ± SEM (n = 4 
with each experiment performed in duplicate). (c & d) Exposure to CuO nanoparticles at 0.002, 




 for 6 h; data represent the mean ± sd (n = 3). (* P < 0.05, ** P < 0.01, 
*** P < 0.001). 
 
5.3.3 Intracellular ROS formation in A549 cells cultured in 21% 
oxygen and 13% oxygen 
Intracellular ROS is reported as an area under the curve (AUC; % h) of 
increased ROS generation over 4 h (illustrated in Figure 5-4a and 5-4b; see appendix 
for full data set). Each experiment consisted of ROS quantification every 60 min 
(n=3) over 4 h at each H2O2 or CuO NP concentration and was performed in 
duplicate or triplicate. Thus the data illustrated in Figure 5-4a and 5-4b represent 30-
45 individual measurements and contributes to a single robust data point in the 
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analysis of ROS generation over time (% h) versus H2O2 or CuO NP concentration 
(μM or cm2/cm2) under physiological and atmospheric oxygen levels (Figure 5-4c 
and 5-4d). These results indicate that at low concentrations of H2O2 (2.5 µM) the  
 









Figure 5-4: Top panel: Representative figures to illustrate the effect of different culture 





. The data represent duplicate experiments of n = 3 and the shaded 
areas illustrate how the AUC values were determined for each plot. Bottom panel: The area 
under the response curve (AUC; % h) of four or five such plots (see appendix Figure S1 and 
S2) was used to generate each data point in the evaluation of the effect of atmospheric vs. 
physiological oxygen levels on ROS generation over time (% h) in response to (c) H2O2, 2.5 µM 






AUC of ROS production over 4 h in cells cultured under physiological O2 levels was 
32% greater compared to cells cultured in 21% O2 (185 ± 40 versus 138 ± 14 % h; 
Figure 5-4c). At higher concentrations of H2O2, cells cultured at both oxygen levels 
produced equivalent quantities of ROS over time. Although a strong positive dose 
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response was observed between 2.5 to 250 µM H2O2, no increase in ROS production 
was observed at concentrations above 250 µM in both culture conditions. As NP-
induced ROS generation is a significant driver of NP toxicity, we examined whether 
cells cultured under physiological oxygen levels would be more sensitive to ROS 
generated from CuO NP using a similar study design and data analysis to that 
described above. ROS elevation was measured at five CuO particle surface area 
doses (representative results in Figure 5-4b; full data in appendix) and the AUC (% 
h) was calculated to show the effect of ROS elevation over 4 h in cells cultured under 
atmospheric or physiological oxygen. The AUC of values of the cells cultured at 
13% were on average 19% lower at each concentration bar the lowest (Figure 5-4d). 
A review of the literature failed to find any studies reporting in vitro ROS production 
or nanotoxicity using cells cultured in physiological oxygen levels. 
A549 cells cultured under hyperoxic conditions show a reduced dose-
dependent sensitivity to nanoparticle-induced stress than those cultured under 
normoxia. 
The MTT assay was used to evaluate the effect of CuO NP on cell viability 
when cultured under different oxygen pressures (Figure 5-5). No significant 
difference was seen in the half-maximal effective concentration (EC50) of cells 
cultured at 13% oxygen compared to 21% oxygen after exposure to CuO particles for 


















Figure 5-5: The effect of CuO nanoparticles on the viability of A549 cells after 24 h exposure to 
different oxygen levels. Cellular metabolic activity was measured spectrophotometrically at 560 
nm and viability calculated as a percentage of the control (assay medium alone) over a particle 




. The data represent the mean ± SD of 
n = 3; each experiment performed in triplicate. 
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5.4 Discussion 
We demonstrated that when the human alveolar epithelial-derived A549 cell 
line is cultured under atmospheric oxygen (21%) oxidative stress responses of the 
cells to NP challenge are diminished. We showed that cells exhibiting this 
impairment have elevated GSH levels, which presumably act as a protective 
mechanism against copper oxide (CuO) NP-induced oxidative stress (Figure 5-2). 
A549 cells cultured at 13% oxygen (i.e., the physiological oxygen level reflecting an 
oxygen pressure comparable to that in the lung) possess lower GSH levels and are 
more responsive to NP challenge. 
The unique properties such as increased surface area, reactivity, solubility and 
oxidative potential conferred upon the materials at nanoscale which makes them 
interesting for consumer and health products also raises concern regarding their 
safety for human health and the environment (223, 231). Inhaled nanoparticles have 
been known to produce inflammation and have been linked with chronic effects such 
as lung fibrosis and cancer (232). Nanoparticles have also been linked with oxidative 
damage (DNA damage, mitochondria damage) due to production of oxidative stress 
(233). Nanoparticles can generate free radicals and these radicals upon interaction 
with cellular proteins and fatty acids can produce oxidative stress (94). The oxidative 
stress mechanism is probably the most well developed paradigm for explaining 
nanoparticle toxicity. A number of in vitro models have shown a clear link between 
nanoparticle exposure and the generation of oxidative stress (35-38, 42, 50, 54, 55, 
78, 161, 223, 234-237). 
Intracellular GSH levels measured over 8 h in A549 cells cultured at 21% O2 
were on average 81% higher than those measured in cells cultured at 13% O2 (47 ± 2 
versus 26 ± 7 nmol GSH/mg protein, respectively; Figure 5-2). In comparison, GSH 
values measured in lung biopsies of 24 healthy volunteers were found to be 11.2 ± 
0.6 nmol GSH/mg protein (238). Compared to this value, which may not be 
reflective of the alveolar environment, A549 cells cultured under atmospheric 
oxygen exhibited a 5-fold upregulation of baseline GSH synthesis which can be 
attributed to the higher oxygen pressure and other oxidative stress-inducing artefacts 
in vitro, e.g. cell culture medium can itself generate ROS upon exposure to high 
oxygen levels (239). This response was only partially attenuated under physiological 
culture conditions of 13% oxygen. 
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The proposed mechanism of adaptive upregulation of GSH in response to 
elevated oxygen pressure is outlined in Figure 5-6 below. GSH is synthesized from 
three amino acids: L-γ-glutamate, L-cysteine, and L-glycine. The availability of 
intracellular L-cysteine is low, therefore uptake into the cell is proposed to be the 
rate-limiting step for GSH synthesis (240). To be transported into the cell, 
extracellular L-cysteine undergoes auto-oxidation to the disulfide L-cystine, which is 
a substrate of the Na
+
-independent anionic amino acid transport system 
-
 xc-, which 
exchanges cystine for intracellular L-glutamate (35). Once in the cell, the disulfide 
form of L-cystine is reduced to L-cysteine, which becomes available for GSH 
synthesis or is transported out of the cell by neutral amino acid transporters. The 
cystine-cysteine exchange cycle operates continuously (241) with the availability of 
L-cystine providing the driving force. Increasing the concentration of extracellular 





Figure 5-6: Proposed mechanism for elevation of intracellular GSH concentration via 
alteration of environmental O2 concentration.  
 
The electrophile diethylmaleate (DEM) depletes GSH by direct interaction 
with reactive cysteine sulfhydryl groups to form a stable adduct (242). GSH 
depletion leads to activation of the redox sensitive transcription factor Nuclear 
Factor-E2-Related Factor 2 (Nrf2), which is thought to stimulate pathways resulting 
in an increased influx of cystine via the cystine-glutamate exchanger resulting in a 
compensatory stimulation of GSH synthesis (242). Under this mechanism, exposure 
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to DEM depletes GSH levels initially followed by a rebound phase of increased GSH 
synthesis. This is consistent with the temporal profile of intracellular GSH 
production reported by Sato and co-workers for pancreatic cell lines and islet cell 
lines after challenge with 100 µM DEM (243). They showed that GSH levels 
decreased initially, followed by a 2-fold increase above control level after 24 h. 
The exposure of A549 cells cultured at 13% O2 to 100 μM DEM reduced 
GSH levels by approximately 30% during the first 2 h of exposure followed by a 
rebound phase during which GSH levels steadily increased to baseline concentration 
level (Figure 5-3a). In contrast, cells cultured at 21% O2 exhibited no change in GSH 
levels in response to DEM (Figure 5-3b). The absence of any change of GSH in cells 
cultured under atmospheric conditions is in agreement with the work of Horton et al. 
(244) and Yang et al. (245) who reported no change in GSH level in A549 cells 
when they were challenged with 125 µM and 250 µM DEM. The mechanism 
underlying the lack of response to DEM in A549 cells cultured 21% O2 is not known, 
although we postulate that adaptive increases in GSH are masked by the high basal 
GSH levels measured at atmospheric oxygen levels. Thus, low concentrations of 
DEM do not deplete GSH levels sufficiently to activate Nrf2 leading to an 
upregulation of GSH synthesis.  
Our GSH measurements indicate that the cells cultured under the hyperoxic 
conditions adapt to oxidative stress via an increase in baseline GSH levels. These 
results are in agreement with the findings of Atkuri and co-workers (246), who 
investigated the effect of atmospheric oxygen level on the intracellular redox state in 
cultures of primary T cells. By measuring the GSH/GSSG ratio they concluded that 
culturing T cells under 21% O2 leads to the development of highly oxidative 
intracellular environment (intra-cellular nitric oxide and intra-cellular ROS were 1.5 
to 2 times higher (p<0.001)) in comparison to cells cultured under a physiological 
oxygen level of 5% O2. 
To investigate the differences in adaption to oxidative stress we measured the 
amount of reactive oxygen species (ROS) generated after the cells were challenged 
with hydrogen peroxide. Hydrogen peroxide is a known radical generator which 
causes the generation of oxidative stress. Dihydrorhodamine-123 is a redox sensitive 
dye which passively enters the living cells where it binds to the mitochondria upon 
oxidation to rhodamine-123 by ROS. Our results indicate that at low concentrations 
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of H2O2 (2.5 µM) the cells cultured under normoxia produce 30% more ROS as 
compared to cells cultured hyperoxia. To ensure that the fluorescence generated was 
from the ROS and DHR-123 interaction, we incubated the cells with radical 
scavenger PEG-catalse. Upon incubation with PEG-catalase the ROS levels stayed 
similar to the medium control (data not shown) in both the culture conditions. To 
ensure that this was not an artefact we performed live cell fluorescence studies using 
atmospheric controlled plate reader (BMG Labtech) so as not to compromise the 
normoxic state by exposing the plate to 21% atmospheric oxygen while reading the 
plate. 
As NP-induced ROS generation is a significant driver of NP toxicity, we 
examined whether cells cultured under physiological oxygen levels would be more 
sensitive to ROS generated from CuO NP using a similar study design and data 
analysis to that described above. ROS elevation was measured at five CuO particle 
surface area doses (representative results in Figure 5-4b; full data in the appendix) 
and the AUC (% h) was calculated to show the effect of ROS elevation over 4 h in 
cells cultured under atmospheric or physiological oxygen. The exposure of A549 
cells cultured at 21% O2 to copper oxide (CuO) nanoparticles (a nanomaterial known 
to induce cytotoxicity via oxidative stress pathways) showed decreased intracellular 
reactive oxygen species (ROS) levels compared to cells cultured at 13% O2 (Figure 
5-4d), supporting the hypothesis that key indicators of toxicity, such as ROS 
generation, may be suppressed in vitro by cellular adaption to culture conditions.  
Although no significant difference was seen in the half-maximal effective 
concentration (EC50) of cells cultured at 13% oxygen compared to 21% oxygen after 
exposure to CuO particles for 24 h. The EC50 value in 13% oxygen was 23% lower 








, P = 0.06). Interestingly, in 
a study by Kang and co-workers (247), much greater reduction in GSH (to 10% of 
control) was used to produce a 50% reduction in EC50 values using the MTT assay 
(untreated cells EC50=31 µM, DEM 500 µM treated cells EC50=15 µM) to measure 
the cytotoxic effect of Cd++ on A549 cells. It may be that cellular compensation 
mechanisms designed to withstand acute oxidative stress make the widely used MTT 
assay a low sensitivity end-point for nanotoxicology.  
Our findings that cells with elevated GSH levels are also less sensitive to 
GSH disrupting agents and are protected from oxidative stress are consistent with our 
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hypothesis that cells adapt to hyperoxic conditions (summarised in Figure 5-7) 
rendering them less sensitive to the NP toxicity endpoints advocated under the 




        
Figure 5-7: Summary of the effects of DEM, CuO nanoparticles and hydrogen peroxide on 
intracellular GSH and ROS levels adapted from Bannani et al. (241). Cells cultured under 
atmospheric oxygen concentrations adapt to hyperoxic conditions by generating higher 
intracellular GSH levels. Challenge with 100 µM DEM only affects cells cultured in 
physiological oxygen conditions under which the lower level of GSH undergoes a characteristic 
depletion followed by a rebound as the System Xc transporter mechanism is activated (Figure 
5-3a). GSH levels in unadapted cells were reduced by CuO nanoparticles in a time dependent 
(Figure 5-3a) and dose dependent (Figure 5-3c) manner. The adapted cells are not sensitive to 
DEM challenge (Figure 5-3b) and cellular GSH concentration was only reduced by the highest 
dose of CuO nanoparticles (Figure 5-3d). Challenge with hydrogen peroxide produced a dose 
response in intracellular ROS, with the effect of the adaptation to the oxidative environment 
only conferring protection against the lowest dose used (Figure 5-4c). Cellular ROS was 
elevated in non-adapted cells after exposure to copper NP across the entire dosage range, 
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5.5 Conclusion 
We have demonstrated that A549 cells cultured using an atmospheric oxygen 
concentration (21%) adapt to hyperoxia by producing higher levels of the antioxidant 
GSH. Cells featuring this adaptation were less susceptible to interference with their 
antioxidant balance by DEM or CuO NP. Furthermore, intracellular ROS generation 





was attenuated. This is consistent with the hypothesis that generation of intracellular 
ROS will be subject to altered sensitivity in cells cultured under different oxygen 
tension.  
Oxidative stress is proposed as an early indicator of nanotoxicity (tier 1 under 
the three tier model of Xiao et al. (38, 43, 58)). In contrast to the sensitivity of 
oxidative stress markers (ROS generation and GSH depletion) to oxygen potential, 
the MTT assay results indicated that despite the EC50 value of cells cultured at 13% 
oxygen being 23% lower that of cells cultured at 21% oxygen, cells cultured under 
physiological conditions were not significantly more sensitivity in terms of this tier 3 
toxicological endpoint. Further work will determine whether tier 2 markers (e.g. 
activation of inflammatory cytokines and chemokines) are affected by the cellular 
responses to hyperoxic culture that we report. A much bigger question is to what 
extent these findings can be generalised across different cell types and nanotoxicity 
endpoints. We raise important concerns regarding the impairment of oxidative stress 
responses in cells cultured at 21% oxygen. The data provided herein leads us to 
caution that cells used under standard protocols for nanotoxicology screening may be 
limited in their ability to report biological mechanisms related to oxidative stress. 
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Chapter 6                                      
Discussion 
6.1 Current state of nanotoxicology 
In 2004, the Royal Society and the Royal Academy of Engineering published 
a key review of the opportunities and uncertainties associated with nanotechnology 
applications, which was a key report highlighting the potential environmental and 
human health risk issues of NPs (3). Since then, more than 50 reviews carried out by 
governmental and international organizations, industry associations and research 
institutes have considered NP risk issues, concluding that multiple deficiencies of 
toxicity and exposure data make it impossible to perform sound risk assessment of 
NPs (248). 
A recent review by Hristozov et al. (249) of available data discussed the state 
of the art in the area of NP risk assessment. The authors surveyed 42 environmental, 
health and safety databases including NAPIRhub, Hazardous Substances Data Bank, 
Chemical Safety Data Searcher etc. for seven engineered NP including: carbon 
nanotubes (CNTs), C60 fullerene, titanium dioxide (TiO2), silver (Ag), zinc oxide 
(ZnO), iron (III) oxide (Fe2O3) and silica (SiO2) NP. All the records were counted 
and categorised into: (1) manufacture, use and disposal; (2) physical and chemical 
properties; (3) environmental fate and pathways; (4) ecotoxicological information; 
(5) toxicological information; and (6) guidance on safe use. The authors found that 
majority of information obtained concerned TiO2, followed by ZnO and Fe2O3 and 
most of them were situated in toxicological information category. The authors found 
that for TiO2 of the 302 data records in toxicological information (Figure 6-1 top 
panel) section only 99 records (33%) were usable and out of 44 data records in 
physical and chemical category only 5 records (12%) were usable (Figure 6-1 bottom 
panel).  
This search was not exhaustive as data in scientific literature including 
journal articles, books, conference proceedings and reports were not included due to 
large number of publications. A search with the key string ((nanoparticle OR 
nanomaterial OR nano) AND (toxicity OR ecotoxicity OR exposure OR health effect 
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OR medicine OR drug)) in the ‘topic’ section of ISI Web of Knowledge article 
database on 28 June 2012 returned 51,861 articles (approximately). A further 



























Figure 6-1: Distribution of total data records (top panel) and usable data (bottom panel) records 
for six different NPs in all the databases; titanium dioxide (dark blue), silver (red), zinc oxide 
(green), iron(III) oxide (purple), carbon nanotubes(light blue), C60 fullerene (orange) (adapted 
from Hristozov et al. (249)). 
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Year of publication 
((nanoparticle OR nanomaterial OR nano) AND (toxicity OR ecotoxicity OR 
exposure OR health effect OR medicine OR drug) AND (lung OR airway OR 
respiratory OR pulmonary)) in the ‘topic’ section of ISI Web of Knowledge article 
database on 28 June 2012 returned 2,366 articles. A look at the distribution of these 
published articles published every year from 2000 till 2011 indicates an increasing 













Figure 6-2: Distribution of number of publications per year published between the years 2000 
till 2011. Search was made on ISI Web of Knowledge database on 28 June 2012. The following 
search string was used within the ‘topic’ field of the database search engine: ((nanoparticle OR 
nanomaterial OR nano) AND (toxicity OR ecotoxicity OR exposure OR health effect OR 
medicine OR drug) AND (lung OR airway OR respiratory OR pulmonary)). 
 
Figure 6-2 shows a snapshot of the current state of research and assuming that 
the distribution of usable data across scientific literature amongst various categories 
may be similar to the data set reviewed by Hristozov et al. (249) then the opportunity 
to utilize the nanotechnology sector to its fullest would be difficult.  
 
6.2 Redefining nanotoxicity research protocols 
The body of literature (42, 77, 80, 85, 86, 161, 236, 250) confirms the 
essential role which NP characterization plays in identifying the key physico-
chemical characteristics of NP with regard to assessing the potential toxicity of NP in 
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biological systems. It is important to characterize the test material as thoroughly as 
possible, especially in biologically relevant systems, to ensure the results are 
reproducible and also to provide the basis for understanding the properties of NP that 
determine their biological effects. With respect to particle characterization in 
biologically relevant media it has been demonstrated how serum (177, 218) 
(commonly used supplement in cell culture medium) often affects the dispersion 
(aggregation/agglomeration) profile of NP in suspension. Further it has been shown 
how the adsorption of cell culture medium components on the surface of NP affects 
the cellular impact of NP (251, 252), usually providing the cells with some protection 
from the cytotoxic effect of NPs. Another discrepancy highlighted when reviewing 
the literature is the usage of high dosage/concentrations and the dose metrics used for 
expressing the concentration of particles exposed to cells or animals. For example, a 
study by Yokohira et al. (253) tested the carcinogenicity of TiO2 (80 nm) by 
instilling 0.5 mg/rat lung of NP in F344 male rats and upon hisopathological 
examination concluded that there were no lung lesions i.e. theTiO2 NPs were non-
carcinogenic. However, in another study by Roller et a.l (254) TiO2 (25 nm) were 
instilled in rats at 15, 30 and 60 mg/rat lung dose and the authors found that the TiO2 
NPs clearly showed carcinogenicity. There is a basic error in both these studies and 
that is their use of dose metrics. A study by Bellmann et al. (255) identified that 
particle overload occurred at a lung burden of 3 mg/rat lung (material: test toner) as 
identified by number of PMNs in BALF and the clearance of gamma labelled tracer 
particles. In contrast, at a lung burden of 0.4 mg/rat lung the alveolar clearance rate 
was not significantly impaired. In light of this information the first study by 
Yokohira et al. uses a very low dose whereas the study by Roller et al. uses an 
extremely high dose. Another example cited by Oberdorester et al. (161) points to 
the high-bolus type dose used in in vivo studies which can be misinterpreted by the 
popular non-scientific press. The case in point is a study by Wang et al. (256) who 
instilled 7.5 mg nano-TiO2 intranasally in mice which resulted in significant 
oxidative stress and inflammation in the brain. However, Oberdörster points out that 
the dose in this case was the equivalent of intranasally instilling ∼17.5 g of the 
material into a human subject.  
It is not only in vivo studies which get the dosage wrong, but also in vitro 
studies. A study by Long et al. (257) demonstrated oxidative stress induction by 
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microglia cells caused by doses of well characterized nano TiO2 at 25 μg/ml and 
higher. It has been argued that ‘whilst this result represents an interesting hypothesis 
forming finding, an extrapolation to real-world exposure scenarios is not possible 
given that the dose administered to the microglia cells was already greater than will 
be received by alveolar macrophages in the lung following 24 h of inhalation at a 
high concentration of 1 mg m
−3 
(258). Considering that only 1% or 2% of the NPs 
deposited in the lung may translocate to the blood circulation, and of that none or 
<1%, may translocate to the CNS (24), the relevancy of results from unrealistic high 
in vitro doses for real-world in vivo conditions should be seriously questioned.  
Apart from dosage/concentration issues, the debate regarding the units used 
(surface area, mass, number of NP) has been discussed previously in Chapter 1 and 
Chapter 3. There is a growing understanding of NP behaviour in suspension and it is 
not only low density drug delivery NPs for which the delivered dose in vitro is a 
concern but also high density particles like gold NP as demonstrated by Cho et al. 
(179). Even after using well characterized NPs, a biologically relevant dose metric 
and considering particokinetics in vitro, it may be possible to make methodological 
errors thus leading to misinterpretation of results. In developing a cell-based safety 
screening programme it is generally recommended that more than one cell type is 
utilised in conjunction with standardised assays that are sensitive, predictive and 
robust (259). However, the literature indicates that NP toxicity studies are often 
performed and reported using single cell line.  
The issue of choosing the correct controls can also be problematic. For 
example, it has been discovered that some particles display a high intracellular 
dissolution rate (example: zinc oxide). Often the toxicity associated with these NP is 
due to the dissolution of ions either in the cell or in suspension (260). Therefore, it is 
important in such cases to use Zn ions (such as ZnCl2) as a control to truly 
understand the mechanisms of toxicity.  
Apart from the lack of controls, a common methodological error has been to 
culture cells under atmospheric oxygen condition. One of the proposed paradigms for 
nanotoxicity is the generation of oxidative stress (35-38, 42, 50, 54, 55, 78, 161, 223, 
234-236). What has been overlooked, however, is the fact that standard cell culture 
practices use atmospheric oxygen (i.e. 150 mm Hg, ~21%, O2) which in itself 
constitutes a hyperoxic environment. With the exception of the cornea, epidermis and 
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respiratory tract epithelial layer, cells in vivo typically experience 1-10 mmHg 
oxygen pressure (equating to ~ 1-5% O2). In the respiratory tract, small airway 
epithelial cells and alveolar cells experience approximately 100 mm Hg oxygen (~ 
13% O2) (92). Despite this, most mammalian cells are cultured using 21% O2 which 
exposes them to elevated levels of ROS (93, 94). 
In the present work the shortcomings discussed above in the in vitro 
nanotoxicity methods were addressed by trying to develop, standardize and validate 
in vitro cytotoxicity tests so that the methods are more robust, reliable and 
reproducible. In Chapter 2 a novel primary cell culture method was developed to 
harvest primary human nasal epithelial cell in a pain free way. The method is non-
invasive, self administered and permits repeated isolation from the same source. The 
cell viability of the lavaged cells was approximately 50% and more than 90% of the 
cells were epithelial in nature. In the freshly lavaged cells sometimes ciliated cells 
(with live beating cilia) could also be seen under the microscope. Although the cells 
were healthy and viable, they did not proliferate and were thus not well suited for NP 
toxicity screening. However, this method has other possible advantages, as it could 
be beneficial in performing geno-toxicity studies across higher numbers of 
volunteers. For example, it is envisioned that one could fill a 96-well plate with 
samples from a diverse range of subjects, including diseased and non-diseased 
groups.  
As demonstrated in Chapter 3, the choice of dose metric is very important in 
cytotoxicity studies as particle behaviour in suspension is very different to behaviour 
of soluble chemicals. An Excel
®
-based particokinetics program (EXCEL) was 
written to model the movement of particles in suspension due to gravitation and 
diffusion. The model results of calculated delivered dose values were compared to 
experimental uptake data from Khanbeigi et al. (169) and as well as delivered dose 
values generated by the ISDD program developed by Hindergarten et al. (89). 
EXCEL results showed a reasonable correlation with both the experimental data and 
ISDD values over a wide variety of particle sizes and exposure times. The EXCEL 
program differs from ISDD in the aspect that it may double count some particles, 
dependent upon particle size and density, leading to a slightly over-estimated 
delivered dose value. On the other hand, the program’s flexibility allows it to 
compute the delivered dose from a particle size distribution curve (instead of a 
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simple mean particle size value) thus allowing it to take into consideration non-
agglomerated particle size polydispersity. The results in Chapter 3 led to the 
conclusion that in vitro particle-cell interaction data should be reported in terms of 
the delivered dose metric as opposed to the commonly used administered dose. This 
would help us in making valid comparisons of NP toxicity across different 
nanoparticle sizes and material types.  
It is increasingly recignised that NP characterization plays an essential role in 
identifying the key physico-chemical characteristics of NP with regard to assessing 
the potential toxicity of NP in biological systems. In Chapter 4, NPs were 
characterized in terms of size and zeta potential in both water and more importantly 
in a biologically relevant medium. It was found that NPs remained stable in serum-
supplemented cell culture medium compared to aggregation in serum depleted 
medium and water. Thus it is important to report physicochemical properties of 
nanoparticles such as size as they would manifest the experiment. Further, an 
ascorbic acid depletion assay was used to determine the ex vivo oxidative potential of 
NPs. It was found that CuO NP had the highest oxidative potential and this correlated 
well with CuO showing the highest cytotoxicity in two cell lines compared to all the 
other particles tested. The cytotoxcity data was normalised to delivered dose values 
using the EXCEL program developed in Chapter 3 and the differences in EC50 values 
for cell viability (comparison administered vs. delivered dose) showed that there was 
one order of magnitude difference for the LNC particles. The differences in nominal 
and delivered dose EC50 values for LNC 50 and LNC 150 demonstrated that 
normalization of in vitro results to administered dose values may lead to reporting of 
effective toxic or minimum active doses that are artificially higher than they should 
be in safety studies. This study thus ilustrated how using particokinetic modeling in 
designing in vitro cell-based assays can lead to more accurately assess most of dose-
response effects of nanoparticle systems.  
In Chapter 5, the commonly overlooked flaw of using atmospheric oxygen 
(i.e. 150 mm Hg, ~21%, O2) to culture cells, was explored. Since generation of 
oxidative stress due to NP-cell interactions has been highlighted as an important 
paradigm for certain types of NP toxicity, the oxidative environment generated by 
atmospheric culture conditions may induce a protective response mechanism in 
cultured cells, rendering them less sensitive to nanoparticle-induced oxidative stress. 
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In Chapter 5 we tested this hypothesis and showed that (i) the culture of respiratory 
epithelial cells in a hyperoxic environment produces an adaptation in terms of 
increased GSH levels, (ii) the adapted cells were less sensitive in terms of 
nanotoxicity assay end-points, particularly ROS production and altered GSH 
synthesis interference. This work may explain, in part, why in vitro-in vivo 
correlation is often poor and raises questions regarding the physiological relevance of 
studies conducted with epithelial cells cultured under hyperoxic conditions. We 
conclude that the adaptation demonstrated herein by cells cultured in 21% O2 renders 
these assay systems inappropriate for studies where sensitivity to oxidative stress is 
necessary and question whether this may be the case for the majority of in vitro 
nanotoxicity assay systems. 
 
6.3 Future work 
Approximately €10 billion are spent on animal experimentation worldwide 
every year, out of which ~€2 billion is for toxicological studies. Given that more than 
100 million experimental animals are used and that products worth €5.6 trillion are 
regulated by such testing (69), the usage of in vitro assays becomes more and more 
important. In a Nature review article, Thomas Hartung proposed that the crux of the 
matter is the predictive power, reliability and usefulness of these model systems (69). 
The aim of this work was to address some shortcomings in the current practice of in 
vitro NP toxicity testing. However, more work remains to be done in end of these 
study areas to make the current in vitro tests reliable.  
To culture the primary human nasal epithelial cells successfully, further 
modifications need to be made to the culturing techniqueand further characterisation 
is required. For example, culturing cells in bronchial epithelial growth medium 
(BEGM – Lonza, UK) supplemented with BEGM SingleQuot Kit Supplement & 
Growth Factors (Lonz, UK) including insulin, hydrocortisone, transferrin, 
choleratoxin, T3, EGF and retinoic acid, may be one method to improve conditions 
such that growth, expansion, and viability of the primary human nasal epithelial cells 
is achieved (145, 261). Further, the nasal cells still require characterisation, for 
example with antibody staining of cytokeratins 4, 5, 6, 8, 10, 13 and 18, as well as 
epithelial cell specific markers.  
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The particokinetic model reported in Chapter 3 can be further improved by 
taking into account the cumulative cell surface residence time. It could also be 
possible to modify the ISDD program so that it takes into account a non-aggregated, 
but polydisperse particle sample. Currently such analysis has to be performed 
manually using ISDD, whereas in the EXCEL program this process has been 
automated. In Chapter 4 it could be seen that the application of the particokinetic 
model to normalise the results to delivered dose values allowed for a highly robust 
comparison of nanoparticles of different properties. To expand upon this, particle 
characterization in RTLF could be performed using the technique developed by 
Braeckmans et al. (222) fluorescence single particle tracking coupled with maximum 
entropy doconvolution method. It would be highly interesting to compare the 
properties of the particles in cell culture medium and RTLF. Further it has been 
shown that protein corona formed around the particle influences the particle-cell 
interaction (262, 263) so it would be interesting to investigate which nanoparticle 
physicochemical characteristics, especially size and surface chemistry, will dictate 
the type and amount of protein and phospholipid adsorption to the particle surface 
(i.e. the macromolecule corona). This in turn will influence the particokinetics and 
toxicity profile of the particles in the nose and lung. Further, a comparison of the 
different proteins adsorbed onto the particles suspended in cell culture medium could 
be made to the ones adsorbed onto the particle suspended in RTLF. These studies 
would significantly advance our understanding of particle interactions at the air-lung 
interface, informing our understanding of bio-persistence and potential toxicity. 
Furthermore, such studies would generate insightful information which may help to 
guide the design of safer engineered particles for such purposes as inhalation drug 
delivery.  
In terms of toxicity testing it would be helpful to perform cytotoxicity testing 
using live-dead cell staining, GSH depletion, intra-cellular ROS generation and 
cytokine release. This might help in comparing particokinetics-normalised results to 
in vivo studies where PMN recruitment and inflammatory cytokine released are 
usually reported in BAL samples. 
In Chapter 5 we demonstrated that standardised cell culture conditions are 
inappropriate for assessing toxicity arising from oxidative stress, because culturing 
cells at atmospheric oxygen pressure (150 mm Hg or ~21% O2) results in phenotypic 
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adaptations to the hyperoxic environment that mask toxicity. These observations 
have significant repercussions in predictive toxicology, not only for novel engineered 
and environmental nanoparticles, but also in non-particulate drug safety testing. 
However, further work is required to elaborate fully the nature of the cellular 
adaption occurring under atmospheric oxygen tension and the extent to which this 
desensitises cell models to the induction of inflammation and cell injury/death. To do 
this we propose to investigate (1) the pathways upregulating intracellular GSH in 
response to hyperoxia, e.g. increased cystiene import versus de novo synthesis and 
(2) how cellular adaptation to hyperoxia influences the regulation of chemical- and 
particle-induced inflammatory pathways and cytotoxicity (apoptosis and necrosis). 
To address the transition from protective adaptation to inflammation and ultimately 
cell death, we will examine the expression of a panel of genes under the regulation of 
Nrf2 (including glutamate cysteine ligase), AP1, NFκB and p53, parallel to 
transcription factor binding assays in detailed dose response experiments. Further we 
could include chemicals (TCDD (2,3,7,8-tetra-chlorodibenzo-p-dioxin) an 
arylhydrocarbon receptor agonist) and particles (TiO2 NP) which are known not to 
cause oxidative stress and compare it to the results obtained from challenges of 
H2O2, DEM and CuO NP and this will help to determine the extent to which cell 
adaptations to culture conditions attenuate or mediate the response of the cells to a 
chemical or particle challenge. Preparation of a comprehensive database of in vivo 
respiratory toxicity measurements (including biochemical readouts, inflammation 
and tissue histology) compiled from the literature for the relevant panel of toxicants 
over an equivalent dose range, would allow data to be compared with results 
generated as discribed above to assess whether dose-response effects in cells cultured 
at physiological oxygen tension correlate better with dose-responses measured in 
vivo than data produced in cells cultured at atmospheric oxygen tension. Such a study 
could be extended to examine the behaviour of primary airway epithelial cells in the 
different oxygen environment and use some of the advanced in vitro cultures such as 
biculture systems (264-266) or a triple co-culture system consisting of epithelial 
cells, human monocyte-derived macrophages and dendritic cells simulating the 
epithelail airways (267, 268). Further, the application of IVIVC (in vitro-in vivo 
correlation) analysis to the entire hierarchy of responses to toxicity (i.e. cellular 
adaption, inflammation, cell injury and cell death) will also make it possible to 
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distinguish between cellular responses that are influenced to a greater or lesser extent 
by the incubator oxygen tension.  
In vitro assays based on cell cultures are widely used, but their 
implementation is limited by poor predictive capacity, especially for particle testing. 
In response, the National Academy of Science, Toxicity Testing in the 21
st
 Century 
(81) has set forth a vision of the paradigm shift needed in toxicity screening of 
nanoparticles. This vision rests on a comprehensive suite of in vitro assays in human 
cells and cell lines enabling identification of perturbations of toxicity pathways. The 
reliance on toxicity pathway perturbations as the basis for human health risk 
assessment will require sufficient understanding of such pathways to permit the shift 
away from animals to occur with confidence (43). To achieve this, we must address 
one of the major shortcomings of in vitro cell models, which is the inconsistency in 
transcriptional regulation of toxicity pathways in vitro as compared to that which 
occurs in vivo. These differences result from the difference in microenvironment, 
lack of multicellular interactions and inadequate or inappropriate metabolism. The 
toxicokinetic work presented here provides solutions to some of these critical 
limitations and may provide important stepping stones towards a breakthrough in the 
acceptance of in vitro testing methods and the replacement of animal models in 
toxicity screening. 
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Intracellular ROS reflect differences in protective GSH levels 
Intracellular ROS levels were measured using dihydrorhodamine-123 (DHR-
123, non-fluorescent), a redox sensitive dye which passively enters living cells where 
it binds to the mitochondria upon oxidation by ROS to the fluorescent, rhodamine-
123 (R-123).  R-123 fluorescence was measured in live cells using an atmospheric 
controlled plate reader (BMG Labtech) so as not to alter oxygen levels while reading 
the plate.   
Each experiment consisted of 4 measurements over 4 h at each H2O2 and 
nanoparticle concentration and was performed in triplicate on two occasions and 
these data (Figure S1 a - d and Figure S2 a-e) were used to generate an area under the 
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Figure S 1: Representative figures to illustrate the effect of different culture conditions on ROS 
generation in A549 cells after 1-4 h exposure to hydrogen peroxide (a) 2.5, (b) 25, (c) 250 and (d) 
500 µM. The data represent duplicate experiments of n=3 and the area under the response curve 
of these plots was used to generate each data point in the evaluation of the effect of atmospheric 
vs. physiological oxygen levels on ROS generation in A549 (AUC % h; increase compared to 
control) 1-4 h exposure H2O2, 2.5 to 500 µM  (Figure 3c). The fluorescence was measured at an 
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Figure S 2: Representative figures to illustrate the effect of different culture conditions on 
ROS generation in A549 cells after 1-4 h exposure to CuO nanoparticles (a) 0.0002, (b) 




. The data represent duplicate experiments of n=3 
and the area under the response curve of these plots was used to generate each data point 
in the evaluation of the effect of atmospheric vs. physiological oxygen levels on ROS 
generation in A549 (AUC % h; increase compared to control) 1-4 h exposure CuO 




 (figure 3d). The fluorescence was measured at an Ex of 
490 nm and Em of 530 nm in an atmosphere-controlled plate reader. 
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